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 II  
Abstract 
 
Box C/D small nucleolar ribonucleic protein complexes (snoRNPs) either direct 2’-O-
methylation of the pre-ribosomal RNA (pre-rRNA) or function as chaperones in pre-
rRNA processing. It has been demonstrated that box C/D snoRNP biogenesis is a highly 
intricate and co-ordinated process that is mediated by a large, dynamic complex, known 
as the pre-snoRNP. This complex contains the box C/D snoRNA and a number of 
common core proteins, which become stably associated with the snoRNA, as well as 
factors linked to assembly, 3’ RNA processing and transport. Interestingly, the product 
of the gene linked to the neurodegenerative disorder spinal muscular atrophy, the 
survival of motor neurons protein (SMN), interacts with the box C/D snoRNP common 
core protein fibrillarin and is vital for the cellular localisation of both fibrillarin and box 
C/D snoRNA. The SMN protein operates with Gemins2-8 and UNRIP in what is termed 
the SMN complex, which has known functions in the assembly of the spliceosomal 
small nuclear RNPs (snRNPs). As the SMN protein interacts with fibrillarin and is also 
required for the cellular localisation of both fibrillarin and box C/D snoRNA this study 
set out to investigate the association of fibrillarin with the box C/D snoRNPs and the 
role of the SMN complex in this process.  
 
In this study it was revealed that the C terminal domain of fibrillarin is essential for 
cellular localisation and interactions with the box C/D snoRNP assembly factors, which 
suggests that this domain may mediate fibrillarin association with the box C/D 
snoRNPs. Also in this study the SMN protein was shown to interact with the box C/D 
snoRNP assembly factors NUFIP and BCD1, which are stable components of the pre-
snoRNP. Analysis of the interaction of SMN with the pre-snoRNP, however, indicates 
that if SMN does associate with the pre-snoRNP then it is only a transient interaction. 
Further analysis revealed that as well as the SMN protein, Gemin2, 5, 6 and 7 are 
essential for the localisation of box C/D snoRNA and that Gemin5 is also required for 
the accumulation of box C/D snoRNA. This study strengthens the case that the SMN 
complex is involved in box C/D snoRNP biogenesis, with the data suggesting that it 
functions as a transport factor rather than in the association of fibrillarin with the box 
C/D snoRNPs. Analysis of the snRNP transport factor, snurportin1, revealed that it also 
interacts with numerous components of the pre-snoRNP; however, does not interact 
with SMN.  
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Chapter one 
 
 
 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 2 
1.1 . Non-coding RNAs (ncRNAs) 
 
Non-coding RNAs (ribonucleic acids) are functional RNAs that are not translated into 
proteins. The ncRNAs operate through base pairing to target sequences and have roles 
in a variety of cellular processes ranging from protein translation, pre-mRNA splicing, 
gene regulation and maintenance of chromosome structure. 
 
A variety of ncRNAs are involved in protein translation and these include the ribosome, 
transfer RNAs (tRNAs), the signal recognition particle (SRP) and the small nucleolar 
RNAs (snoRNAs). The factory of protein translation is the ribosome, which catalyses 
the translation of nucleotide sequences into protein molecules. The eukaryotic ribosome 
consists of four ncRNAs known as ribosomal RNAs (rRNAs). The tRNAs function with 
the ribosome as adapters between amino acids and the messenger RNAs (mRNAs). The 
signal recognition particle (SRP), which contains an ncRNA component known as 7SL, 
is involved in the transportation of specific nascent proteins to the endoplasmic 
reticulum for modification. Another example of ncRNAs required for protein translation 
are the box C/D and H/ACA snoRNAs that function in the chemical modification and 
maturation of rRNA, which is required for the production of a functional ribosome.  
 
In eukaryotes pre-mRNA splicing is performed by the spliceosome, which consists of 
ncRNAs known as small nuclear RNAs (snRNAs). The biogenesis of the snRNAs 
requires another type of ncRNA known as the small Cajal body-specific RNAs 
(scaRNAs) that function in the chemical modification of snRNA sequences.  
 
The ncRNAs also have roles in gene regulation and maintenance of chromosome 
structure. Examples of ncRNAs that function in gene regulation are the micro RNAs 
(miRNAs) and the small interfering RNAs (siRNAs). These ncRNAs bind target mRNA 
sequences and prevent translation either through degradation of mRNA or blocking 
translation (Lui et al, 2005; Sen et al, 2005). It has been predicted that up to one third of 
all human protein synthesis is under miRNA control (Bentwich et al, 2005; Berezikov et 
al, 2005). Examples of ncRNAs that function in the maintenance of chromosome 
structure are the telomerase complex and Xist (X-inactive-specific transcript). The 
enzyme telomerase, which is responsible for telomere maintenance, contains an ncRNA 
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that functions as a template for elongating telomeres. The Xist ncRNA has roles in X 
chromosome inactivation through the recruitment of histone-modifiying enzymes.  
 
A lot of the ncRNAs discussed associate with proteins in what are termed ribonucleic 
protein complexes (RNPs). The ncRNAs and RNPs have been linked to a variety of 
human diseases, for instance the miRNAs and telomerase have been implicated in 
cancer and cardiovascular disease (Oulton and Harrington, 2000; Lu et al, 2005). The 
mutation of the U50 box C/D snoRNA has been linked to prostate cancer (Dong et al, 
2008) while the snRNAs and spliceosome have been implicated in retinitis pigmentosa 
and spinal muscular atrophy (SMA; Vithana et al, 2001; Winkler et al 2005; Shpargel 
and Matera, 2005; Zhang et al, 2008). Furthermore, Diamond-Blackfan anemia (Flygare 
and Karlsson, 2006), Treacher Collins syndrome (Trainor et al, 2009) and a range of 
cancers (Dai and Lu, 2008) have been linked to ribosome biogenesis.  
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1.2. Small nucleolar ribonucleic protein complexes (snoRNPs) 
 
The small nucleolar ribonucleic protein complexes (snoRNPs) function in the chemical 
modification of rRNA during ribosome biogenesis. These complexes consist of 
snoRNA and a number of common core proteins. In higher eukaryotes there are over 
150 snoRNPs categorised into two main classes based on their function and structure: 
the box C/D and box H/ACA snoRNPs. It is, however, worthy of note that a few 
snoRNPs function as chaperones in precursor rRNA (pre-rRNA) processing (Omer et 
al, 2000).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: The chemical modification of rRNA by the box C/D and H/ACA 
snoRNPs 
The top panel shows the conversion of uridine to pseudouridine performed by the box 
H/ACA snoRNPs. The bottom panel shows the 2’-O-methylation of the ribose sugar 
backbone of rRNA performed by the box C/D snoRNPs. Blue circles represent nitrogen 
while red circles correspond to oxygen. Black lines indicate carbon and covalent bonds.  
 
 
Both box C/D and H/ACA snoRNPs have been identified in a range of eukaryotes from 
metazoans to plants, yeast, and kinteoplastid protozoans. Interestingly, homologues of 
snoRNPs have also been found in archaeal, indicating that the snoRNPs are of an 
ancient origin 
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1.2.1. Box C/D snoRNPs 
 
The eukaryotic box C/D snoRNPs direct the 2’-O-methylation of target rRNA residues 
and consist of box C/D snoRNA and the common core proteins: fibrillarin, NOP56, 
NOP58 and 15.5K (Tyc and Steitz, 1989; Lyman et al, 1999; Lafontaine & Tollervey, 
1999, 2000; Newman et al, 2000; Watkins et al, 2000; Figure 1.2 and Table 1.1).  
 
The box C/D snoRNAs are characterised by the conserved C box (RUGAUGA, where 
R is purine) and D box (CUGA), which are located near the 5’ and 3’ end of the 
snoRNA, respectively (Figure 1.2). In most human box C/D snoRNAs the C and D 
boxes are brought together through base pairing of the terminal 5’ and 3’ nucleotides to 
form a terminal stem loop structure. Many yeast (and some human) box C/D snoRNAs, 
however, lack a terminal stem loop and the C/D box is formed through transient 
external or stable internal base-pairing (Darzacq and Kiss, 2000). The majority of box 
C/D snoRNPs also contain another set of less conserved motifs, the C’ and D’ boxes, 
located in the central region of the snoRNA (Kiss-Laszlo et al, 1998). The box C/D 
snoRNAs contain a guide sequence located adjacent to the D and / or D’ box which 
binds target rRNA sequences. Once bound to the snoRNA, the rRNA nucleotide base-
paired five nucleotides upstream of the conserved CUGA motif is methylated (Kiss-
Laszlo et al, 1996; 1998; Figure 1.2).  
 
Fibrillarin is the methyltransferase component of the box C/D snoRNPs and transfers a 
methyl group from the co-factor S-adenosyl-L-methionine (AdoMet) to the donor site 
located on the ribose sugar of the target rRNA residue (Tollervey et al, 1993; Figure 
1.1). The related common core proteins NOP56 and NOP58 have 45% sequence 
identity and belong to a family of proteins, which includes the U4 small nuclear RNP 
(snRNP) core protein hPRP31, that contain a conserved NOP domain proposed to 
function in RNP association (Gautier et al, 1997). Both NOP56 and NOP58 are essential 
for ribosome biogenesis; however, their exact function is not clear (Gautier et al, 1997). 
The 15.5K common core protein belongs to the L7Ae protein family that share a 
homologous RNA binding domain, which includes the box H/ACA snoRNP core 
protein NHP2 (Watkins et al, 1998) and a number of ribosomal proteins (Koonin et al, 
1994). The association of 15.5K to the box C/D snoRNA is essential for the binding of 
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the other common core proteins and it has been proposed that the binding of 15.5K 
results in a conformational change in the snoRNA providing additional binding sites 
(Watkins et al, 2002).  
 
Much of the box C/D snoRNP structural data has been produced in studies of archaeal 
box C/D snoRNPs, which contain homologues of fibrillarin, 15.5K (L7Ae in archaea) 
and a single homologue of NOP56 and NOP58 known as Nop5 (Table 1.1). 
Interestingly, L7Ae is also a core protein of the archaeal box H/ACA snoRNPs and a 
ribosomal protein (Khun et al, 2002). Analysis of the archaea proteins suggest that the 
box C/D snoRNPs adopt a symmetrical structure with a copy of fibrillarin, Nop5 and 
L7Ae located at both the C/D and C’/D’ box (Aittaleb et al, 2003; Rashid et al, 2003; 
Tran et al, 2003; Figure 1.2 A). This model was indicated, in part, by the crystallisation 
of a tetrameric complex consisting of archaeal Nop5 and fibrillarin. In this complex two 
dimers of fibrillarin and Nop5 associate with one another though the coiled-coil 
domains of Nop5 (Aittaleb et al, 2003). This model provides a mechanism by which 
fibrillarin can associate at both catalytic sites of the snoRNP and direct two independent 
modifications (Figure 1.2 A). Interestingly, the coiled-coil domains of Nop5 are not 
required for the assembly of the archaeal box C/D snoRNP; however, these domains are 
essential for the function of the complex (Zhang et al, 2006). This indicates that the self-
dimerisation of Nop5p within the box C/D snoRNP may be important for structure 
positioning fibrillarin.    
 
Humans Yeast Archaea 
   
fibrillarin Nop1p fibrillarin 
   
NOP56 Nop56p  
  Nop5 
NOP58 Nop58p  
   
15.5K Snu13p L7Ae 
 
Table 1.1: The box C/D snoRNP common core proteins  
The table shows the box C/D snoRNP common core protein homologues from humans, 
yeast and archaea. Archaea contain a single homologue of the eukaryotic NOP56 and 
NOP58 proteins known as Nop5. 
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The eukaryotic box C/D snoRNPs are proposed to adopt a pseudo-symmetrical model 
similar to the archaeal box C/D snoRNPs. The in vitro construction of the Xenopus U25 
box C/D snoRNP, followed by UV cross-linking, indicates that 15.5K and NOP58 
associate with the C/D box while NOP56 binds the C’/D’ box (Figure 1.2 B; Cahill et 
al, 2002). As with the archaeal box C/D snoRNPs, fibrillarin was shown to associate 
with the Xenopus U25 box C/D snoRNP at both the C/D and C’/D’ boxes, indicating 
two copies of fibrillarin are present (Figure 1.2 B). The positioning of fibrillarin at both 
the C/D and C’/D’ boxes is also in agreement with functional data that some box C/D 
snoRNPs can perform two independent rRNA modifications (Kiss-Laszlo et al, 1998; 
Figure 1.2 B). 
 
A      B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: The box C/D snoRNP 
Schematic diagram of the structure of (A) an archaeal (B) an eukaryotic box C/D 
snoRNP. The grey line represents the box C/D snoRNA with the conserved sequences 
shown in white on black boxes. The thicker grey lines represent the guide region. Red 
lines represent the pre-rRNA with the methylation site indicated by a sphere. The core 
proteins are shown as grey ovals behind the snoRNA. Image provided by N.J.Watkins, 
Newcastle University, UK.  
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1.2.2. Box H/ACA snoRNPs 
 
The eukaryotic box H/ACA snoRNPs direct pseudouridylation of target rRNA residues 
(Figure 1.1) and consist of snoRNA and the common core proteins: NHP2, NOP10, 
GAR1 and dyskerin (Watkins et al, 1998; Henras et al, 1998). Dyskerin is responsible 
for the pseudouridylation of target rRNA residues (Lafontaine et al, 1998; Zebarjadian 
et al, 1999). 
 
The box H/ACA snoRNAs are characterised by the conserved H (ANANNA, with N 
being any nucleotide) and ACA boxes. The majority of box H/ACA snoRNAs form a 
twin hairpin structure with the conserved H box located in a hinge region separating the 
hairpins (Figure 1.3). A minority of box H/ACA snoRNAs form a single hairpin 
structure. Whether the box H/ACA snoRNA forms a single or double hairpin structure 
the conserved ACA box is located three nucleotides upstream from the 3’ end. Within 
the snoRNA hairpins there are internal RNA loops, commonly known as 
pseudouridylation pockets, which contain between 9 and 13 nucleotides on each strand 
that bind target rRNA (Figure 1.3). Once the target rRNA is bound pseudouridylation 
occurs around 14-16 bases upstream of either the H or ACA box depending upon the 
specific snoRNP (Ganot et al, 1997; Ni et al, 1997; Balakin et al, 1996). 
 
The majority of the structural data on box H/ACA snoRNPs comes from studies of 
archaea; however, eukaryotic box H/ACA snoRNPs are predicted to have a similar 
structure (Watkins et al, 1998). The archaeal box H/ACA snoRNPs contain homologues 
of all the human core proteins; however, in archaea dyskerin is known as Cbf5 and 
NHP2 is referred to as L7Ae (Table 1.2). Analysis of the crystal structure of a single 
hairpin archaeal box H/ACA snoRNP revealed that the upper loop of the snoRNA 
hairpin binds a composite surface made up of L7Ae, Nop10 and Cbf5 (Li and Ye, 2006; 
Figure 1.3). Cbf5 was also shown to bind to the ACA box, which with the interaction 
with the upper RNA loop positions the catalytic domain of Cbf5 across the 
pseudouridylation pocket (Li and Ye, 2006). Archaeal Gar1 is the only box H/ACA core 
protein that does not bind directly to the snoRNA and crystallisation studies as well as 
biochemical studies indicate Gar1 interacts with directly with Cfb5, where it is 
presumed to function in substrate loading and release (Baker et al, 2005, Charpentier et 
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al, 2005; Henras et al, 2004; Rashid et al, 2006; Hamma et al, 2005; Manival et al, 
2006; Li and Ye, 2006).    
 
 
 
 
 
 
 
Table 1.2: The box H/ACA snoRNP common core proteins 
The table shows the box H/ACA snoRNP common core protein homologues from 
humans, yeast and archaea.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: The eukaryotic box H/ACA snoRNP  
The grey line represents the box H/ACA snoRNA with the conserved sequences shown 
in white on black boxes. The thicker grey lines represent the guide region. A red line 
represents the pre-rRNA with the pseudouridylation site indicated by Nψ. The core 
proteins are shown as grey spheres behind the snoRNA. Figure adapted from Reichow 
et al, 2007. 
 
 
Box H/ACA snoRNAs containing a twin hairpin structure have been predicted to 
associate with two sets of the core proteins (Watkins et al, 1998; Figure 1.3). 
Interestingly, mutation of the single ACA box of box H/ACA snoRNAs with a twin 
hairpin structure results in the loss of both copies of Cbf5, indicating that common core 
protein association is coupled (Baker et al, 2005). 
 
Humans Yeast Archaea 
      
dyskerin Cbf5p Cbf5 
      
GAR1 Gar1p Gar1 
      
NOP10 Nop10p Nop10 
      
NHP2 Nhp2p L7Ae 
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1.2.3. The small Cajal body-specific RNPs (scaRNPs) 
 
The small Cajal body-specific RNPs (scaRNPs) function in the chemical modification 
of spliceosomal snRNAs. The scaRNPs are functionally and structurally similar to the 
snoRNPs and perform 2’-O-methylation and pseudouridylation of target snRNA 
residues (Kiss, 2001; Kiss et al, 2002; Darzacq et al, 2002). The chemical modifications 
performed by the scaRNPs are mostly found in regions of the snRNAs involved in the 
spliceosomal RNA-RNA interactions and are vital for their function (Zhao and Yu, 
2004).   
 
The scaRNPs are composed of scaRNA associated with snoRNP common core proteins. 
The scaRNAs that direct 2’-O-methylation contain the conserved C (RUGAUGA, 
where R is purine) and the D (CUGA) boxes, as well as the less conserved internal C’ 
and D’ boxes. The scaRNAs that guide pseudouridylation contain the conserved H 
(ANANNA, with N being any nucleotide) and ACA boxes (Kiss, 2001). The box C/D 
and H/ACA scaRNAs have been predicted to associate with the respective core proteins 
of the box C/D and H/ACA snoRNPs, although to date only the association of fibrillarin 
and GAR1 has been demonstrated experimentally (Darzacq et al, 2002). Interestingly, a 
number of scaRNAs have been shown to contain both the C/D and H/ACA box motifs, 
for example the U85 scaRNP (Figure 1.4), and these scaRNPs can direct both the 2’-O-
methylation and pseudouridylation of target snRNA residues (Jady and Kiss, 2001). It is 
proposed that the scaRNPs, which contain both the C/D and H/ACA box motifs, 
associate with both sets of snoRNP core proteins (Jady and Kiss, 2001).  
 
The scaRNPs function in the modification of snRNA specifically in the Cajal bodies 
and their localisation is regulated by a Cajal body retention element termed the CAB 
box (Cajal Body box). The sequence of the CAB box is UGAG with the first and second 
bases varying amongst scaRNPs (Richard et al, 2003). 
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Figure 1.4: The human U85 scaRNA  
Computer predicted two-dimensional structure of the human U85 scaRNA. The 
scaRNA nucleotide sequences are shown in black lettering. The positions of the 
conserved C, D, H and ACA boxes are labelled and indicated by black outlined boxes. 
Numerical values correspond to nucleotide number. Image taken from Richard et al, 
2003.  
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1.3. Ribosome biogenesis 
 
The eukaryotic ribosome is composed of two subunits, the 40S (small ribosomal 
subunit) and the 60S (large ribosomal subunit), each consisting of different rRNAs and 
ribosomal proteins. The 40S subunit contains a single rRNA species, known as 18S, 
while the 60S subunit contains three rRNA species, referred to as 5S, 5.8S and 25S / 
28S (yeast / human). In eukaryotes the 5S rRNA is synthesised as a single transcript in 
the nucleoplasm. However, the 18S, 5.8S and 25 / 28S rRNAs are transcribed in the 
nucleolus as a large single pre-rRNA known as the 35S in yeast and the 47S in humans 
(Lafontaine and Tollervey, 2001). As the large pre-rRNA transcript migrates through 
the nucleolus it is chemically modified (Figure 1.1) and processed to produce the 
mature length rRNAs.   
 
1.3.1. rDNA gene organisation and transcription 
 
In humans there are between 300 and 400 copies of the 47S rDNA gene, which are 
transcribed by RNA polymerase I. The 47S rDNA genes are arranged in tandem repeats 
of around 13 kilobases (Kb) in size and are found on the p arms of chromosomes 13, 14, 
15, 21 and 22 (Grummt and Pikaard, 2003; Russell & Zomerdijk, 2005). In the yeast 
Saccharomyces cerevisiae (S. cerevisiae) there are around 150 copies of the 35S rDNA 
gene arranged in tandem repeats on chromosome 12 and transcribed by RNA 
polymerase I. The clusters of rDNA genes are known as nucleolar organiser regions 
(NORs) and recruit factors required for transcription and processing of the rRNA 
resulting in the formation of the nucleolus. Several rDNA clusters from different 
chromosomes often gather together to form a single nucleolus (Schwarzacher and 
Mosgoeller, 2000). 
 
The nucleolus consists of three sub-compartments, the inner fibrillar centre (FC), the 
dense fibrillar component (DFC) and the granular component (GC) (Schwarzacher and 
Mosgoeller, 2000). The rDNA genes are located, either within, or at the periphery of the 
FC and are transcribed at the border between the FC and DFC (Chooi and Leiby, 1981). 
As the pre-rRNA transcript migrates through the DFC and then the GC it is modified 
and processed by factors that are localised to these compartments (Figure 1.5 and 1.6).  
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The human 5S rDNA genes are found in tandem repeats separate from the 47S rDNA 
genes on the q arm of chromosome 1 and are transcribed by RNA polymerase III in the 
nucleoplasm (Bogdanov et al, 1995). In S. cerevisiae the 5S genes are located between 
each tandem repeat of the 35S rDNA, but are independently transcribed by RNA 
polymerase III (Lafontaine and Tollervey, 2001; Granneman and Baserga, 2004). 
 
1.3.2. Processing of the large pre-rRNA transcript 
 
Due to the ease of manipulation and genetic suitability the most extensive study of pre-
rRNA processing has been performed using the yeast S. cerevisiae (Venema and 
Tollervey, 1999; Granneman and Baserga, 2004; Figure 1.5); however, pre-rRNA 
processing in higher vertebrates is similar. The processing of pre-rRNA is performed by 
a variety of endo and exonucleases and a few snoRNPs, which function as chaperones 
(Granneman and Baserga, 2004).  
 
In S. cerevisiae the 18S, 5.8S and 25S rRNAs are transcribed as long 35S pre-rRNAs 
that contain 5’ and 3’ external transcribed regions (ETS) as well as two internal 
transcribed regions (ITS1 and 2; Figure 1.5). Pre-rRNA processing begins with initial 
cleavages at the A0 (5’ ETS) and the A1 sites (5’ ETS / 18S boundary) resulting in the 
removal the 5’ ETS sequence and forming the 32S precursor. Cleavage at the A2 site 
(ITS1) produces two precursors, the 20S precursor that contains 18S, and the 27SA2 
precursor that contains 25S and 5.8S (Figure 1.5). The 20S precursor is transported to 
the cytoplasm where cleavage at the D site produces the mature 18S rRNA (Fatica et al, 
2003; Schafer et al, 2003). Two alternative pathways process the 27SA2 precursor 
resulting in the formation of two slightly different 5.8 rRNAs (Figure 1.5). Around 85 
% of the 27SA2 is cleaved at the A3 site (ITS1) and then trimmed by exonucleases to the 
B1S site. The other 15 % (of 27SA2) is cleaved at B1L site. After this point processing in 
both pathways is identical with cleavage at the B2 site (3’ ETS) and B1 site (Figure 1.5). 
Due to the alternative cleavages earlier on two 27SB precursors are produced, 
designated S or L. Both the 27S transcripts are processed from C2 to C1 and are also 
subjected to 3’-5’ exonucleolytic digestion of the ITS2 to site E. The end result of the 
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two pathways is the production of identical 25S rRNA and two forms of 5.8S, known as 
5.8SS and 5.8SL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: pre-rRNA processing in S. cerevisiae 
The S. cerevisiae 18S, 5.8S and 25S rRNA are transcribed as a single 35S pre-rRNA 
transcript which is shown at the top of the panel. Black lines represent external and 
internal transcribed regions (ETS and ITS, respectively), which are removed during 
processing. Solid black boxes represent the 18S, 5.8S and 25S rRNAs (as indicated). 
Red arrows and red lettering indicate cleavage and processing sites. Black arrows 
represent progression of processing. Figure adapted from Granneman and Baserga, 
2004.  
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Figure 1.6: Overview of ribosome biogenesis in humans and yeast 
The rRNA is represented as a black line with a label indicating its species. A red line 
represents the nucleolar boundary. The FC (fibrillar centre), DFC (dense fibrillar centre) 
and GC (granular component) are separated by black dotted lines. A green line 
represents the nuclear membrane. Green ovals correspond to nuclear pores. Black 
arrows show progression of biogenesis.  Ribosomal subunits, snoRNPs and SSU 
processome shown as coloured shapes. 
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1.3.3. Chemical modification of rRNA 
 
The most common chemical modifications on rRNA are the methylation of the 2-
hydroxyl of ribose sugars (2’-O-methylation) and the isomerization of uridines to 
pseudouridines (pseudouridylation) (Figure 1.1), which are performed by the box C/D 
and H/ACA snoRNPs, respectively. These chemical modifications occur in the DFC of 
the nucleolus in tandem with the cleavage / processing of the large pre-rRNA (Figure 
1.6). 
 
The number of rRNA modifications performed by the snoRNPs varies in different 
organisms, for example the rRNA of S. cerevisiae has 54 methylation and 44 
pseudouridylation sites, while human rRNA has 105 methylation and 91 
pseudouridylations sites (Bakin, 1998; Ofengand and Bakin, 1997; Maden, 1990).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Modification sites on the yeast large ribosomal subunit  
Two views of the yeast large ribosomal subunit showing pseudouridylation sites (Ψ, 
red), 2’-O-methylation sites (Nm, yellow) and other modifications (orange). P, E and A 
sites of tRNA and mRNA binding and the polypeptide exit tunnel are indicated. 
Modifications are shown by displaying the full van der waals radii, rRNA backbone 
displayed in grey and protein chains maroon. Image provided by Decatur and Fournier, 
2002. 
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The three-dimensional representation of the locations of modified rRNA nucleotides in 
the yeast ribosome revealed that they are in areas of functional importance. These 
include the peptidyl transferase centre, the P, E and A sites of tRNA and mRNA 
binding, the polypeptide exit tunnel and sites of ribosome subunit-subunit interactions 
(Figure 1.7; Decatur and Fournier, 2002). The positions of the chemical modifications 
are highly conserved and have been proposed to function as “fine tuners” of rRNA 
structure (Ofengand et al, 2002; Decatur and Fournier, 2002; King et al, 2003). The 
global inhibition of rRNA modifications results in growth defects in yeast indicating 
that rRNA modification is essential for the biogenesis and function of the ribosome 
(Tollervey et al, 1993; Zebarjadian et al, 1999; King et al, 2003). It has been revealed 
that a few modification sites are of more functional importance than others and the 
inhibition of modification on these sites results in growth defects in yeast (Esguerra et 
al, 2008). However, more precise methods of analysis were required to determine the 
effect of individual chemical modifications.  
 
1.3.4. A number of snoRNPs function as chaperones in pre-rRNA 
processing 
 
A number of the box C/D and H/ACA snoRNPs are essential for the processing of the 
large pre-rRNA in both yeast and higher eukaryotes. These snoRNPs are predicted to 
function by base pairing to specific pre-rRNA regions and orchestrating the folding of 
the pre-rRNA into a confirmation that allows efficient processing. The U3 (Hughes and 
Ares, 1991), U14 (Li et al, 1990; Liang and Fournier, 1995) and U22 box C/D snoRNPs 
(Tycowcski et al, 1994), as well as the snR10 (Tollervey, 1987), snR30 (U17 / E2; 
Morrissey and Tollervey, 1997) and E3 (Mishra and Eliceiri, 1997) box H/ACA 
snoRNPs are all required for the production of the 18S rRNA. The vertebrate specific 
U8 box C/D snoRNP is essential for the processing of 5.8S and 28S and is also 
predicted to be involved in the structural rearrangements required for the production of 
the two mature rRNAs (Peculis and Steitz, 1993).   
 
The most studied of the snoRNPs that function in pre-rRNA processing is the U3 box 
C/D snoRNP. The U3 snoRNA contains two functional regions designated the 5’ and 
the 3’ domains. The 5’ domain consists of sequence elements that bind to target pre-
rRNA sequences, such as the GAC box, A box, A’ box, 5’ hinge and 3’ hinge (Terns 
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and Terns, 2002; Figure 1.8). The 3’ domain of the U3 snoRNA contains the sequence 
elements to which the core proteins associate. Interestingly, the U3 snoRNA contains 
two unique elements one being the C’/D box, which associates with the core proteins 
15.5K, NOP56, NOP58 and fibrillarin, and the other being the B/C box, which binds a 
second copy of 15.5K and the U3 specific hU3-55K protein (Watkins et al, 2000; 
Grannemen et al, 2002; 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: The Human U3 box C/D snoRNP 
The U3 snoRNA is shown in black lettering except for conserved box motifs that are 
shown as white lettering on black background. The U3 snoRNA 5’ hinge region base 
pairs with 5’ETS (red) of pre-rRNA while the A and A’ boxes base pair with the 18S 
rRNA (blue). The 3’ domain of U3 snoRNA contains the C’/D box, to which 15.5K 
(grey oval), NOP56 (dark green oval), NOP58 (light green oval) and fibrillarin (yellow 
oval) associate, and the U3 specific B/C box, which binds a second copy of 15.5k and 
the U3 specific hU3-55K protein (purple oval). The arrow shows first cleavage site of 
pre-rRNA. Image provided by N.J.Watkins, Newcastle University, UK. 
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Analysis of the interactions of yeast U3 snoRNA with the 35S pre-rRNA revealed that 
the interaction of the U3 snoRNA A box with the 5’ETS of the pre-rRNA is essential 
for cleavages at A0, A1 and A2 sites while the interaction of the U3 snoRNA hinge 
region with 18S is required for cleavages at sites A1 and A2 (Beltrame et al, 1994; 
Beltrame & Tollervey, 1995; Sharma & Tollervey, 1999; Figure 1.8). The U3 snoRNP 
does not directly cleave the pre-rRNA but guides the activities of a complex known as 
the small subunit (SSU) processome.  
 
The yeast SSU processome forms co-transcriptionally on the 35S pre-rRNA forming 
large 90S complexes, also known as 5’ terminal knobs, which are visible in miller 
chromatin spreads of actively transcribing rRNAs (Miller & Beatty, 1969; Dragon et al, 
2002). The SSU processome is a dynamic complex, which in yeast, has been shown to 
contain over 40 proteins including RNA helicases, RNA annealing factors and GTPases 
(Dragon et al, 2002). The five main sub-complexes that make up the SSU processome 
are the U3 snoRNP, MPP10 (M phase phosphoprotein 10) complex, tUTP (transcription 
required- U three protein) complex, bUTP complex and cUTP complex (Dragon et al, 
2002). It has been proposed that the SUU processome functions in cleavages at the A0, 
A1 and A2 pre-rRNA sites through the recruitment of endonucleases (Granneman et al, 
2004). Although no endonucleases have been found associated with the SUU 
processome these factors may transiently bind and therefore be difficult to detect. 
Another possibility is that the interaction of the SSU processome with the pre-rRNA 
forms a ribozyme structure that directly cleaves the pre-rRNA (Collins and Guthrie, 
2000). In addition to the cleavages that produce 18S rRNA the SSU processome also 
associates with factors required for the synthesis of the 40S ribosomal subunit. For 
instance the SUU processome contains the 40S ribosomal subunit proteins: Rps4 
(ribosomal protein s4), Rps6, Rps7, Rps9 and Rps14, which become permanently 
associated with the 18S rRNA (Bernstein et al, 2004).  
 
The U3 box C/D snoRNP also functions in orchestrating the folding of the 18S rRNA 
into its mature conformation. The U3 snoRNP base pairs to the 5’ terminus of the 18S 
rRNA, via it’s A’ and A boxes, and brings the 18S sequences into close proximity 
resulting in the formation of the conserved psuedoknot structure (Hughes, 1996; Figure 
1.9).  
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Figure 1.9: Pseudoknot formation in the 18S rRNA of S. cerevisiae 
Interaction between the 5’ domain of the yeast U3 box C/D snoRNA (black lettering) 
and the 5’ end of yeast 18S rRNA (blue lettering and lines) still associated in 35S pre-
rRNA. The 5’ETS of rRNA is shown (red lines) with A1 cleavage site (located at 5’ETS 
and 18S boundary) represented as a red arrow. Short black lines represent bonds. The 
black arrow shows progression of process. Adapted from Hughes, 1996. 
 
 
1.3.5. Ribosomal assembly and export 
 
The mature 5.8S and 25S / 28S rRNAs (yeast / human) associate with the 5S rRNA in 
the GC of the nucleolus to form the large pre-60S complex, while the 18S rRNA forms 
the small pre-40S complex (Figure 1.6). The pre-60S and pre-40S ribosomal complexes 
are transported through the nucleoplasm to the cytoplasm during which further 
maturation events occur and ribosomal proteins associate (Figure 1.6; Tschochner and 
Hurt, 2003). Once the final maturation steps have been performed the large 60S and 
smaller 40S ribosome subunits interact with an mRNA transcript to form a functional 
ribosome (Figure 1.6).  
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1.4. Box C/D snoRNP biogenesis  
 
Box C/D snoRNP biogenesis proceeds in a large, dynamic multiprotein complex known 
as the pre-snoRNP that contains snoRNA, common core proteins and assembly, 
transport and RNA processing factors (Boulon et al, 2004; Watkins et al, 2004; 2007; 
McKeegan et al, 2007). The cellular localisation(s) where box C/D snoRNP biogenesis 
occurs is not clear with evidence suggesting the nucleoplasm (Terns et al, 1995; 
Watkins et al, 2004; Boulon et al, 2004), Cajal bodies (Verheggen et al, 2001; Boulon et 
al, 2004; Lemm et al, 2006) and cytoplasm (Baserga et al, 1992; Peculis et al, 2001; 
Watkins et al, 2007). 
 
1.4.1. Gene organisation and transcription  
 
Box C/D snoRNAs have a diverse gene organisation that differs between organisms. In 
vertebrates the majority of box C/D snoRNAs are encoded within the introns of 
housekeeping genes and are released by the processing of the excised introns from pre-
mRNA (Kiss and Filipowicz, 1995). In yeast the majority of box C/D snoRNA genes 
are encoded as independent genes, being both monocistronic and polycistronic.  
 
Two examples of human box C/D snoRNAs that have different genomic organisations 
are the U3 and U14 snoRNAs (Figure 1.10).  In the human genome there are four to six 
copies of the U3 snoRNA, which are encoded as monocistronic genes with independent 
promoters. The U3 promoter region consists of a proximal sequence element (PSE) 
(instead of a TATA box), located 55 bases upstream of the U3 snoRNA, and a distal 
sequence element (DSE), around 220 bases upstream of the snoRNA sequence (Figure 
1.10). The PSE site determines the transcription start site while the DSE functions as an 
enhancer (Mazan et al, 1993). The U3 snoRNA is transcribed by RNA polymerase II. 
The U14 snoRNA is encoded within introns 5, 6 and 7 of the heat shock cognate protein 
70 (hsc70; Figure 1.10) and there are also two copies within the introns of ribosomal 
protein genes, which are all transcribed by RNA polymerase II (Lui and Maxwell, 1990; 
Kenmochi et al, 1996). As the U14 snoRNA is an intronic RNA its expression is based 
upon the expression of the host gene. Once transcribed the intronic box C/D snoRNAs 
are excised from the pre-mRNA. 
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Figure 1.10: Genomic organisation of human box C/D snoRNAs 
The top panel shows the organisation of the independently transcribed U3 box C/D 
snoRNA. The DSE is represented as an orange box and the PSE as a yellow box. U3 
snoRNA is shown as a black box. The bottom panel shows the gene organisation of the 
intronic U14 snoRNA, which is expressed from the introns of the hsc70 gene. The 
promoter is shown as a green box, the exons as white boxes and the U14 snoRNA as a 
black box. Arrows represent transcription start sites.   
 
 
1.4.2. Processing of box C/D snoRNAs 
 
Excision of intronic box C/D snoRNAs from host pre-mRNA occurs by one of two 
pathways, the splicing dependent and the splicing independent. The majority of intron-
encoded snoRNAs are excised using the splicing dependent pathway where the intron is 
released from the pre-mRNA as a normal spliced lariat and then processed (Kiss and 
Filipoicz, 1995; Figure 1.11). In the splicing independent pathway, which was originally 
shown for the Xenopus laevis (X. laevis) U16 box C/D snoRNA, the snoRNA is 
released from unspliced pre-mRNA by endonucleotytic cleavages of flanking intronic 
sequences (Caffarelli et al, 1996). The snoRNA produced from both intronic and 
independent box C/D snoRNAs contain extended precursor sequences (pre-snoRNA) 
that are processed to form mature length box C/D snoRNA.  
 
The majority of research on box C/D snoRNA processing has been conducted using the 
yeast S. cerevisiae. Research in yeast has shown that the 5’ extended sequences of 
several species of polycistronic and intronic box C/D pre-snoRNAs are processed by 
two homologous 5’-3’ exonucleases, known as Rat1p and Xrn1p, which also function in 
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5’ processing of the 5.8 rRNA (Petfalski et al, 1998; Figure 1.11). Further studies in 
yeast revealed that the 3’ extended sequences of intronic box C/D pre-snoRNAs are 
processed by a 3’-5’ exonuclease complex known as the exosome (Allmang et al, 1999; 
Figure 1.11). The exosome also functions in the processing of the 3’ sequence of 
polycistronic box C/D snoRNAs once the extended sequences are first cleaved by the 
endonuclease Rnt1p (Kufel et al, 2000, 2003; Chanfreau, et al, 1998; Figure 1.11). 
Interestingly, Rnt1p has been also shown to function in the 3’ cleavage of a number 
yeast intronic box C/D snoRNAs (Giorgi et al, 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Processing of an intronic box C/D snoRNA in yeast 
Exons are represented as white boxes while the box C/D snoRNA mature sequence is 
shown as a black box. The black line represents intronic mRNA sequences and pre-
snoRNA sequences. The 5’-3’ exonuclease Rat1p is shown as a green oval while the 3’-
5’ exonuclease exosome complex is represented as a yellow oval. Exonucleolytic 
processing is represented as black dashed arrows. Black arrows show progression of 
processing. 
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The exosome is a multiprotein complex found in both the nucleus and cytoplasm. 
Interestingly, the composition of the yeast exosome differs slightly between the nucleus 
and the cytoplasm; however, there are ten common components (Rrp41, Rrp46, Mtr3, 
Rrp42, Rrp43, Rrp45, Rrp4, Rrp40, Csl4 and Rrp44) (Mitchell et al, 1997; Allmang et 
al, 1999). In addition to the 3’ processing of box C/D pre-snoRNAs the exosome has 
known functions in the processing snRNAs, mRNA degradation and the 3’ processing 
of the 5.8S rRNA (Allmang et al, 1999, 2000; Anderson and Parker, 1998; Burkard et 
al, 2000; Torchet et al, 2002; Libri et al, 2002). The use of yeast mutants revealed that 
3’ processing of box C/D snoRNA requires the specific function of the Rrp6p 
component of the exosome (Allmang et al, 1999; Figure 1.11). 
 
In yeast the processing of the box C/D pre-snoRNA 3’ extended sequences is regulated 
by the Lhp1p protein (homologue of the human La protein), which has previously been 
shown to be essential for the stability of snRNAs during biogenesis (Xue et al, 2000; 
Pannone et al, 1998; Kufel et al, 2000; Figure 1.12). The Lsm (Like Sm) proteins are 
proposed to chaperone the association of the Lhp1p protein with the 3’ snoRNA 
poly(U) sequences which then prevents excessive degradation of the 3’ end of the 
snoRNA (Kufel et al, 2003).  
 
The association of the box C/D snoRNP common core proteins with the snoRNA has 
also been implicated in regulating the processing of box C/D snoRNAs (Figure 1.12). It 
has been proposed that the association of core proteins displaces Lhp1p and defines the 
3’ end of the mature snoRNA (Kufel et al, 2003; Figure 1.12). Furthermore, analysis of 
the yeast U18 box C/D snoRNA revealed that the common core proteins are present 
throughout processing, and in particular the association of Nop1p (fibrillarin in humans) 
is a prerequisite for 3’ cleavage of pre-snoRNA sequences by Rnt1p (Giorgi et al, 2001; 
Figure 1.12). Interestingly, Nop1p interacts directly with the Rnt1p, indicating that 
fibrillarin functions in the recruitment of this endonuclease (Giorgi et al, 2001).  
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Figure 1.12: A model of 3’ processing of the yeast U3 snoRNA 
The U3 box C/D snoRNA is shown as a black line. The Rnt1p endonuclease is 
represented by a red oval while the Lhp1p protein is shown as a green oval. The box 
C/D snoRNP common core proteins are shown as a large blue circle. The 3’ to 5’ 
exonuclease exosome complex is represented as a yellow oval. Exo and endo 
nucleolytic activities are represented as black dashed arrows. Black arrows show 
progression of processing. 
 
 
 
 26 
The processing of box C/D pre-snoRNAs in higher eukaryotes has not been as well 
characterised as in yeast; however, homologues of a number of yeast snoRNA 
processing factors also interact with the box C/D pre-snoRNP in human cells. For 
instance the La, Lsm4, Rrp46 (exosome) proteins associate with U3 and U8 box C/D 
pre-snoRNPs (Watkins et al, 2004; 2007). Analysis of the interactions of these factors 
with the U8 pre-snoRNA, of which there are four precursors (I to IV, with I being the 
longest), provided data on the order of binding of these factors (Watkins et al, 2007). 
The La protein specifically associates with pre-snoRNP complexes containing the U8 
pre-snoRNA intermediate I while RNA processing factors such as Rrp46 and Lsm4 
only associate later on in biogenesis with U8 pre-snoRNP complexes containing 
snoRNA intermediates III and IV (Watkins et al, 2007). Interestingly, the core proteins 
associate with the U8 pre-snoRNA intermediate I, which indicates that the core proteins 
bind early on in the biogenesis of the U8 snoRNP. Less is known about the 5’ 
processing of box C/D pre-snoRNAs in higher eukaryotes with the only identified 
endonuclease being XendoU. This endonuclease was identified in X. laevis and is 
required for 5’ cleavage events that the release intronic U86 box C/D snoRNA (Laneve 
et al, 2002). 
 
 
1.4.3. The 5’ cap hypermethylation of box C/D snoRNAs 
 
The 5’ end of RNAs transcribed by RNA polymerase II, which includes mRNAs, 
snRNAs and independently transcribed snoRNAs, contain a post transcriptionally added 
5’ terminal 7-monomethylguanosine cap (m7G). The 5’ m7G cap of snRNAs and 
snoRNAs is converted to a 2,2,7-trimethylguanosine cap (m3G), which involves the 
addition of two methyl groups (Saponara and  Enger, 1969).  
 
The formation and the function of the 5’ cap has been best characterised for snRNAs. In 
snRNA biogenesis the m
7
G cap functions as a nuclear export signal resulting in the 
export of pre-snRNAs to the cytoplasm where further maturation occurs (Ohno et al, 
2000). In the cytoplasm the m
7
G cap of the snRNAs is converted, by the 
methyltransferase trimethlguanosine 1 (TGS1), to an m3G cap that functions as nuclear 
import signal (Mouaikel et al, 2002).  
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The role of the m
7
G / m3G cap of independently transcribed box C/D snoRNAs is not so 
clear, especially considering that the majority of human box C/D snoRNAs do not 
contain 5’ caps as they are processed from either pre-mRNA or polycistrons with 5’-
phosphate terminals (Tollervey and Kiss, 1997). The m3G cap of independently 
transcribed snoRNAs could function either in cellular transport or protect the 5’ end 
from RNA processing. While it is known that the snRNAs obtain their m3G cap in the 
cytoplasm the cellular location where independently transcribed box snoRNAs acquire 
their m3G cap is not clear with both the Cajal bodies and the cytoplasm implicated 
(Verheggen et al, 2002; Watkins et al, 2007).  
 
Several studies have indicated that box C/D snoRNA maturation occurs exclusively in 
the nucleus and this includes the conversion of the 5’ m7G cap to an m3G cap (Terns 
and Dahlberg, 1994; Terns et al, 1995). Interestingly, two isoforms of TGS1 have been 
discovered in human cells and these alternatively localise to the cytoplasm and Cajal 
bodies (Girard et al, 2007). The longer 110kDa TGS1 preferentially localises to the 
cytoplasm while the smaller TGS1, which lacks the N terminal domain, is found 
exclusively in Cajal bodies (Girard et al 2007). The shorter isoform of TGS1 interacts 
with components of the box C/D snoRNPs, which indicates that it functions in 
modification of snoRNA (Girard et al, 2007). Furthermore, analysis in yeast revealed 
that both m
7
G and m3G capped U3 snoRNA are present in the yeast equivalent of the 
Cajal body, known as the nucleolar body (Verheggen et al, 2002). This suggests that the 
m
7
G cap of independently transcribed box C/D snoRNAs is converted to an m3G cap in 
the Cajal bodies.  
 
A number of studies have indicated that box C/D snoRNAs are transported to the 
cytoplasm during biogenesis (Baserga et al, 1992; Peculis et al, 2001; Watkins et al, 
2007). One study using X. laevis oocytes showed that the U3 box C/D snoRNA 5’ m7G 
cap could be converted to an m3G cap in the cytoplasm and that box C/D snoRNAs 
injected into the cytoplasm are imported into the nucleus (Baserga et al, 1992). 
Furthermore U3, U8 and U8 box C/D snoRNAs have been found in the cytoplasm of 
human cells (Watkins et al, 2007) and analysis of the maturation of the U8 snoRNA 
indicates that the m
7
G cap is converted to an m3G cap in the cytoplasm (Watkins et al, 
2007).  
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1.4.4. Role of assembly factors in box C/D snoRNP biogenesis 
 
The box C/D snoRNP common core proteins associate with the snoRNA in a 
hierarchical manner. The binding of 15.5K to the box C/D snoRNA is essential for 
subsequent association of the other common core proteins (Watkins et al, 2002). It has 
been proposed that the binding of 15.5K to the K-turn of the box C/D motif causes a 
conformational change in the RNA, similar to the association of 15.5K with the U4 
snRNA (Vidovic et al, 2000). This change in snoRNA confirmation has been proposed 
to create binding sites for NOP56, NOP58 and fibrillarin (Watkins et al, 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: Schematic representation of the box C/D pre-snoRNP interaction 
network 
The box C/D snoRNP core proteins are shown as ovals while the assembly factors are 
represented as rectangles. The black lines correspond to interactions between proteins. 
The grey lines represent interaction between proteins that are altered by either ATP or 
ADP. FIB corresponds to fibrillarin. Figure adapted from McKeegan et al, 2007.  
 
 
A number of box C/D snoRNP assembly factors (TIP48, TIP49, BCD1, NOP17, NUFIP 
and TAF9) have been proposed to function in the early recruitment of the core proteins 
to the pre-snoRNP (McKeegan et al, 2007). These assembly factors associate with box 
C/D pre-snoRNP complexes containing pre-snoRNA and form an intricate interaction 
network with the common core proteins (Figure 1.13; Watkins et al, 2004; McKeegan et 
al, 2007).  
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It is proposed that during box C/D snoRNP biogenesis restructuring / remodelling 
events occur, possibly facilitated by the assembly factors, resulting in the stable 
association of the common core proteins with the snoRNA. This is supported by the fact 
that there are very few direct interactions between the core proteins themselves and that 
there is an increase in the stability of the association of both NOP56 and NOP58 
between nucleoplasmic and nucleolar box C/D snoRNPs (Watkins et al, 2004; 
McKeegan et al, 2007).  
 
1.4.4.1. TIP48 and TIP49 
 
TIP48 and TIP49 (TBP (TATA binding protein) interacting protein of 48kDa or 49kDa) 
are a conserved class of AAA ATPases that interact with one another via Walker A and 
B motifs forming hexameric ring structures (Puri et al, 2007). The TIP48 and TIP49 
proteins have functions in modifying chromatin structure (Shen et al, 2000) and in 
transcription activating complexes (Cho et al, 2001).  
 
TIP48 and TIP49 have been shown to associate with nucleoplasmic box C/D pre-
snoRNP complexes in both mouse and human cells (Newman et al, 2000; Watkins et al, 
2004; 2007). The depletion of either TIP48 or TIP49, in human cells, results in the 
reduction of box C/D snoRNA levels which indicates that both proteins are required for 
box C/D snoRNP biogenesis (Watkins et al, 2004). In vitro interaction assays, using 
human proteins, showed that both TIP48 and TIP49 interact with the common core 
proteins 15.5K and fibrillarin, with the interaction with 15.5K dependent upon the 
presence of ATP (McKeegan et al 2007; Figure 1.13). TIP48 and TIP49 also interact 
with other box C/D snoRNP assembly factors, namely NUFIP, BCD1 and TAF9 and in 
addition TIP49 interacts with NOP17 (McKeegan et al, 2007; Figure 1.13). 
 
Studies of the yeast homologues of TIP48 and TIP49 (known as Rvb1 and Rvb2, 
respectively) also indicate that these proteins function in box C/D snoRNP biogenesis. 
Mutation of the Walker A and B motifs of Rvb1 and Rvb2 result in the reduction of box 
C/D snoRNA levels suggesting that these motifs are vital for the function of Rvb1 and 
Rvb2 in box C/D snoRNP biogenesis (King et al, 2001). Furthermore, loss of Rvb2 
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results in the accumulation of fibrillarin outside the nucleolus indicating that Rvb2 
functions in box C/D snoRNP biogenesis (King et al, 2001).  
 
As TIP48 and TIP49 are the only assembly factors in the box C/D pre-snoRNP that are 
ATPases it has been proposed that these proteins function in the restructuring events 
that result in the stable association of the common core proteins to the snoRNA 
(Watkins et al, 2004). Interestingly, TIP49 associates with both U3 pre-snoRNA and 
mature snoRNA, although it is absent from nucleolar snoRNPs, which could indicate 
that TIP49 functions in the latter stages of box C/D snoRNP biogenesis perhaps in 
structural rearrangements (Watkins et al, 2004).  
 
1.4.4.2. BCD1 
 
The BCD1 protein (Box C/D snoRNA accumulation) was initially identified as a box 
C/D snoRNP interacting factor in a panoramic yeast two-hybrid screen of non-coding 
RNA processing proteins (Peng et al, 2003). Sequence analysis of BCD1 revealed the 
presence of a zinc finger domain, but no other notable structures or motifs. 
 
The interaction of BCD1 with box C/D snoRNPs was further confirmed in yeast using 
TAP tag purification of BCD1, which resulted in the co-purification of box C/D 
snoRNA (Peng et al, 2003). The depletion of BCD1 in yeast results in the reduction of 
box C/D snoRNA levels suggesting that BCD1 is required for box C/D snoRNP 
biogenesis (Peng et al, 2003; Hiley et al, 2005).  
 
Analysis of the human BCD1 homologue revealed that it associates with nucleoplasmic 
pre-snoRNPs and interacts with fibrillarin, 15.5K, NUFIP and TAF9 (Figure 1.13; 
McKeegan et al, 2007). The depletion of BCD1, in human cells, results in the reduction 
of box C/D snoRNA levels, which again suggests that BCD1 functions in box C/D 
snoRNP biogenesis (McKeegan et al, 2007).  
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1.4.4.3. NOP17 
 
Nop17p (nucleolar localisation protein 17 also known as PIH1) was identified in a yeast 
two-hybrid screen as a protein that interacts with Nop58p and the exosome subunit 
Rrp43p (Gonzales et al, 2005). Further analysis in yeast revealed that Nop17p is 
required for box C/D snoRNA accumulation (Zhao et al, 2008) and for the correct 
cellular localisation of the box C/D snoRNP common core proteins (Gonzales et al, 
2005).  
 
Investigations into the human homologue of Nop17p (NOP17) showed that it is 
essential for maintaining box C/D snoRNA levels (McKeegan et al, 2007; Boulon et al, 
2008). Further analysis revealed that NOP17 associates with nucleoplasmic pre-
snoRNPs and interacts with fibrillarin, TIP48 and TIP49 (McKeegan et al, 2007; Figure 
1.13).  
 
1.4.4.4. NUFIP 
 
NUFIP (Nuclear FMRP interacting protein) is a zinc finger containing transcription 
factor that interacts with the fragile X mental retardation protein (FMRP; Bardoni et al, 
1999; Cabart et al, 2004). NUFIP was originally identified as a box C/D snoRNP 
interacting factor in a yeast two-hybrid screen (McKeegan et al, 2007; Boulon et al, 
2008).  
 
Analysis of human NUFIP revealed that it associates with nucleoplasmic box C/D pre-
snoRNPs and interacts with all the box C/D snoRNP core proteins and assembly factors 
(Figure 1.13; McKeegan et al, 2007). NUFIP is also essential for the accumulation of 
box C/D snoRNA, which indicates that it functions in box C/D snoRNP biogenesis 
(Boulon et al, 2008).  
 
The high number of interactions between NUFIP, the common core proteins and 
assembly factors indicates that NUFIP may function as a central scaffold or bridging 
protein in the box C/D pre-snoRNP. This potential function of NUFIP was investigated 
using an in vitro assembly assay and revealed that NUFIP could mediate the assembly 
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of a partial box C/D snoRNP consisting of NOP56, 15.5K and snoRNA (McKeegan et 
al, 2007). This provided functional evidence that NUFIP may bridge the interactions of 
the core proteins with the snoRNA in box C/D snoRNP biogenesis.  
 
1.4.4.5. TAF9 
 
TAF9 (transcription activating factor 9) is a TATA binding protein that functions in 
RNA polymerase II transcription (Milgrom et al, 2005). TAF9 was implicated in box 
C/D snoRNP biogenesis in a yeast two-hybrid screen, which revealed it interacts with 
NOP56 (Ito et al, 2001). 
 
Investigations of human TAF9 showed that it associates with nucleoplasmic pre-
snoRNPs (McKeegan et al, 2007) and interacts with the common core protein 
fibrillarin, but interestingly not NOP56, as well as the assembly factors BCD1, NUFIP, 
TIP48 and TIP49 (McKeegan et al, 2007; Figure 1.13).  
 
1.4.5. Transport factors 
 
The cellular localisation(s) where box C/D snoRNP biogenesis occurs is not clear, with 
evidence suggesting the nucleoplasm (Terns et al, 1995; Watkins et al, 2004; Boulon et 
al, 2004), Cajal bodies (Verheggen et al, 2001, 2002; boulon et al, 2004; Lemm et al, 
2006) and cytoplasm (Baserga et al, 1992; Peculis et al, 2001; Watkins et al, 2007). A 
variety of proteins known to function in the transport of other factors associate with the 
box C/D pre-snoRNP complexes and these, more than likely, target the pre-snoRNP to 
sub-cellular locations where biogenesis occurs (Yang et al, 2000; Boulon et al, 2004; 
Watkins et al, 2004, 2007).  
 
1.4.5.1. Nuclear export factors 
 
A number of snRNP nuclear export factors associate with box C/D pre-snoRNPs and 
these include CBC (Cap Binding complex), PHAX (phosphorylated adaptor for RNA 
export) and CRM1 (Chromosome maintenance region 1) (Boulon et al, 2004; Watkins 
et al, 2004, 2007). The role of these proteins in box C/D snoRNP biogenesis is not as 
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well defined as in snRNP biogenesis; however, they have been proposed to function in 
either intra-nuclear transport or nuclear export of box C/D pre-snoRNPs.  
  
CBC, PHAX and CRM1 have all been shown to interact with U3 and U8 pre-snoRNA 
in the nucleoplasm of human cells (Boulon et al, 2004; Watkins et al, 2004, 2007).  
Analysis of PHAX revealed that it interacts with the m
7
G cap of U3 pre-snoRNAs in the 
absence of both CBC and CRM1 and has been proposed to function in the localisation 
of U3 snoRNA to the Cajal bodies as the over expression of U3 snoRNA results the 
accumulation of PHAX in the Cajal bodies (Boulon et al, 2004). However, PHAX has 
also been found associated with cytoplasmic U8 pre-snoRNP complexes which could 
indicate that it functions in the nuclear export of box C/D pre-snoRNPs (Watkins et al, 
2007).  
 
CRM1 has been found associated with nucleoplasmic U3 pre-snoRNAs that have an 
m3G cap (Boulon et al, 2004). It has been proposed that CRM1 functions in the export 
of box C/D pre-snoRNAs from the Cajal bodies as inhibition of CRM1 prevents the 
localisation of labelled U3 snoRNA to the nucleolus and results in its accumulation in 
the Cajal bodies (Boulon et al, 2004). Furthermore both CRM1 (Boulon et al, 2004) and 
m3G capped U3 pre-snoRNAs (Verheggen et al, 2002) are enriched in Cajal bodies. 
 
1.4.5.2. Snurportin1 
 
Snurportin1 has known functions in the nuclear import of m3G capped snRNA (Yong et 
al, 2002) and has also been implicated in the biogenesis of box C/D snoRNPs as it has 
been found associated with cytoplasmic U8 pre-snoRNP complexes that contain m3G 
capped snoRNA (Watkins et al, 2007). The depletion of Snurportin1, in human cells, 
results in the accumulation of U8 snoRNA in the cytoplasm and Cajal bodies (Watkins 
et al, 2007), which suggests that Snurportin1 functions in the nuclear import of 
cytoplasmic U8 pre-snoRNPs. 
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1.4.5.3. Nopp140 
 
Nopp140 is a highly phosphorylated protein that shuttles between the nucleolus and 
cytoplasm in mammalian cells (Meier and Blobel, 1992). Nopp140 was identified as a 
potential box C/D snoRNP factor when it was shown to interact with fibrillarin and was 
found associated with nucleoplasmic box C/D pre-snoRNPs (Yang et al, 2000; Watkins 
et al, 2004). Furthermore, expression of a dominant negative form of Nopp140 results in 
the accumulation of fibrillarin outside of the nucleolus (Yang et al, 2000). However, 
analysis in yeast showed that the Nopp140 homologue (Srp40p) was only essential for 
maintaining box H/ACA and not box C/D snoRNA levels (Yang et al, 2000). This could 
indicate the Nopp140 has a more vital for the biogenesis of the box H/ACA snoRNPs 
than the box C/D snoRNPs.  
 
1.4.6. Sites of box C/D snoRNP biogenesis 
 
Box C/D snoRNP biogenesis occurs, at least in part, in the nucleoplasm where the 
snoRNA is transcribed as an extended precursor by RNA polymerase II (Figure 1.14). 
The processing of the pre-snoRNA extended sequences by endo and exo nucleases has 
been shown to be mediated / regulated by the association of the common core proteins 
(Giorgi et al, 2001) and proteins such as La (Kufel et al, 2003; Watkins et al, 2004; 
2007). The association of the common core proteins with the snoRNA has been 
proposed to be facilitated by the assembly factors that associate with the nucleoplasmic 
pre-snoRNP complexes (Watkins et al, 2004, 2007; McKeegan et al, 2007; Figure 1.14). 
 
The Cajal bodies have also been implicated in box C/D snoRNP biogenesis as not only 
have box C/D snoRNA genes have been found associated with the Cajal bodies (Gao et 
al, 1997) but these nuclear bodies are enriched in both snoRNA and the common core 
proteins (Verheggen et al, 2001). The Cajal bodies have been proposed as the site of the 
association of the core proteins (Verheggen et al, 2001), and also the site where 
independently transcribed snoRNAs obtain their m3G cap (Verheggen et al, 2002; 
Boulon et al, 2004; Figure 1.14). However, as of yet, there is no direct evidence that 
either core protein association or m3G cap formation occurs in this nuclear body. 
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Figure 1.14: Box C/D snoRNP biogenesis 
A black line represents the box C/D snoRNA with the 5’ m7G cap shown as an orange 
circle and the 3’ extended sequence as an orange rectangle. The core proteins are 
represented by a blue oval. The assembly, RNA processing and transport factors are 
represented by a brown oval. The 5’ m3G cap of mature snoRNA is shown as by a dark 
blue circle. The Cajal body is represented as a grey outlined box while the nucleolus is 
shown as a solid grey box. Grey arrows show the progression of biogenesis. The nuclear 
membrane is represented by black outlined rectangles. Image provided by N.J.Watkins, 
Newcastle University, UK.  
 
 
Several studies have indicated that box C/D snoRNA biogenesis occurs exclusively in 
the nucleus (Terns and Dahlberg, 1994; Terns et al, 1995); however, there is evidence 
that box C/D snoRNP biogenesis occurs, in part, in the cytoplasm (Figure 1.14). For 
instance not only do the U3, U8 and U13 pre-snoRNPs interact with the snRNP nuclear 
export proteins PHAX, CBC, CRM1 and Ran (Boulon et al, 2004; Watkins et al, 2004, 
2007) but U3, U8 and U13 snoRNAs have been found in cytoplasmic extracts (Watkins 
et al, 2007). Furthermore, investigation of cytoplasmic U8 pre-snoRNPs revealed two 
complexes: one pre-snoRNP containing 5’ m7G capped snoRNA and the nuclear export 
factor PHAX and another pre-snoRNP complex containing 5’ m3G capped snoRNA and 
the nuclear import factor Snurportin1 (Watkins et al, 2007). This could indicate the 
PHAX exports the U8 pre-snoRNP to the cytoplasm where the m
7
G cap is converted to 
an m3G cap and then the pre-snoRNP associates with Snurportin1 and is transported 
back to the nucleus.  
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1.5. Small nuclear ribonucleic protein complexes (snRNPs) 
 
The small nuclear RNPs (snRNPs) function in pre-mRNA splicing as part of a larger 
RNP complex known as the spliceosome. The snRNPs consist of core proteins and a 
ncRNA, known as the snRNA, which recognises intronic sequences and is essential for 
processes that remove the intron. 
 
1.5.1. SnRNP structure 
 
The U1, U2, U4, U5 and U6 snRNPs are responsible for the majority of pre-mRNA 
splicing. The vertebrate snRNAs are between 100 and 200 nucleotides long and contain 
a conserved site Sm site (with the exception of U6) that has the consensus sequence 
RAUUUUUGR (where R is purine). The Sm proteins (B/B’, D3, D2, D1, E, F and G) 
associate with the Sm site in a heptameric ring structure known as the Sm core. The 
snRNAs also contain stem loop structures that bind snRNP type specific core proteins 
(Figure 1.15). 
 
The best structurally characterised snRNP is U1 which contains a 164 nucleotide long 
snRNA that forms a twin hairpin structure consisting of four stem loops (I, II, III and 
IV; Figure 1.15). The Sm core of the U1 snRNP is located between the hairpin structure 
while the U1-70K and U1-A core proteins interact with stem loops I and II, 
respectively. The U1-C core protein associates with the U1 snRNP through an 
interaction with the U1-70K protein (Oubridge et al, 1994; Stark et al, 2001; Figure 
1.15).  
  
The U6 snRNP is distinctive from the other snRNPs as the snRNA does not contain an 
Sm site and does not associate with Sm proteins. The U6 snRNAs associate with the 
Lsm proteins (2, 3, 4, 5, 6, 7 and 8) that form a heptameric ring structure at a 3’ uridine 
rich sequence (Achsel et al, 1999; Vidal et al, 1999). The Lsm proteins contain the Sm 
motif (Hermann et al, 1995) and have been proposed to function in the formation of the 
U4/U6.U5 tri-snRNP (Achsek et al, 1999) and also the regulation of the 3’ processing 
of some RNAs (Kufel et al, 2003). Unsurprisingly, the U6 snRNPs undergo a different 
biogenesis pathway to the other snRNPs. 
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Figure 1.15: Human U1 snRNP structure 
The snRNA sequence is represented as black text except for the conserved Sm site, 
which is shown as white text on black. Numerical values alongside snRNA sequence 
correspond to nucleotide number. The Sm proteins are represented by a green ovals and 
the U1-A protein is shown as a yellow oval. The U1-C and U1-70K proteins are 
represented as red and blue ovals, respectively.  
 
 
The U4, U5 and U6 snRNPs function in pre-mRNA splicing as part of a U4/U6.U5 tri-
snRNP complex. The formation of the U4/U6.U5 tri-snRNP complex is a hierarchical 
process that occurs in the Cajal bodies (Stanek et al, 2003; Schaffert et al, 2004). The 
formation of the U4/U6.U5 tri-snRNP first requires the association of 15.5K to the 5’ 
stem loop of the U4 snRNA, which stabilizes a K-turn structure, followed by the 
binding of hPRP31 (61K) and a number of other core proteins (Notrott et al, 1999; 
Vidovic et al, 2000). A U4/U6 di-snRNP is then formed, which involves the p110 
protein (Stanek et al, 2003), followed by the association of the CypH (20K), hPRP4 
(60K) and hPRP3 (90K) core proteins (Nottrott et al, 1999; 2002). The U5 snRNP is 
incorporated into the U4/U6.U5 tri-snRNP through an interaction between the U5 
specific hPRP6 (102K) and the U4 specific hPRP31 protein (Makarova et al, 2002).  
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1.5.2. Pre-mRNA splicing and snRNPs  
  
Pre-mRNA splicing is performed by the spliceosome which is formed by the ordered, 
stepwise association of snRNPs and splicing factors to the pre-mRNA in what are 
termed the E, A, B and C complexes. 
 
Assembly of the spliceosome begins with the formation of the E complex, which 
involves the binding of the U1 snRNP to the 5’ splice site and the association of the 
branch point binding protein (BBP) and U2 auxiliary factor (U2AF) to the branch site 
and 3’ pyrimidine tract, respectively (Figure 1.16). The A complex is formed by the 
association of the U2 snRNP to the branch point site through interactions with U2AF 
and BBP, which are subsequently displaced (Will and Luhrmann, 1997). 
 
Prior to associating with the spliceosome the U4, U6 and U5 snRNPs are preassembled 
into the U4/U6.U5 tri-snRNP in Cajal bodies (Schaffert et al, 2004). In the tri-snRNP 
the U4 and U6 snRNAs interact stably through direct base paring while U5 loosely 
associates through interactions between core proteins. The U4/U6.U5 tri-snRNP 
interacts with the spliceosome at the 5’ splice site (Maroney et al, 2000) forming the B 
complex, and results in numerous structural changes creating a complex RNA-RNA 
interaction network between the pre-mRNA and the snRNPs (Figure 1.16). 
 
The structural changes that occur in the formation of complex B cause the displacement 
of the U1 and U4 snRNPs resulting in the U6 and U5 snRNPs directly interacting with 
the U2 snRNP (Hastings and Krainer 2001), forming the C complex. These 
rearrangements bring the 5’ splice site and the branch point into close proximity, which 
in conjunction with other splicing factors results in the release of the intronic lariat and 
ligation of the exons (Figure 1.16). The final enzymatic processes that result in the 
excision of the lariat is not fully understood; however, it is possible that the snRNAs are 
themselves the catalysts forming an active site / ribozyme in coordination with metal 
ions (Yean et al, 2000).  
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Figure 1.16: Pre-mRNA splicing 
The exons are shown as black rectangles while the intron is represented as a white 
rectangle. The 3’ splice site, branch point and 5’ splice site are shown as red ovals. The 
branch point protein (BBP) and U2AF are represented by yellow and blue shapes, 
respectively. The U1 (green), U2 (orange), U4 (red), U6 (yellow) and U5 snRNPs (pale 
green) are represented as coloured circles. The arrows indicate progression of splicing.  
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1.5.3. snRNP Biogenesis 
 
The biogenesis of the U1, U2, U4 and U5 snRNPs is a tightly orchestrated and regulated 
process that occurs in both the cytoplasm and nucleoplasm utilising numerous 
assembly, RNA processing and transport factors (Will and Luhrmann, 2001; Patel and 
Bellini, 2008; Figure 1.17).  
 
1.5.3.1. Transcription and nuclear export 
 
The U1, U2, U4 and U5 snRNAs are transcribed by RNA polymerase II in the 
nucleoplasm from independent genes (Hernandez, 2001). The snRNAs contain their 
own independent promoters with a PSE, which functions as a TATA box, and a DSE, 
which functions as an enhancer. The transcribed pre-snRNAs contain a 5’ m7G cap and 
an extended 3’ sequence (Medlin et al, 2003).  
 
In the nucleoplasm pre-snRNAs are subjected to exonucleoytic processing, which 
results in the production of more stable pre-snRNAs containing a small five to ten 
nucleotide 3’ extension (Medlin et al, 2003). The 5’ m7G cap of pre-snRNAs functions 
as an export signal and is bound by CBP, which recruits PHAX, and in turn binds the 
export receptor CRM1 to form pre-snRNP export complexes (Ohno et al, 2000; Segref 
et al, 2001). The PHAX associated with the pre-snRNP export complexes is 
phosphorylated by CK2 kinase and recruits RanGTP resulting in the export of the 
complexes via the nuclear pore complex (NPC; Figure 1.17). In the cytoplasm PHAX is 
dephosphorylated by protein phosphatase 2A and GTP hydrolysis of Ran causes the 
disassembly of the export complexes (Ohno et al, 2000; Kitao et al, 2008). Once 
disassembly has occurred the protein components of the export complex are recycled 
back to the nucleus.  
 
1.5.3.2. Cytoplasmic modifications 
 
In the cytoplasm the Sm proteins (B/B’, D1, D2, D3, E, F and G) associate with the Sm 
site of the snRNAs forming a heptameric Sm core. The formation of the Sm core is 
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facilitated by the survival of motor neurons (SMN) complex (Paushkin et al, 2002; 
Figure 1.17). 
 
The SMN complex binds preformed Sm sub-complexes (D3/B, D1/D2 and E/F/G), 
which are associated with plCln (a component of PRMT5 (protein arginine 
methyltransferase 5) complex), and then catalyses the formation of the Sm core on the 
pre-snRNAs (Chari et al, 2008). The SMN complex consists of the SMN, Gemins2-8 
and UNRIP (unr (upstream of N-ras) interacting protein) factors, several of which 
interact with the Sm proteins. The SMN protein directly binds the B, D1 and D3 Sm 
proteins (Friesen et al, 2001; Brahms et al, 2001), Gemin3 interacts with the B, D2 and 
D3 Sm proteins (Charroux et al, 1999) and Gemin4 associates with the B, D1, D3 and E 
Sm proteins (Charroux et al, 2000). Gemin5 interact with the B, D1, D2, D3 and E Sm 
proteins (Gubitz et al, 2002), Gemin6 binds to the D2, D3, B and E Sm proteins 
(Pellizzoni et al, 2002) and Gemin7 interacts with the B, D2, D3 and E Sm proteins 
(Baccon et al, 2002; Carissimi et al, 2005). 
 
 In vitro assembly assays, using human cell extracts, showed that SMN and Gemin2, 3, 
4 and 6 are essential for Sm core formation (Sphargel and Matera, 2005; Feng et al, 
2005). Recently, however, a minimal complex consisting of just SMN and Gemin2 has 
been shown to be sufficient to facilitate Sm core formation (Kroiss et al, 2008, Chari et 
al, 2008). This could imply that either some of the Gemin proteins have redundant 
functions in Sm core assembly or that they have roles outside of snRNP biogenesis. 
 
As the Sm proteins are able to spontaneously assemble on snRNAs in vitro (Raker et al, 
1999) the SMN complex, more than likely, functions as either an enhancer of the 
kinetics of Sm core formation or as a regulatory protein ensuring that Sm cores are only 
assembled on snRNAs that fulfil a certain criteria. The SMN complex could function in 
a regulatory role as it binds to a specific site (5’-AUUUUUG-3’) on the snRNAs, a 
certain distance away from the Sm binding site (Yong et al, 2004). Using these markers 
of spatial orientation the SMN complex could determine which snRNAs are suitable for 
Sm core formation. The SMN complex may also thwart spontaneous association of Sm 
proteins on deleterious snRNAs by preventing the formation of a free pool of Sm core 
proteins. Interestingly, Gemin5 is able to interact with the Sm site and parts of adjacent 
stem loops structures of snRNAs independently of the SMN complex (Battle et al, 
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2006). This could indicate that Gemin5 catalyses the formation of the SMN complex on 
the snRNAs.  
 
After the formation of the Sm core the snRNAs 5’ m7G caps are converted to m3G caps 
by TGS1 (Figure 1.17). Interestingly, SMN has been shown to interact with TGS1, 
which could indicate that SMN recruits TGS1 to the snRNAs (Mouaikel et al, 2003). 
Finally in the cytoplasm the 3’ extended sequences of the pre-snRNAs are trimmed by 
yet unidentified factors in metazoans (Wieben et al, 1985). However, in yeast pre-
snRNAs have been shown to be processed by the 3’-5’ cytoplasmic exosome (Allmang 
et al, 1999).  
 
1.5.3.3. Nuclear import  
 
The nuclear import of snRNPs can occur through two pathways, which either use the 5’ 
m3G cap (m3G cap dependent pathway) or the Sm core as a nuclear localisation signal 
(NLS; Sm dependent pathway). Despite the different NLS both pathways utilise the 
nuclear import receptor importin β (Figure 1.17). 
 
In the m
3G cap dependent pathway the nuclear import factor Snurportin1 binds the 5’ 
m3G cap of the snRNAs, via its C terminal domain, and interacts with the import 
receptor importin β, with its N terminal domain (Huber et al, 1998). SMN has been 
proposed to function in the Sm dependent pathway as not only does the SMN complex 
facilitate the formation of the Sm cores but it also interacts with importin β (Narayanan 
et al, 2002). Furthermore, SMN and importin β have been shown to be sufficient for 
snRNP nuclear import (Narayanan et al, 2002; Ospina et al, 2005). The pre-snRNP 
import complexes containing both SMN and Snurportin1 (Narayanan et al, 2002) are 
transported to nucleus through a NPC (Rollenhagen et al, 2003). The dissociation of an 
importin β complex in the nucleoplasm usually requires RanGTP hydrolysis; however, 
this is not the case in snRNP import possibly because the Ran binding site on importin β 
is partially obstructed by Snurportin1 (Vetter et al, 1999; Wohlwend et al, 2007).  
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Figure 1.17: U1, U2, U4 and U5 snRNP biogenesis 
The snRNA is shown as a grey line with the 5’ m7G cap shown as an orange circle and 
the 3’ extended sequence as an orange rectangle. Core proteins and assembly, transport 
and RNA processing factors are represented as coloured shapes. The 5’ m3G cap of 
mature snRNA is shown as by a dark grey circle. The Cajal body is represented as a 
grey outlined box while the nuclear speckle is shown as a solid grey box. Nuclear 
membrane is shown as a thick black line. Nuclear pore complex is represented as black 
ovals. Key steps of biogenesis are indicated. Arrows represent progression of 
biogenesis. 
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1.5.3.4. Nuclear maturation 
 
Once the pre-snRNPs have entered the nucleus they localise to the Cajal bodies where 
the scaRNPs perform pseudouridylation and 2’-O-methylation of target snRNA residues 
(Jady et al, 2003; Figure 1.17). These chemical modifications are essential for the 
function of the snRNPs, for instance the chemical modifications within the first 20 
nucleotides of the U2 snRNA are vital for the formation of the spliceosomal E complex 
(Donmez et al, 2004).  
 
The Cajal bodies have been implicated as the site where the snRNP core proteins are 
associated and the U4/U6 di and U4/U6.U5 tri-snRNPs are formed (Stanek et al, 2003; 
Nesic et al, 2004; Schaffert et al, 2004). Once the final maturation processes in the Cajal 
bodies are complete the mature snRNPs localise to nuclear speckles where they are 
stored until they are required for pre-mRNA splicing (Lamond and Spector, 2003; 
Figure 1.17). 
 
1.5.4. U6 snRNP biogenesis 
 
The U6 snRNA is transcribed from an independent gene with a 3’ terminal stretch of 
uridines by RNA polymerase III. The mature U6 snRNA contains a 5’ γ-
monomethylphosphate (mpppG) cap; however, it is not known at what stage or where 
this cap is formed (Singh and Reddy, 1989).  
 
Unlike the U1, U2, U4 and U5 snRNPs the biogenesis of U6 snRNP is believed to be an 
entirely nuclear process. The 3’ uridine sequence of U6 snRNA is initially bound by the 
La protein, which stabilises the snRNA (Wolin and Cadervall, 2002). A heptameric ring 
of Lsm proteins then replaces the La protein but the mechanisms that facilitate its 
formation are not known (Achsel et al, 1999). The U6 snRNA also undergoes 2’-O-
methylation and pseudouridylation at specific residues; however, unlike the other 
snRNPs these events are performed by the nucleolar snoRNPs (Tycowski et al, 1998; 
(Ganot et al, 1999). The mature U6 snRNPs localise to the Cajal bodies where they are 
formed into the U4/U6 di and U4/U6.U5 tri-snRNPs (Stanek et al, 2003; Nesic et al, 
2004; Schaffert et al, 2004) prior to localising to the nuclear speckles.  
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1.6. SMN and spinal muscular atrophy (SMN)  
 
The SMN complex functions in the assembly of the snRNPs and has also been 
implicated in the biogenesis of telomerase RNPs (Bachand et al, 2002), miRNPs 
(Mourelatos et al, 2002) and snoRNPs (Jones et al, 2001; Pellizzoni et al, 2001; Lemm 
et al, 2006). The SMN complex has been under intense investigation as mutation of the 
gene encoding the SMN1 protein is linked to the neurodegenerative disease SMA. 
 
1.6.1. The SMN complex 
 
The SMN complex consists of SMN, Gemins2-8 and UNRIP. The Gemins were named 
based on the observation that they co-localise with SMN in nuclear Gems and Cajal 
bodies. The SMN complex is found diffusely in the cytoplasm and enriched in Cajal 
bodies and nuclear Gems (Figure 1.18 B; Liu and Dreyfuss, 1996). Interestingly, only 
cytoplasmic SMN complexes contain the UNRIP factor (Carissimi et al, 2005). 
 
The SMN complex is held together through direct interactions between the protein 
components. SMN interacts with Gemin2, 3, 5, 7 and 8 while Gemin4 and 6 associate 
with the complex through interactions with Gemin3 and 7. Gemin8 also interacts with 
Gemin6 and 7. The UNRIP protein interacts with Gemin6 and 7 (Figure 1.18 A). The 
exact stoichiometry of the SMN complex is unknown and it has been proposed that the 
SMN protein self oligomerises resulting in the formation of larger complexes (Paushkin 
et al, 2002). 
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Figure 1.18: SMN structure and localisation 
(A) Schematic diagram of the SMN complex. The SMN complex proteins are shown as 
green ovals.  
(B) Localisation of SMN. HeLa SS6 cells were transfected with a plasmid expressing 
the SMN protein fused to an N terminal FLAG tag. Immunofluorescence was performed 
using anti-FLAG antibodies to detect tagged SMN. Anti-coilin antibodies were used to 
identify the Cajal bodies and DAPI (4,6-diamidino-2-phenylindol) staining of DNA 
used to show nucleoplasm. Merged image of shows SMN (green), coilin (red) and 
DAPI (blue). White arrow indicates a nuclear Gem associated with a Cajal body. The 
bar to the bottom right of the panel represents 5 μm (micrometers).  
(C) Schematic of SMN domain organisation. SMN contains a central tudor domain 
flanked by a N terminal lysine (K) rich sequence, C terminal proline (P) rich sequence, 
and a C terminal domain YG-box (tyrosine glycine). Numerical values above panel 
indicate amino acid number. 
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The SMN protein contains a number of conserved motifs such as an N terminal domain 
K-rich (lysine), which is a characteristic RNA binding motif (Figure 1.18 C; Bertrandy 
et al, 1999), and a central tudor domain, which mediates interactions with the RGG 
motifs of numerous proteins including coilin and the Sm proteins (Selenko et al, 2001; 
Whitehead et al, 2002). The C terminal domain of SMN contains a P-rich (proline) 
sequence that binds the protein profilin, which functions in actin dynamics (Giesemann 
et al, 1999), and an YG-box (tyrosine and glycine) which is potentially involved in 
SMN self association and oligomerisation (Lorson et al, 1998).  
 
A number of the other SMN complex proteins also contain conserved motifs, for 
instance Gemin3 contains a DEAD box RNA helicase motif, which are known to 
function in RNA metabolism (Charroux et al, 1999). Gemin5 houses 13 WD repeats in 
the N terminal domain, which are implicated in coordinating multi-protein complex 
assemblies, and coiled-coil motifs in the C-terminal domain, that have known roles in 
protein dimerization (Gubitz et al, 2002). Furthermore, Gemin5 has been shown to 
associate with snRNAs independently of the SMN complex (Battle et al, 2006). Gemin7 
contains several RGG motifs that are required for the interaction with SMN (Baccon et 
al, 2002). The UNRIP factor contains WD repeats, which are implicated in coordinating 
multiprotein complex assemblies (Carissimi et al, 2005). Gemins2, 4, 6 and 8 have no 
obvious protein motifs (Liu et al, 1997; Charroux et al, 2000; Pellizzoni et al, 2002). 
 
1.6.2. Genetics of SMA 
 
In SMA the anterior horn alpha motor neurons progressively die resulting in atrophy of 
the surrounding muscle due to lack of nervous stimulation. SMA is an inherited disorder 
with around 1 in 6000 children affected and frequently results in early infant mortality 
(Schmalbruch and Haase, 2001). 
 
The SMA locus maps to an inverted 500 kb repeat on chromosome 5q13, which 
contains the SMN1 gene (Wirth, 2000). The cause of SMA in 96 % of cases is a 
mutation that results in the loss of expression of SMN1 (Wirth, 2000). Interestingly, 
humans (and other higher primates) have a second centromeric copy of SMN1 known as 
SMN2 that only differs by five nucleotides. However, a C>T transition at position + 6 
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of exon 7 (840) of SMN2, which is within an exon splicing region, causes the frequent 
skipping of exon7 resulting in the population of expressed SMN2 being around 10 % 
full length and 90 % SMNΔexon7 (Gavrilov et al, 1998; Soler-Botija et al, 2005). 
Despite the loss of exon7 SMN2 appears to be able to compensate for the loss of SMN1 
and allows the survival of some SMN1-deleted patients. In SMA patients the number of 
SMN2 genes correlates with the severity of the disease, for example patients with type 1 
SMA (the most severe form) have one or two copies of SMN2, patients with less severe 
SMA type II have three or four copies of SMN2 while SMA patients carrying five or six 
copies of SMN2 are only moderately affected with the disease (Prior et al, 2004; Wirth 
et al, 2006). The ability of SMN2 to compensate for the lack of SMN1 has also shown 
in a SMA mouse model (Monani et al, 2000). A minority of SMA patients (4 %) have 
mutations in SMN1 that do not prevent its expression but rather disturb the function of 
expressed SMN1 and, so far, around forty of these mutations have been characterised 
(Wirth et al, 1999; Bussaglia et al, 1995; Sun et al, 2005). 
 
The underlying molecular mechanisms that cause the death of alpha neurons and result 
in SMA are not known. Several possibilities have been investigated but it remains 
unclear how the mutation of SMN1, which is required in all cells types, leads to the 
specific degeneration of anterior horn alpha motor neurons. A number of SMN 
functions have been analysed in the context of SMA and these include snRNP 
biogenesis (Zhang et al, 2008), outgrowth and pathfinding of neuritis (McWhorter et al, 
2003), formation of the neuromuscular junction (Chan et al, 2003), axonal RNA 
transport (Rossoll et al, 2003) and muscle specific SMN roles (Rajendra et al, 2007).   
 
1.6.3. SMN, SMA and snRNP biogenesis 
 
The SMN complex is involved in the biogenesis of the spliceosomal snRNPs where it 
functions in Sm core assembly and in processes required for snRNP nuclear import 
(Yong et al, 2004). It is plausible that that dysfunction of snRNP biogenesis could lead 
to SMA due to issues of pre-mRNA splicing.  
 
Experiments in animal models have shown that the injection of purified snRNPs into 
SMN depleted X. laevis and zebrafish embryos is able to prevent the developmental 
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arrest and motor neuron degeneration of the respective embryos (Winkler et al, 2005). 
Investigations into the effect of the SMN mutations on snRNP biogenesis in human 
cells have indicated that binding of Sm core proteins with the snRNAs is disrupted 
(Shpargel and Matera, 2005). For instance SMN lacking exon7 (SMN2) or containing 
SMA type I mutations (I116F, E134K, Q136E, and Y272C) are unable to support 
snRNP formation using in vitro assembly assays (Shpargel and Matera, 2005). It also 
appears that the localisation of snRNPs is affected in environments expressing the 
mutant SMN proteins. For example, in cells expressing SMN lacking exon7 snRNPs 
fail to localise to Cajal bodies (Shpargel and Matera, 2005), a phenotype that is seen in 
SMA patient fibroblast cells (Renvoise et al, 2006). The E134K (tudor domain) and 
Y272C (YG box) SMA causing mutations of SMN have also been shown to prevent the 
nuclear import of SMN and snRNPs (Narayanan et al, 2004).  
 
Analysis of tissues from a SMA mouse model has shown that alterations in pre-mRNA 
splicing are not just occurring in alpha motor neurons but in all cell types (Zhang et al, 
2008). What is particularly interesting is that in different cell types, from the SMA 
mouse model, different pre-mRNAs are affected as well as the repertoires of snRNPs 
(Zhang et al, 2008). A possible explanation for the cell type specific changes in pre-
mRNA splicing is that as each cell type has different sets of splicing factors and the loss 
of SMN results in a unique change in the cellular repertoires of snRNPs, this results in 
cell type specific alterations of pre-mRNA splicing. This differential effect of the loss of 
SMN provides evidence of how the loss or dysfunction of a ubiquitous protein can 
cause tissue specific changes and in the case of SMN the specific death of alpha motor 
neurons in the anterior horn. 
 
1.6.4. SMN, SMA and mRNA trafficking  
 
SMN has been proposed to function in the intracellular trafficking of mRNA in motor 
neurons. Immunocytochemical analysis of neurites and growth cones of cultured 
neurone cells revealed that SMN is enriched in granules that possess bi directional 
cytoskeletal movements consistent with mRNA transport (Zhang et al, 2003; Bassell 
and Singer, 2001). Further evidence of SMN functioning in mRNA transport in neurons 
came from the observation that SMN interacts with two related heterogeneous nuclear 
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RNPs (hnRNP) R and Q that bind mRNA (Rossoll et al, 2002). Interestingly, hnRNP R 
was shown to interact with β-actin mRNA which requires localisation to the growth 
cones and is proposed to be involved in axonal growth. Investigations into the 
relationship between SMN and the hnRNPs revealed that the loss of SMN causes a 
disruption of hnRNP localisation and the subsequent loss of β-actin mRNA from growth 
cones (Rossoll et al, 2003). As the loss of SMN leads to the subsequent loss of β-actin 
mRNA at growth cones this could lead to reduced axonal growth and SMA.  
 
1.6.5. SMN, SMA and muscle specific functions  
Analysis of a Drosophila melanogaster SMA model indicated that dysfunction of a 
muscle specific function of SMN may cause SMA (Rajendra et al, 2007). This SMA 
model revealed that in depleted SMN environments the expression of the muscle 
specific actin isoform actin88F is reduced in the absence of any pre-mRNA splicing 
defect (Rajendra et al, 2007). SMN has also been shown to directly interact with two 
muscle proteins, α-actinin and αβ-crystallin (Rajendra et al, 2007). Furthermore, 
analysis of skeletal muscle tissue from SMN knockout mice and human SMA type III 
patients with no neuronal degeneration revealed dystrophic muscle phenotypes 
(Cifuentas-Diaz et al, 2001; Muqit et al, 2004).  
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1.7. SMN and box C/D snoRNP biogenesis 
 
The SMN complex was linked to box C/D snoRNP biogenesis in a yeast two-hybrid 
screen that indicated that the SMN protein interacts with the box C/D snoRNP common 
core protein fibrillarin (Liu and Dreyfuss, 1996; Jones et al, 2001). This interaction was 
confirmed by in vitro interaction assays and immunoprecipitation assays using human 
cell extracts (Jones et al, 2001; Pellizzoni et al, 2001). Mutational analysis of fibrillarin 
revealed that the N terminal domain RGG motif of fibrillarin mediates the interaction 
with SMN (Pellizzoni et al, 2001; Jones et al, 2001). The identity of the SMN domain 
that interacts with fibrillarin, however, is not clear with one study indicating the YG box 
(Pellizzoni et al, 2001) while another study proposing the tudor domain (Jones et al, 
2001).   
 
SMN is also essential for the correct localisation of box C/D snoRNP common core 
proteins and snoRNA. For instance, in human cells depleted of SMN both fibrillarin and 
NOP56, which are normally found in Cajal bodies and the nucleolus, were displaced 
(Lemm et al, 2006). Furthermore, the expression of a dominant negative SMN 
(SMNΔN27), deficient in snRNP assembly, resulted in the redistribution of fibrillarin 
and U3 snoRNA to structures at the nucleoli periphery, which also contain SMNΔN27 
(Pellizzoni et al, 2001). Taken together this reveals that the presence of functional SMN 
is vital for the localisation of snoRNP factors and suggests that SMN is involved in box 
C/D snoRNP biogenesis.  
 
SMN also interacts with the box H/ACA core protein GAR1 and the expression of 
SMNΔN27 results in the mislocalisation of GAR1 (Jones et al, 2001; Pellizzoni et al, 
2001) indicating that SMN functions in the biogenesis of both box C/D and H/ACA 
snoRNPs.  
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1.8. Sub nuclear structures  
 
The nucleus is a highly organised structure containing a variety of non membrane bound 
compartments and nuclear bodies (Figure 1.19). A number of these nuclear 
compartments and bodies have been implicated in the biogenesis and function of 
snoRNPs, scaRNPs and the snRNPs and these include the nucleolus, the Cajal bodies, 
nuclear Gems and speckles.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.19: Sub nuclear structures 
Schematic representation of the mammalian nucleus highlighting the various sub-
nuclear bodies. Image taken from Spector, 2001.  
 
 
1.8.1. The nucleolus 
 
The most prominent feature of the nucleus is the nucleolus, which is between 3-5 μm in 
diameter (Sirri et al, 2008), and the site where the majority of ribosome synthesis 
occurs. The nucleolus is formed around clusters of rDNA genes arranged in tandem 
repeats known as NORs. In mammalian cells there may be numerous NORs, which 
results in the formation of multiple nucleoli. The nucleolus consists of three sub-
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compartments, the inner FC, the DFC and the GC (Figure 1.20; Schwarzacher and 
Mosgoeller, 2000). The rDNA genes are located, either within, or at the periphery of the 
FC and are transcribed by RNA polymerase Ι at the border between the FC and DFC 
(Chooi and Leiby, 1981). As the pre-rRNA transcript migrates from the FC through the 
DFC and finally the GC it is modified and processed by factors that are localised to 
these compartments.  
 
 
 
       
 
 
 
 
 
 
Figure 1.20: The nucleolus 
An electron microscope image of a human nucleolus. The HeLa cell fixed in 
glutaraldehyde and osmium tetroxide, embedded in Epon and the section contrasted 
with uranyl acetate and lead citrate. The FC is shown by asterisk and is bordered by the 
DFC which is immersed in the GC. Multiple smaller nucleoli are present in addition to 
the indicated nucleoli. Bar embedded bottom right of image represents 0.5 μm. Image 
taken from Sirri et al, 2008. 
 
 
The nucleolus is a dynamic structure, which is dissembled during mitosis and 
reassembled during G1 phase (Leung et al, 2004). Nucleoli also respond to changes in 
metabolic activity and growth rate in order to produce a sufficient supply of ribosomes. 
Given the central role of the nucleolus it is not surprising that it is a tightly regulated 
and has also been implicated in cell cycle regulation and stress responses (Visintin and 
Amon, 2000). 
 
Proteomic analysis revealed that the human nucleolus contains over seven hundred 
proteins (Scherl et al, 2002; Andersen et al, 2002, 2005) with only one third of these 
known to be involved in ribosome biogenesis (Andersen et al, 2005). This could 
indicate that processes other than ribosome biogenesis occur in the nucleolus and based 
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on the identified proteins these may include cell cycle regulation, DNA repair and 
mRNA processing (Boisvert et al, 2007).  
 
1.8.2. Cajal bodies 
 
Cajal bodies (previously known as coiled bodies) are of around 0.1-2.0 μm in diameter  
and depending on cell type and the stage of the cell cycle there are between one and ten 
per cell (Figure 1.21; Spector, 2006). These bodies have been proposed as sites of box 
C/D snoRNP biogenesis (Verheggen et al, 2001, 2002; Boulon et al, 2004), snRNP 
modification (Jady and Kiss et al, 2001; Sleeman and Lamond, 1999), snRNP core 
protein assembly (Nesic et al, 2004) and U4/U6 di-snRNP and U4/U6.U5 tri-snRNP 
formation (Stanek et al, 2003; Schaffert et al, 2004). The protein coilin, which is vital 
for the formation of Cajal bodies, is often used as a marker of the Cajal bodies and most 
likely functions as a structural component (Figure 1.21; Kaiser et al, 2008). SMN is also 
enriched in Cajal bodies and has not only been shown to interact with coilin but is also 
vital for Cajal body formation (Liu and Dreyfuss, 1996; Matera and Frey, 1998; 
Shpargel and Matera, 2005; Lemm et al, 2006; Kaiser et al, 2008). The role of SMN in 
the Cajal bodies is not clear; however, the import of SMN to Cajal bodies has been 
shown to be dependent upon snRNP biogenesis (Matera and Shpargel, 2005).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.21: Cajal bodies 
HeLa SS6 cells were grown on coverslips and fixed using paraformaldehyde. To detect 
Cajal bodies immunofluorescence was performed using anti-coilin antibodies (green). 
DAPI staining of DNA was used to indicate the nucleoplasm (blue). White arrow 
indicates a Cajal body. The bar to the bottom right of the panel represents 5 μm. 
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1.8.3. Nuclear Gems 
 
 
Nuclear Gems are highly enriched in SMN and are sometimes associated with Cajal 
bodies. These bodies appear to be distinct from Cajal bodies, as they do not contain the 
Cajal body marker coilin or snRNPs. The function of this body, however, is not clear 
which has led to the proposal that the Gems and Cajal bodies may simply be different 
manifestations of the same structure (Carvalho et al, 1999; Young et al, 2001; Herbert et 
al, 2002).  
 
1.8.4. Nuclear speckles 
 
Pre-mRNA splicing factors, including the snRNPs, are distributed throughout the 
nucleoplasm and enriched in nuclear speckles, of which there are between twenty-five 
and fifty per cell (Spector, 1993; Fu, 1995). Larger nuclear speckles often correspond to 
interchromatin granule clusters (IGCs) and are irregular in shape and around 08-1.8 μm 
in diameter (Spector, 2006). Nuclear speckles are very dynamic and appear to be 
storage sites for pre-mRNA splicing factors rather than active sites of splicing (Misteli 
et al, 1997). 
 
1.8.5. OPT (oct1 / PTF / transcription) domains 
 
Transcription sites are diffusely located in the nucleoplasm; however, a number of 
transcription factors are concentrated in OPT (oct1 / PTF / transcription) domains. 
There are between one and three OPT domains per cell which are often found located 
close to the nucleolus being between 1.0-1.5 μm in diameter. The OPT domains consists 
of transcription factors and nascent transcripts; however, their function is not clear 
(Pombo et al, 1998).   
 
1.8.6. Cleavage bodies 
 
In addition to being diffusely localised in the nucleoplasm a number of factors involved 
in mRNA 3’ processing are concentrated in cleavage bodies. There are one and four 
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cleavage bodies per cell that are between 0.3-1.0 5μm in diameter, which are sometimes 
localised nearby Cajal bodies (Schul et al, 1996).  
 
1.8.7. Perinucleolar compartment 
 
The perinucleolar compartment is found associated with the surface of the nucleoli and 
has been implicated in RNA metabolism. There are between one and four perinuclear 
compartments per cell of 0.3-1.0 μm in diameter and contain RNA polymerase III 
transcripts as well as RNA binding proteins (Huang, 2000). The function of the 
perinucleolar compartment is not clear but interestingly these structures are 
predominately found in cancer cells (Huang, 2000). 
 
1.8.8. PML (promyelocytic leukaemia) bodies 
 
PML bodies have been linked to transcriptional regulation and nuclear protein 
sequestration. There are between ten and thirty PML bodies per cell that are 0.3-1.0 μm 
in diameter (Maul et al, 2000).    
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1.9. Research aims 
 
The biogenesis of box C/D snoRNPs in human cells has been shown to occur in large, 
dynamic multiprotein pre-snoRNP complexes that consist of snoRNA, common core 
proteins and a variety of assembly, transport and RNA processing factors (Boulon et al, 
2004; Watkins et al, 2004; 2007; McKeegan et al, 2007). The precise function of many 
of these factors and the processes required for the association of the common core 
proteins with the box C/D snoRNA have yet to be fully defined. Furthermore, the 
location of box C/D snoRNP biogenesis is not clear with data indicating the 
nucleoplasm (Terns et al, 1995; Watkins et al, 2004; Boulon et al, 2004), Cajal bodies 
(Verheggen et al, 2001; Boulon et al, 2004; Lemm et al, 2006) and cytoplasm (Baserga 
et al, 1992; Peculis et al, 2001; Watkins et al, 2007).  
 
As the SMN complex has been linked to box C/D snoRNP biogenesis through an 
interaction with fibrillarin this study set out to further analyse the association of 
fibrillarin with the box C/D snoRNP and the role of the SMN complex in this process. 
These aims were broken down into the following objectives: 
 
 Develop assays to investigate box C/D snoRNP biogenesis  
 Investigate the association of fibrillarin with the box C/D snoRNP 
 Analyse the interactions of fibrillarin with box C/D snoRNP assembly factors 
 Characterise the interactions between the SMN complex and box C/D pre-
snoRNP factors 
 Determine the role of the SMN complex in box C/D snoRNP biogenesis 
 Analyse the interaction of Snurportin1 with the box C/D pre-snoRNP and the 
SMN complex  
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Chapter two 
 
 
 
 
Materials and methods 
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2.1. General molecular biology 
 
2.1.1. Polymerase chain reaction (PCR)  
 
PCR (polymerase chain reaction) was used to amplify DNA (deoxy ribonucleic acid) of 
interest. PCR reactions were set up using 100-500 ng (nanograms) of template DNA, 1 
x Qiagen PCR buffer (containing 15 mM (milliMolar) MgCl2), 0.2 mM dNTP 
(deoxyribonucleotide triphosphate), 200 mM forward primer, 200 mM reverse primer 
and 2.5 units (U) of HotstarTaq DNA polymerase (Qiagen), in a total volume of 100 µl 
(microlitre). The HotstarTaq DNA polymerase required incubation at 95 °C for 15 
minutes for activation. 
 
2.1.2. Agarose gel electrophoresis 
 
1 x loading buffer (40 % glycerol (v/v), 60 % TE buffer (Tris-ethylene diamine tetra-
acetic acid [EDTA]) (v/v), 10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and 1 x 
bromophenol blue was added to the DNA to be analysed. DNA samples were loaded 
onto an appropriate percentage agarose gel, containing 0.035 µg/ml (microgram per 
millilitre) ethidium bromide, and run in 1 x TAE (Tris-Acetate EDTA) buffer (400 mM 
Tris-HCl, 20 mM acetic acid, 0.1 mM EDTA, pH 8.0) at 80 volts for 1 hour. The gel 
was visualised using ultraviolet light and a Syngene gel imaging and documentation 
system.  
 
2.1.3. DNA extraction and purification from agarose gel 
 
DNA was removed from the agarose gel by means of a razor blade and purified using a 
QIAquick gel extraction kit (Qiagen), according to manufacturers guidelines.  
 
2.1.4. DNA quantification  
 
DNA concentration was determined by spectrophotometry with absorbance measured at 
wavelengths of 260 and 280 nm (nanometers). The purity of DNA was analysed by the 
ratio of absorbance at 260 / 280 nm.  
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2.1.5. Restriction enzyme digestion 
 
Typically 0.2-1.5 µg of DNA was digested using 10 U of the required restriction 
endonuclease (Promega) in a final volume of 20 µl, which also contained 1 x restriction 
enzyme buffer (as described by manufacturer). Digestion was performed at 37 °C for 
two hours. 
 
2.1.6. Ligation of isolated DNA into plasmid 
 
Ligation reactions were performed with a three to one ratio of insert DNA to plasmid 
DNA. A typical ligation reaction contained 3 U of T4 DNA ligase (Promega), 1 x T4 
DNA ligase buffer (as described by manufacturer) and DNA in a final volume of 10 µl, 
which was incubated overnight at 4 °C. 
 
2.1.7. Transformation of bacteria with plasmids  
 
To propagate plasmids 50 ng of DNA (or 5 µl of a ligation reaction (Chapter 2.1.6)) was 
added to 100 µl of chemically competent DH5 Escherichia coli (E. coli; provided by 
K.S.McKeegan, Newcastle University, UK) and cells stored on ice for 20 minutes. The 
cells were subjected to heat shock treatment at 42 °C for 45 seconds and incubated on 
ice. After 2 minutes 200 µl of luria broth (LB) was added to the cells and the sample 
incubated for 1 hour at 37 °C with constant agitation. Following incubation the cells 
were streaked on LB agar plates, containing appropriate antibiotics for the selection of 
successful transformations, and plates incubated at 37 °C overnight. Single colonies 
were picked from the LB plates and grown in 5 mls of LB, containing the appropriate 
antibiotic for selection. The samples were grown overnight at 37 °C in a rotating 
incubator set at 225 revolutions per minute (rpm). DNA was extracted from the samples 
using a QIAprep Spin Miniprep kit (Qiagen), according to manufacturers guidelines.  
 
2.1.8. DNA sequencing 
 
To confirm that the correct insert had been cloned into the plasmids restriction digests 
were performed as described in Chapter 2.1.5. Furthermore, to ensure that no mutations 
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had occurred during PCR plasmids were sent for DNA sequencing, which was 
performed by GATC Biotech.  
 
2.2. DNA constructs  
 
2.2.1. U3 and U14 box C/D snoRNA pcDNA5 expression plasmids 
 
To create a pcDNA5/FRT/TO plasmid that expressed mouse U14 (mU14) snoRNA a 
section of the mouse hsc70 gene, consisting of intron 5 (containing the U14 snoRNA) 
and sections of the surrounding exons 5 and 6, was amplified by PCR (primers listed in 
Table 2.1) from an hsc70 expression plasmid (pRLMU14.5; Watkins et al, 1996). The 
amplified DNA was cloned into the BamHI and XhoI restriction sites of the 
pcDNA5/FRT/TO plasmid (Invitrogen).  
 
Table 2.1: Primers used to create mU14 and StreptoTag U3 pcDNA5/FRT/TO 
expression plasmids 
 
 
 
To create a pcDNA5/FRT/TO plasmid that expressed human U3 snoRNA under Tet 
regulation a Tet-operator 2 (Tet02) sequence (5´-TCCCTATCAGTGATAGAGA-3´) 
was inserted into the U3 snoRNA promoter region. To create these Tet inducible U3 
snoRNAs PCR was performed on a pCR4 TOPO plasmid (Invitrogen) that expressed 
human U3 snoRNA with a streptavidin tag (StreptoTag U3; Granneman et al, 2004). 
The first round of PCR was performed using either the StreptoTag U3 A-1 or A-2 
primers (Table 2.1), which inserted the Tet02 sequence between the PSE and U3 
snoRNA sequence (Figure 2.1). The use of different primer combinations inserted the 
Tet02 sequence in slightly different locations (Figure 2.1). The product of the first round 
Primer  Sequence 
mU14 (hsc70) forward 5'-GCGCGGTACCCTGCAAGACTTCTTCAATGG-3’ 
mU14 (hsc70) reverse 3'-GCGCCTCGAGGAGTGACATCCAAGAGC-5’ 
StreptoTag U3 A-1 F 3'-CTGATAGGGATTCTCTATCACTGATAGGGACAAACTTTTAAACTGATGGCG-5' 
StreptoTag U3 A-1 R 5'-GTGATAGAGAATCCCTATCAGTGATAGAGATTAAGACTATACTTTCAGGG-3' 
StreptoTag U3 A-2 F 3'-GATAGGGATGCTATCTCTATCACTGATAGGGACTTTTAACTGATGGCGAGAAAC-5 
StreptoTag U3 A-2 R 5'-GATAGAGATAGCATCCCTATCAGTGATAGAGATTAAGACTATACTTTCAGGG-3' 
StreptoTag U3 B F 5'-ACGCGTATGCGAGATCTCTGCAGCTTTGAA-3' 
StreptoTag U3 B R 3'-ACGCGTATGCGAGATCTCCCGAGATCG-5 
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of PCR was then amplified using the StreptoTag U3 B primers (Table 2.1) and cloned 
into the mlu1 restriction site of the pcDNA5/FRT/TO expression plasmid, upstream of 
the CMV (cytomegalo virus) promoter (see Figure 2.2). 
 
         PSE           U3 snoRNA 
GTTAAAAGTTTGCGGCAGATGTAGACCTAGCAGAGGTGTGCGAGGAGGCCGTTAAGACTATACTTTCAG 
                    
GTTAAAAGTTTGTCCCTATCAGTGATAGAGAAGAGGTGTGCGAGGAGGCCGTTAAGACTATACTTTCAG 
             
GTTAAAAGTTTGCGGCAGATGTAGACCTAGCATCCCTATCAGTGATAGAGATTAAGACTATACTTTCAG 
             
Figure 2.1: Tet-responsive U3 box C/D snoRNA promoter 
The top panel shows a section of the U3 box C/D snoRNA gene with the PSE (proximal 
sequence element; white lettering on black background), U3 snoRNA sequence (white 
lettering on red background) and intervening sequences (black lettering). Middle and 
bottom panels show the location of the inserted Tet02 operator sequences (Blue text). 
 
 
2.2.2. Fibrillarin and SMN pcDNA5 expression plasmids 
 
Human fibrillarin and SMN were both cloned into a modified a pcDNA5/FRT/TO 
expression plasmid, which contained DNA coding for two FLAG tags (N-
DYKDDDDK-C; 2 x FLAG) and a tag consisting of six histidines (6 x His), both 
downstream of the transcription start site (modified plasmid provided by A.Knox, 
Newcastle University, UK). These tags were expressed fused to the N terminal domain 
of any insert cloned into the multiple cloning site (Figure 2.2). The DNA inserted into 
the pcDN5/FRT/TO expression plasmid, which codes for the 2 x FLAG and 6 x His 
tags, is as follows: 
 
5’-ATG GAC TAC AAA GAC GAT GAC GAT AAA GAC TAC AAA GAC GAT GAC GAT AAA 
GGT CAC CCA GGA TCA CTG GAA GTT CTG TTC CAG GGG CCC CTG CAT CAC CAC CAT 
CAC CAT GGA TC-3’ 
 
Fibrillarin cDNA was amplified by PCR using primers in Table 2.2 from a pCINeo 
VSV-fibrillarin expression plasmid (provided by G.Pruijn, Nijmegen centre for 
molecular life sciences, Netherlands). SMN cDNA was amplified using primers from 
Table 2.2 from a SMN pET17b expression plasmid (provided by U.Fischer, University 
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of Wurtzberg, Germany). The fibrillarin and SMN cDNAs were cloned into BamHI and 
XhoI restriction sites of the modified pcDNA5/FRT/TO expression plasmid.  
 
 
Primer  Sequence  
fibrillarin forward 5'- CGCGGGATCCATGAAGCCAGGATTCAGTCCCCG-3’ 
fibrillarin reverse 3’-CGCGCTCGAGTCAGTTCTTCACCTTGGGGGGTGG-5’ 
SMN forward 5'-CGGGGGATCCATGGCGATGAGCAGCGGCGG-3’ 
SMN reverse 3'-CGCCTCGAGTTAATTTAAGGAATGTGAGCACC-5’ 
 
Table 2.2: Primers used to create fibrillarin and SMN pcDNA5/FRT/TO 
expression plasmids 
 
 
2.2.3. Degradation domain (DD) proteotuner plasmid 
 
To express human fibrillarin fused to an N terminal degradation domain (DD) fibrillarin 
cDNA with 2 x FLAG and 6 x His tags was amplified by PCR (Table 2.3), from the 
modified pcDNA5/FRT/TO plasmid (Chapter 2.2.2.), and cloned into the ecoR47III and 
XhoI restriction sites of the pPTuner IRES2 reporter plasmid (Clontech; DD-fibrillarin 
reporter plasmid). 
 
Primer Sequence  
pTuner fib forward 5'-GCGCAGCGCTATGGACTACAAAGAC-3' 
pTuner fib reverse 3'-CGCGCTCGAGTCAGTTCTTCACCTTGGGGGGTGG-5' 
 
Table 2.3: Primers used to create DD-fibrillarin reporter plasmid 
 
 
2.2.4. Fibrillarin deletion mutants 
 
Human fibrillarin deletion mutants were produced by PCR amplification (Table 2.4) of 
human fibrillarin cDNA from a pCINeo VSV-fibrillarin plasmid (provided by G.Pruijn, 
Nijmegen centre for molecular life sciences, Netherlands). The amplified fibrillarin 
deletion mutants (with the exception of N-fibrillarin) were cloned into pGEMT-easy 
plasmids (Promega) as described by the manufacturer. The N-fibrillarin deletion mutant 
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was amplified by PCR and cloned into a pET100 directional plasmid (Invitrogen) as 
described by the manufacturer. The fibrillarin deletion mutants were sub cloned from 
the pGEMT-easy plasmids into pECFP-C1 plasmids (Clontech) using HindIII and 
BamH1 restriction sites and also into pET17b expression plasmids (Invitrogen) using 
HindIII and Xba1 restriction sites. 
 
Primer  Sequence 
full length fibrillarin 5’-ATGAAGCCAGGATTCAGTCCCCG-3’ 
  3’-TCAGTTCTTCACCTTGGGGGGTGG-5’ 
R-fibrillarin 5'-ATGAAGCCAGGATTCAGTCCCCG-3' 
(amino acids 1-81) 3'-TCACGACTGGTTTCCTCTTTTTCCTCCC-5'   
R-N-fibrillarin 5’-ATGAAGCCAGGATTCAGTCCCCG-3’ 
(amino acids 1-141) 3’-TCAGGGGTTCCAGGCTCGGTACTC-5’ 
N-C-fibrillarin 5’-ATGGGGAAGAATGTGATGGTGGAG-3’ 
(amino acids 82-321) 3’-TCAGTTCTTCACCTTGGGGGGTGG-5’ 
C-fibrillarin 5’-ATGCGCTCCAAGCTAGCAGCAGCAATCC-3’ 
(amino acids 142-321) 3’-TCAGTTCTTCACCTTGGGGGGTGG-5’ 
N-fibrillarin 5’-CACCGGATCCATGGGGAAGAATGTGATGGTGGAG-3’ 
(amino acids 82-141) 3'-CTCGAGTCAGGGGTTCCAGGCTCGGTACTC-5'   
 
Table 2.4: Primers used to create fibrillarin deletion mutants 
 
 
2.3. Cell culture, cell transfection and extract preparation 
 
2.3.1. Cell culture 
 
Human HeLa SS6 (cervical carcinoma) and human HEK293 (embryonic kidney) cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Sigma). Media was 
supplemented with 100 µg/ml streptomycin (Sigma), 100 U/ml penicillin (Sigma) and 
10 % foetal bovine serum (FBS, Sigma). Cells were grown at 37 °C with 5 % carbon 
dioxide in a humidified incubator and split when 80 % confluent using trypsin (Sigma). 
 
For long-term storage an 80 % confluent flask of cells was washed in phosphate 
buffered saline (PBS) and cells harvested using 1 ml of trypsin. The trypsin in the 
harvested cells was neutralised by the addition of 10 x volume of DMEM media and 
 65 
cells pelleted using a swing bucket centrifuge at 600 rpm for 5 minutes. The supernatant 
was removed from the cell pellet and the cells resuspended in 1ml of freezing buffer (10 
% DMSO, 90 % FBS) and dispensed into cryo-vials (Greiner). The cryo-vials 
containing cells were stored at –80 °C overnight then transferred to liquid nitrogen.   
 
To prepare cells from a frozen stock the cryo-vials (containing frozen cells) were 
rapidly thawed in a 37 °C water bath and transferred to a sterile 10 ml centrifuge tube 
(Greiner) and diluted in 10 mls of warm DMEM media. The cells were then centrifuged 
at 600 rpm for 5 minutes, supernatant discarded and pellet resuspended in 10 mls 
DMEM media and transferred to a cell culture flask.  
 
2.3.2. Development of inducible HEK293 cells  
 
The Tet-inducible mU14, U3 box C/D snoRNA, FLAG-fibrillarin, FLAG-SMN and 
control HEK293 cell lines were developed using the Flp-In T-Rex HEK293 cell system, 
as described by the manufacturer (Invitrogen). 
 
The Flp-In T-Rex HEK293 cells contain a single integrated FRT (Flp Recombination 
Target) site and stably express the Tetracycline (Tet) repressor protein. To create 
inducible cell lines the gene of interest was cloned into a pcDNA5/FRT/TO expression 
plasmid, which contains a Tet-inducible promoter, FRT site and hygromycin resistance 
gene (see Chapter 2.2.1 and 2.2.2). The Flp-In T-Rex HEK293 cells were then co-
transfected with the pcDNA5/FRT/TO plasmid (containing gene of interest) and the 
pOG44 plasmid (Invitrogen), which expresses Flp recombinase and mediates 
integration of pcDNA5/FRT/TO plasmid into FRT sites. Transformed HEK293 cells 
were grown in media supplemented with 10 µg/ml of blastocidin and 100 µg/ml of 
hygromycin to select and maintain the Tet-repressor and pcDNA5/FRT/TO inserts, 
respectively. Cells were induced by the addition of 1 µg/ml Tet. 
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Figure 2.2: Schematic representation of integrated pcDNA/FRT/TO plasmids 
Schematic diagram of Tet-inducible (A) mU14 (B) human U3 box C/D snoRNAs and 
(C) 2 x FLAG and 6 x His tagged SMN and fibrillarin in a pcDNA5/FRT/TO 
expression cassette incorporated into the Flp-In T-Rex HEK293 FRT site. The 
incorporation of the pcDNA5/FRT/TO plasmid at the FRT recombination site inserts a 
PSV40 (Simian virus 40 promoter) and ATG start site to the hygromycin resistance gene. 
The pUC origin indicated was required for pcDNA5/FRT/TO plasmid propagation in E. 
coli and the Amp (Amplicillin gene) was used for selection. BGH pA (Bovine growth 
hormone polyadenylation signal) was required for efficient termination and 
polyadenylation of mRNA expressed from the CMV promoter. (B) The StreptoTag U3 
snoRNA gene was inserted upstream of the CMV promoter as it contained its own Tet-
inducible promoter.   
 67 
2.3.3. Electroporation  
 
An Amaxa II electroporator was used to transfect HeLa SS6 and HEK293 cells with 
siRNA duplexes and plasmids. Optimal protocols were used for transfection of HeLa 
SS6 cells (programme I-013, Kit R; Amaxa) and HEK293 cells (programme A-023, Kit 
V; Amaxa) as described by manufacturer. For each million cells 2 µg of plasmid DNA 
or siRNA was transfected.   
 
2.3.4. Chemical transfection of plasmids 
 
Cells were grown in 0.5 ml tissue culture wells and transfected with 2 µg of plasmid 
DNA using FuGENE 6 transfection reagent (Roche Applied Science) as described by 
manufacturer.  
 
2.3.5. siRNA mediated depletion  
 
To deplete target proteins in human cells siRNA mediated depletion was utilised. As a 
control, a siRNA duplex targeting firefly luciferase mRNA (GL2), which is not present 
in either HeLa SS6 or HEK293 cells was used. The GL2 siRNA duplex and has no 
effect on HeLa SS6 cell growth or RNA levels (Elbashir et al, 2002).  
 
To anneal siRNAs 20 µM of each sense siRNA strand was added to annealing buffer 
(100 mM KOAc, 2 mM MgOAc, 30 mM HEPES-KOH (4-(2-Hydroxyethyl)piperazine-
1-ethanesulfonic acid) [pH 7.4]), denatured at 90 °C for 1 minute and then incubated at 
37 °C for 1 hour (Elbashir et al, 2002). The siRNA duplexes were stored at –20 °C.  
  
HeLa SS6 cells or HEK293 cells were transfected with siRNA duplexes using 
electroporation as described in Chapter 2.3.3. For chemical transfection 20,000 cells 
were grown on glass coverslips in 0.5 ml cell culture wells. Twenty-four hours later 
cells were transfected with 3 µl of 20 µM siRNA duplexes (per well; Table 2.5) using 
oligofectamine (Invitrogen) as described by Elbashir et al, 2002 and cells harvested or 
fixed after 60 hours.  
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Table 2.5: The siRNA duplexes 
 
 
2.3.6. Cell extract preparation 
  
For extract production two 162 cm2 flasks of cells were grown to 80 % confluency and 
harvested using trypsin. Cells were pelleted by centrifugation in an Eppendorf minifuge 
set at 300 rpm for 1 minute and washed with PBS.  
 
To produce whole cell extracts the cell pellet was resuspended in 1 ml of cold GL50E 
buffer (1.5 M KCl, 200 mM HEPES, 5 mM EDTA) and sonicated (on ice) using a 
Bandelin Sonopuls HD2070 ultrasonic homogeniser (with a 2 mm diameter MS72 
titanium microtip) set at (6 x) 20 seconds continuous sonication (at 30 % power) with 
40 seconds off (in between pulses). Triton-X100 was then added to the sample to a 
concentration of 0.2 % (v/v) and insoluble material removed by centrifugation (using a 
Eppendorf minifuge) at 13,000 rpm (4 °C) for 10 minutes (Granneman et al, 2004). The 
supernatant was removed and pellet discarded. The cell extract was then either frozen in 
liquid nitrogen and stored at –80 °C or used directly in an assay. 
 
To produce nucleoplasmic and nucleolar extracts cells were harvested as described for 
whole cell extracts. The following protocols were adapted from Jones et al, 2001 and all 
steps were performed on ice or in centrifuges at 4 °C. Cell pellets were resuspended in 
0.5 mls of cold lysis buffer 1 (10 mM Tris-HCl [pH 7.5], 10 mM KCl, 2 mM MgCl2, 
0.05 % Triton-X100 (v/v), 1 mM DTT (dithiothreitol) / 1 x complete mini protease 
Target  Accession  siRNA sense sequence Source 
GL2 X65324 5'-CGUACGCGGAAUACUUCGAUU-3' Elbashir et al, 2002 
NOP56 NM_006392 5'-CAAUAUGAUCAUCCAGUCCAUUA-3' Watkins et al, 2004 
NOP58 NM_015934 5'-CAAGCAUGCAGCUUCUACCGUUC-3' Watkins et al, 2004 
fibrillarin NM_001436 5'-CAGUCGAGUUCUCCCACCGCUCU-3' Watkins et al, 2004 
SMN XM_041492 5'-GUGGAAUGGGUAACUCUUCUU-3' I.Lemm, Max Planck Institute, Germany 
Gemin2 NM_003616 5'-GUACAGAUUUCAACACAUCUU-3' I.Lemm, Max Planck Institute, Germany 
Gemin5 BI868900 5'-GUUUGAAUCAACCCUGCCUUU-3' I.Lemm, Max Planck Institute, Germany 
Gemin6 NM_024775 5'-GACUAUAUUUUAUCCCUCAUU-3' I.Lemm, Max Planck Institute, Germany 
Gemin7 NM_024707 5'-CCUUCAAGCCAUAAAGAUAdTdT-3' I.Lemm, Max Planck Institute, Germany 
hPRP31 NM_015629 5'-AAGCCAAAGCUUCAGAAGUGAUG-3' Schaffert et al, 2004 
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inhibitor cocktail from Roche) and swelled on ice for 20 minutes. Crude nuclear extract 
was then produced by forcing the cell lysate through a 25 gauge needle (5 x) followed 
by centrifugation (using a Eppendorf minifuge) at 3,000 rpm for 5 minutes. The nuclear 
pellet was resuspended in 0.5 ml lysis buffer 1 and sonicated using a Bandelin Sonopuls 
HD2070 ultrasonic homogeniser (with a 2 mm diameter MS72 titanium microtip) set at 
(6 x) 20 seconds continuous sonication (at 30 % power) with 40 seconds off (in between 
pulses). The nucleoli and nucleoplasm was separated by centrifugation (using a 
Eppendorf minifuge) at 8,000 rpm for 5 minutes. The supernatant contained 
nucleoplasmic extract while the pellet was enriched in nucleoli. The nucleoplasmic 
extract was then either snap frozen in liquid nitrogen and stored at –80 °C or used 
directly in an assay. 
 
The enriched nucleoli pellet was resuspended in 0.5 ml lysis buffer 2 (10 mM Tris-HCl 
[pH 7.5], 300 mM KCl, 2 mM MgCl2, 0.05 % Triton-X100 (v/v), 1 mM DTT, 1 x 
complete mini protease inhibitor cocktail from Roche) and swelled on ice for 45 
minutes. The sample was then subjected to sonication, as performed with the 
nucleoplasmic extract, and insoluble material removed by centrifugation (using an 
Eppendorf minifuge) at 13,000 rpm for 5 minutes. The supernatant was removed 
(containing the nucleoli extract) and either snap frozen in liquid nitrogen and stored at –
80 °C or used directly in an assay. 
 
2.3.7. Glycerol gradients preparation 
 
To produce a 10-30 % glycerol gradient 6.5 mls of a 10 % glycerol solution (150 mM 
KCl, 20 mM HEPES, 1.5 mM MgCl2, 10 % glycerol (v/v), 0.02 % Triton-X100 (v/v), 1 
mM DTT) was added to a Beckman SW40 gradient tube. A 30 % glycerol solution (150 
mM KCl, 20 mM HEPES, 1.5 mM MgCl2, 30 % glycerol, 0.2 mM DTT) was then 
added to the bottom of the tube using a large needle until the interface between the two 
solutions reached halfway up the tube. The 10-30 % glycerol gradient was made on a 
gradient master 107ip (Biocomp) set to the SW40 protocol at an angle of 81.5, speed 15 
for 2 minutes 20 seconds. The glycerol gradients were then chilled at 4 °C for 1 hour.  
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Cell extract was applied to the top of the 10-30 % glycerol gradient and the sample 
centrifuged in Beckman optima L-100 ultra centrifuge using a Sw60ti rotor at a speed of 
40,000 rpm for 3 hours 30 minutes at 4 °C with acceleration and deceleration set at 5. 
Fractions were collected from the top of the gradient. 
 
2.3.8. Immunoprecipitation (IP) 
 
Protein G Sepharose beads (GE Healthcare) were washed (3 x) with 1 ml PBS 
containing 0.1 % Triton-X100 (v/v), centrifuged at 300 rpm using an Eppendorf 
minifuge for 1 minute and supernatant discarded. Antibodies against the protein of 
interest were added to 10 µl of washed protein G Sepharose beads, volume made up to 
300 µl with PBS containing 1 % Triton-X100, and incubated on a head over tail blood 
wheel (at 6 rpm) for 1 hour at room temperature or overnight at 4 °C. Following 
incubation the protein G Sepharose beads were washed (3 x) using wash buffer (20 mM 
HEPES [pH 8], 150 mM NaCl, 3 mM MgCl2, 0.5 mM DTT, 10 % glycerol (v/v), 0.1 % 
Triton-X100 (v/v)) as described earlier. Protein G Sepharose beads (with immobilised 
antibodies) were incubated with the cell extract of interest made up to 300 µl with wash 
buffer on a head over tail blood wheel (6 rpm) for 2 hours at 4 °C. As an input / control 
10 % of cell extract was retained. IP samples were washed (3 x) with 1 ml of wash 
buffer (as above), transferred to a new tube (to reduce background) and precipitated 
factors removed from beads using homogenisation buffer (1 % SDS (w/v), 50 mM Tris-
HCl [pH 7.5], 50 mM NaCl, 0.5 mM EDTA).  
 
2.4. Protein separation and analysis  
 
2.4.1. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
Protein samples were combined with 1 x protein loading buffer (75 mM Tris-HCl [pH 
6.8], 1.25 mM EDTA, 20 % glycerol (v/v), 2.5 % SDS (w/v), 0.125 mM bromophenol 
blue), supplemented with 200 mM DTT and denatured at 95 °C for 5 minutes. Samples 
were loaded onto a denaturing SDS-PAGE consisting of a 4 % acrylamide stacking gel 
(4 % acrylamide (37.5:1 acrylamide: bisacrylamide), 125 mM Tris-HCl [pH 6. 8], 0.1 % 
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SDS (w/v)) and a 12 % acrylamide resolving gel (12 % acrylamide (37.5:1 acrylamide: 
bisacrylamide), 375 mM Tris-HCl [pH 8.8], 0.1 % SDS (w/v)). The 12 % denaturing 
SDS-PAGE gel was run at 200 volts in 1 x running buffer (25 mM Tris [pH 8.3] / 250 
mM glycine, 0.1 % SDS (w/v)) until dye front reached the end of the gel. 
 
2.4.2. Coomassie blue staining 
 
To visualise proteins the SDS-PAGE gel was stained using Coomassie blue staining 
solution (0.1 % Coomassie blue (w/v), 40 % methanol (v/v), 10 % acetic acid (v/v)) for 
30 minutes with gentle agitation. The gel was then destained using destaining solution 
(40 % methanol (v/v), 10 % acetic acid (v/v)), which was replenished several times until 
the gel is fully destained, and proteins visible.  
 
2.4.3. Western blot assays 
 
Proteins separated on an SDS-PAGE gel were transferred to nitrocellulose membrane 
(Protan) using a Western blot transfer tank containing transfer buffer (25 mM Tris base, 
150 mM glycine, 10% methanol, [pH 8.3]) run at 40 volts for 2 hours. Nitrocellulose 
membranes were incubated with blocking buffer (PBS, 3 % milk powder (w/v), 0.05 % 
tween 20 (v/v)) for 1 hour at room temperature or overnight at 4 °C. Antibodies were 
diluted to desired concentration in blocking buffer and incubated with the membrane for 
2 hours at room temperature. Membranes were washed (3 x) for 5 minutes and (2 x) 15 
minutes in PBS containing 0.05 % tween 20 (v/v). Secondary HRP (horse radish 
perodixase) conjugate antibody was diluted in blocking buffer and incubated with the 
membrane for 2 hours and washed the same as with the primary antibody. Results were 
visualised using ECL detection (enhanced chemiluminescence; GE healthcare) and 
hyperfilm (Amersham) as described by the manufacturer. 
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Table 2.6: Antibodies used in Western blots assays 
 
 
2.5. RNA extraction, separation and analysis  
 
2.5.1. RNA extraction and seperation 
 
To extract RNA from a cell pellet or IP assay (of around 100 µl) 200 µl of 
homogenisation buffer (Chapter 2.3.8) and 200 µl of phenol: chloroform: isoAmyl 
Alcohol (25:24:1) [pH 6.6 / 8.0] was added, sample vortexed for ~30 seconds and 
centrifuged (using a Eppendorf minifuge) for 3 minutes at 13,000 rpm. The upper 
aqueous phase containing RNA was removed and added to a new tube. RNA was 
precipitated from the sample by the addition of 10 µl of 5 M NaCl and 1 ml of 100 % 
ethanol. The sample was then vortexed, stored at –80 °C for ~30 minutes and 
centrifugation performed (using a Eppendorf minifuge) for 15 minutes at 13,000 rpm. 
Supernatant was removed and RNA pellets left to dry. The resulting RNA pellet was 
dissolved in water and mixed 1:1 with RNA loading buffer (62.5 % formamide, 9.25 % 
formaldehyde, 1.25 x MOPS buffer (3-morpholinopropanesulfonic acid), 50 µg/ml 
bromophenol blue, 50 µg/ml xylene cyanol). Samples were denatured at 95 °C for 2 
minutes then cooled on ice. RNA samples were separated by electrophoresis on an 8 % 
Antibody Raised in Raised against Manufacturer / source Code 
anti-fibrillarin rabbit human fibrillarin Santa Cruz sc-25397 
anti-NOP56 rabbit human NOP56 peptide 
N.J.Watkins;  
Watkins et al, 2000, 2002 N/A 
anti-NOP58 rabbit human NOP58 peptide 
N.J.Watkins;  
Watkins et al, 2000, 2002 N/A 
anti-nucleolin rabbit human nucleolin Abcam ab22758 
anti-SMN (7B10) mouse human SMN 
U.Fischer;  
Jones et al, 2001 N/A 
anti-Gemin2 (H-100) rabbit human Gemin2 Santa Cruz sc50404 
anti-FLAG M2 mouse FLAG sequence Sigma F3165 
anti-Poly histidine mouse polyhistidine sequence Sigma H1029 
anti-mouse immunoglobulin 
HRP conjugate rabbit mouse immunoglobulin Dako P0260 
anti-rabbit immunoglobulin 
HRP conjugate donkey rabbit immunoglobulin Santa Cruz sc-25397 
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acrylamide gel containing 7 M urea in 1 x TBE buffer and run at 350 volts until dye 
front reach the end of the gel. 
 
2.5.2 Northern blot hybridisation 
 
RNA that had been separated on an 8 % acrylamide gel containing 7 M urea (Chapter 
2.4.1), was transferred to Hybond N membrane (Amersham biosciences) using a Trans-
Blot ® Cell (BIO-RAD) overnight at 18 volts (4 °C) in transfer buffer (25 mM NaPO4 
[pH 6.4]). The RNA was then fixed to the membrane using an ultraviolet Stratalinker 
2400 (Stratagene). 
 
Radiolabelled probes against the U3, U8 and U14 box C/D snoRNAs and the U1 
snRNA were produced as described by Watkins et al, 2004. To produce a radiolabelled 
probe against 7SL random primer labelling was utilised. The S domain of 7SL was 
amplified by PCR (using primers in Table 2.7) from a 7SL expression plasmid provided 
by K.Nagai, MRC laboratory of molecular biology, UK (Menichelli et al, 2007). Fifty 
nanograms of the 7SL PCR product was diluted in 10 µl H2O, denatured at 95-100 °C 
for 5 minutes then placed on ice. Once cooled 3 µl of random hexamer mix (250 mM 
Tris [pH 7.5], 50 mM MgCL2, 5 mM DTT, 500 µM dATP, 500 µM dGTP, 500 µM 
dTTP, 150 µg/ml random deoxribonucleotides from Amersham), 2 µl of α-32P labelled 
dCTP and 5 U of klenow polymerase (Promega) was added, and the sample incubated at 
37 °C for 30 minutes. To remove unincorporated nucleotides the 7SL probe was made 
up to 50 µl and spun through a G-50 spin column (GE Healthcare).  
 
Primer Sequence 
7SL forward 5'-CTATGCCGATCGGGTGTCCGC-3' 
7SL reverse 3'-CAGCACGGGAGTTTTGACCTGC-5' 
 
Table 2.7: Primers used to create 7SL probe 
 
Northern blot analysis was performed by incubating the Hybond N membrane, 
containing the fixed RNA, with hybridisation buffer (25 mM NaPO4 [pH 6.5], 6 x SSC 
(Sodium chloride- sodium citrate), 5 x Denhardts, 0.5 % SDS (w/v), 50 % deionised 
formamide, 100 µg/ml denatured salmon sperm DNA) for 2 hours at 42 °C. The 
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radiolabelled probe was denatured at 95-100 °C for 5 minutes then added directly to 
hybridisation buffer containing the membrane and incubated overnight at 42 °C. The 
membrane was washed once with 2 x SSC containing 0.5 % SDS (w/v) to remove 
excess probe, washed twice with 2 x SSC containing 0.5 % SDS (w/v) for 5 minutes at 
room temperature (with constant shaking) and twice with 2 x SSC containing 0.1% SDS 
(w/v) for 5 minutes at room temperature (with constant shaking). The final wash was 
performed with 2 x SSC containing 0.1% SDS (w/v) for 30 minutes at 50 °C (with 
constant shaking). The results were viewed by autoradiography using either Kodak 
Biomax MR / MS (maximum resolution / maximum sensitivity) film or with a 
PhosphorImager screen using a typhoon scanner.   
 
2.5.3 Primer extension assays 
 
Primers complementary to the human U3 and mouse U14 snoRNAs (Table 2.8) were 
radiolabelled using γP32 ATP. Ten pmoles of primer was mixed with 10 U of T4 
polynucleotide kinase (PNK; Promega), 1 µl of T4 PNK buffer (Promega), 5 µl γP32 
ATP and H20 up to 10 µl, and incubated at 37 °C. To remove unincorporated 
nucleotides the probe was made up to 50 µl and spun through a G-50 spin column. 
 
Target Sequence 
human U3 box C/D snoRNA 5’-ACCACTCAGACCGCGTTCTCTCCC-3’ 
mouse U14 box C/D snoRNA 5’-GGAAGGAA CTAGCCAACACAGCAC-3’ 
 
Table 2.8: Oligonucleotides used in primer extension assays 
 
RNA was extracted from the samples using phenol chloroform extraction method as 
described earlier in Chapter 2.5.1; however, after phenol extraction the aqueous phase 
was mixed with an equal amount of chloroform amyl alcohol (24 parts chloroform 1 
part amyl alcohol), sample vortexed for ~30 s and centrifuged using a Eppendorf 
minifuge for 3 min at 13,000 rpm. The purpose of the additional phase was to prevent 
phenol carry over. The upper layer containing the RNA was then removed and RNA 
precipitated using ethanol as described in Chapter 2.5.1.  
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To perform the primer extension RNA was added to 0.5 µl 10 x HY buffer (0.5 M Tris-
HCl [pH 8.4], 0.6 M NaCl, 0.1 M DTT), 0.5 µl radioactive primer, 1 µl H2O and the 
sample denatured at 96 °C for 1 minute. The sample was cooled on ice and then 4.3 µl 
H2O, 0.5 µl 10 x RT buffer (0.5 M Tris-HCl [pH 8.4], 0.2 mM dNTPs, 0.1 M MgCl2, 
0.6M NaCl, 0.1 M DTT) and 5 U AMV reverse transcriptase (Promega) was added and 
the sample incubated for 45 minutes at 43 °C. Once the reaction was complete RNA 
loading buffer was added. the sample denatured at 95 °C for 2 minutes then separated 
on an 8% acrylamide gel containing 7 M urea. The gel was fixed fixing solution (10 % 
methanol 10 % acetic acid) for 10 minutes and dried. The result was viewed using either 
using a PhosphorImager screen and a typhoon scanner or by MS / MR film (Kodak).   
 
2.6. Microscopy 
 
2.6.1. Fluorescent in Situ hybridisation (FISH) 
 
Cells grown on glass coverslips were washed (3 x) in PBS and fixed using PBS 
containing 4 % paraformaldehyde (w/v) for 20 minutes. After fixation cells were 
washed (3 x) in 70 % ethanol and rehydrated in PBS containing 5 mM MgCl2 for 10 
minutes and then incubated in 15 % formamide, 2 x SSC, 10 mM NaPO4 [pH 7] for 10 
minutes at room temperature. For each coverslip 1 µl of each FISH probe (10 µg/µl; 
Table 2.9) was added to 1 µl tRNA (10 µg/µl), 1 µl of sonicated salmon sperm DNA 
(10 µg/µl), 5 µl of 2 x formamide buffer (60 % formamide, 40 mM NaPO4 [pH 7.0]), 10 
µl of FISH hybridisation buffer (dextrane sulphate, 4 x SSC, 0.4 % BSA (bovine serum 
albumin) (w/v)) in a total volume of 20 µl (Taneja and Singer, 1992). Fish solution was 
placed on parafilm, coverslips placed face down on solution and hybridisation 
performed in a humidified incubator at 37 °C for 4 hours. 
  
After hybridisation, coverslips were washed (2 x) in 15 % formamide, 2 x SSC, 10 mM 
NaPO4 [pH 7.0]) at 37 °C for 30 minutes. Coverslips were then washed (2 x) in x SSC 
containing 0.1 % Triton-X100 (v/v) at room temperature for 15 minutes followed by a 
wash (2 x) in 1 x SSC containing 0.1 % Triton-X100 (v/v) at room temperature for 15 
minutes. For DAPI (Sigma-Aldrich) staining the final wash was performed with 0.1 
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µg/ml of DAPI. The coverslips were then immersed briefly (3 x) in H20 and (3 x) in 
70% ethanol then mounted onto glass microscope slides using 3.5 µl Moviol.  
 
Probe Sequence  Source 
U3 
snoRNA 
5'-CGCTCTACACGTTCAGAGAAACTTCTCTAGTAAC N.J.Watkins; 
ACACTATAGAAATGATCCC-3' McKeegan et al, 2007 
U8 
snoRNA 
5'-CGTTCTAATCTGCCCTCCGGAAGGAGGAAACAGG N.J.Watkins; 
AAACAGGTAAGGATTATCCCACCC-3' Watkins et al, 2007 
U2 
snRNA 
5'-CTTCTCGGCCTTTTGGCTAAGATCAAGTGTAGTAT N.J.Watkins; 
CTGTT-3' McKeegan et al, 2007 
U4 
snRNA 
5'-TCACGGCGGGGTATTGGGAAAAGTTTTCAATTAG R.Luhrmann; 
CAATAATCGCGCCT-3' Schaffert et al, 2004 
7SL 5'-TGAGTCCAGGAGTTCTGGGCTGTAGTGCGCTATGCC J.Brown, 
  GATCGGGT-3'  Newcastle University, UK 
 
Table 2.9: FISH probes 
 
 
2.6.2. Immunofluorescence 
 
Cells grown on coverslips were washed (3 x) in PBS and fixed using PBS containing 4 
% paraformaldehyde (w/v) for 20 minutes. After fixation, cells were washed (3 x) in 
PBS and incubated in PBS containing 1.0 % Triton-X100 for 15 minutes at room 
temperature. Cells were washed (4 x) with PBS and then incubated in 10 % FCS (v/v), 
PBS [pH 7.4], 0.1 % Triton-X100 (v/v). After incubation for 1 hour at room 
temperature (or overnight at 4 °C) 50 µl of PBS with 10 % FCS (v/v), containing 
desired concentration of primary antibody (Table 2.10), was placed on top of the 
coverslips. After 2 hours the coverslips were rinsed (3 x) and washed (3 x) for 10 
minutes with PBS. The secondary antibody was then applied as for the primary 
antibody and washed as described above. For DAPI staining the final wash was 
performed with 0.1 µg/ml of DAPI. Finally coverslips were immersed (3 x) in water and 
(3 x) in 70 % ethanol prior to being mounted onto glass slides using 3.5 µl Moviol.  
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Antibody Raised in Raised against Manufacturer Code 
anti-FLAG M2 mouse FLAG sequence Sigma F3165 
anti-BMS1 rabbit human BMS1 peptide Eurogenetc N/A 
anti-coilin rabbit human Coilin Santa Cruz sc32860 
anti-mouse Immunoglobulin 
alexa 555 conjugate donkey mouse immunoglobulin Invitrogen A31570 
anti-rabbit immunoglobulin 
alexa 488 conjugate donkey rabbit immunoglobulin Invitrogen A21208 
 
Table 2.10: Antibodies used in immunofluorescence 
 
 
2.6.3. Widefield microscopy 
 
Cells subjected to FISH and immunofluorescence were visualised using an Axiovert 
200M inverted microscope with a Plan-Apochromat, 100 x / 1.40 oil DIC, ∞ / 0.17 
objective (Zeiss).  The Zeiss filter sets used were as follows: 02 (DAPI), 20 (Cy3), 26 
(Cy5), 38 High Efficiency (GFP). The microscope was provided by J.Brown, Newcastle 
University, UK. 
 
 
2.7. Protein expression, purification and in vitro interaction assays 
 
2.7.1. Recombinant protein expression and purification 
 
To produce recombinant N terminal GST (Glutathione S-Transferase) tagged fibrillarin, 
N-C-fibrillarin (amino acids 82-321), Snurportin1, NOP17, NUFIP, TIP48 and TIP49 
the respective cDNAs were cloned into pGEX-6P-1 / 2 expression plasmids (Table 
2.11).  To express GST tagged proteins, chemically competent BL21 E. coli (provided 
by K.S.McKeegan, Newcastle University, UK) were transformed with the expression 
plasmid (containing the cDNA of the protein of interest) by heat shock at 42 °C for 45 
seconds. Successful transformations were selected using the appropriate antibiotic on 
LB agar plates (see Chapter 2.1.7). Transformed E. coli were grown in large LB cultures 
at 37 °C in a shaking incubator (set at 225 rpm) until an optical density of 0.35-4 was 
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reached (with the absorbance of the spectrophotometer set at A600). The expression of 
protein of interest was induced by addition of IPTG (isopropyl-beta-D-
thiogalactopyranoside), to final concentration of 1 mM, and cells left overnight at 18 °C 
in a shaking incubator (set at 225 rpm). Cells were harvested in a swing bucket 
centrifuge at 4200 rpm for 30 minutes and resuspended in 50 mls of buffer A (20 mM 
Tris-HCl [pH 8.0], 300 mM KCl, 0.1 % tween 20 (v/v), 10 % glycerol (v/v), 1 mM Tris-
hydroxy-phosphine). The cell suspension was sonicated, on ice, for 3 x 30 second bursts 
at full amplitude and cell debris removed by centrifugation at 24,500 rpm for 30 
minutes using a Beckman A-20 rotor. For each litre of original culture 100 µl of washed 
glutathione Sepharose beads (GE Healthcare; washed in buffer A) were incubated with 
cell supernatant, under constant agitation for 2 hours at 4 °C. The glutathione Sepharose 
beads with bound GST proteins were captured using an elution column and washed with 
50 mls of cold buffer A. GST tagged proteins were eluted from the glutathione 
Sepharose beads by incubation with 2.5 mls of cold buffer A supplemented with 50 mM 
reduced glutathione for 1 hour. The reduced glutathione was removed from the protein 
sample using desalt columns (Amersham) and AKTA protein purification system. 
Purified proteins were then stored at –80 °C after snap freezing in liquid nitrogen. 
 
Protein (all human) Plasmid Source References 
fibrillarin pGEX-6P-1 K.S.Mckeegan McKeegan et al, 2007 
N-C-fibrillarin (amino acids 82-321) pGEX-6P-1 K.S.Mckeegan McKeegan et al, 2007 
Snurportin1 pGEX-6P-1 K.S.Mckeegan McKeegan et al, 2009 (in prep) 
NOP17 pGEX-6P-1 K.S.Mckeegan McKeegan et al, 2007 
NUFIP pGEX-6P-1 P.Cabart Cabart et al, 2004 
TIP48 pGEX-6P-1 N.J.Watkins McKeegan et al, 2007 
TIP49 pGEX-6P-1 N.J.Watkins McKeegan et al, 2007 
BCD1 (amino acids 1-360) pGEX-6P-2 K.S.Mckeegan McKeegan et al, 2007 
 
Table 2.11: Expression plasmids used to produce recombinant GST tagged 
proteins 
 
N-C-fibrillarin (amino acids 81-321), 15.5K, TIP48 and TIP49 were also expressed 
from plasmids that introduced N terminal 6 x His fusion tags (see Table 2.12). Due to 
solubility issues recombinant deletion mutants of NOP56 (amino acids 1-458) and 
NOP58 (amino acids 1-435), which lacked the C terminal charged regions, had to be 
expressed. The C terminal charged region of NOP56 and NOP58, which was removed 
in the deletion mutants, has been shown not to be required for box C/D snoRNP 
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formation in yeast (Gautier et al, 1997; Lafontaine and Tollervey, 2000). The cDNA of 
NOP56 and NOP58 proteins was cloned into a pBAD/Thio-TOPO plasmid, which 
inserted an N terminal thioredoxin tag and C terminal His tag (See Table 2.11). The 6 x 
His tagged recombinant proteins were expressed and harvested as previously described 
for the GST tagged proteins; however, they were purified by immobilized metal affinity 
chromatography using His trap columns (GE healthcare). Immobilised 6 x His tagged 
proteins were eluted from the His trap columns using buffer A supplemented with 500 
mM imidazole in an AKTA purification system (Amersham). 
 
Protein (all human) Plasmid Source References 
N-C-fibrillarin (amino acids 82-321) pET200 TOPO K.S.McKeegan N/A 
15.5K pET15b E.S.Maxwell N?A 
TIP48 pET15b E.S.Maxwell Newman et al, 2000 
TIP49 pET15b E.S.Maxwell Newman et al, 2000 
NOP56 (amino acids 1-458) pBAD/Thio-TOPO K.S.McKeegan McKeegan et al, 2007 
NOP58 (amino acids 1-435) pBAD/Thio-TOPO K.S.McKeegan McKeegan et al, 2007 
 
Table 2.11: Expression plasmids used to produce recombinant 6 x His tagged 
proteins 
 
 
2.7.2. Expression of in vitro-translated [
35
S]methionine-labelled 
proteins 
 
In vitro-translated 
35
S-labelled proteins were expressed in the presence of [
35
S] 
methionine in rabbit reticulocyte lysate using coupled in vitro transcription and 
translation kits (Promega), according to the manufactures’ guidelines. To determine 
expression the in vitro-translated 
35
S-labelled proteins were separated on a 12 % SDS-
PAGE gel and visualised by autoradiography. In vitro-translated 
35
S-labelled proteins 
were snap frozen in liquid nitrogen and stored at –80 °C. See Table 2.13 for details of 
expression plasmids. 
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Protein (all human) Plasmid Source References 
SMN pET17b U.Fischer N/A 
Gemin2 pET17b U.Fischer Jones et al, 2001 
Gemin3 pET17b U.Fischer N/A 
Gemin4 pET17b U.Fischer N/A 
Gemin5 pET17b U.Fischer N/A 
Gemin6 pET17b U.Fischer N/A 
Gemin7 pET17b U.Fischer N/A 
Gemin8 pET17b U.Fischer N/A 
UNRIP pET17b U.Fischer N/A 
NUFIP pcDNA P.Cabart Cabart et al, 2004 
TIP48 pET15b E.S.Maxwell Newman et al, 2000 
TIP49 pET15b E.S.Maxwell Newman et al, 2000 
TAF9 pET17b R.Tjian Klemm et al, 1995 
NOP17 pGEM-T easy K.S.McKeegan McKeegan et al, 2007 
PHAX pET17b K.S.McKeegan McKeegan et al, 2009 (in prep) 
fibrillarin pET17b C.M.Debieux N/A 
R-fibrillarin (amino acids 1-81) pET17b C.M.Debieux N/A 
R-N-fibrillarin (amino acids 1-141) pET17b C.M.Debieux N/A 
N-C-fibrillarin (amino acids 82-321) pET17b C.M.Debieux N/A 
C-fibrillarin (amino acids 142-321) pET17b C.M.Debieux N/A 
N-fibrillarin (amino acids 82-141) pET100 C.M.Debieux N/A 
 
Table 2.13: Expression plasmids used to produce in vitro-translated 
35
S-labelled 
proteins 
 
 
2.7.3. In vitro protein-protein interaction assays 
 
To perform a protein-protein in vitro interaction assay 20 µl of glutathione Sepharose 
beads (GE healthcare) were washed (3 x) in 1 ml cold buffer A (20 mM Tris-HCl [pH 
8.0], 300 mM KCl, 0.1 % tween 20 (v/v), 10 % glycerol (v/v), 1 mM Tris-hydroxy-
phosphine) and pelleted by centrifugation, using a Eppendorf minifuge at 300 rpm for 1 
minute. The washed beads were then incubated with the GST tagged protein of interest 
in a total volume of 200 µl with buffer A. After 2 hours at 4 °C, with constant agitation, 
the glutathione Sepharose beads were washed in cold buffer A (3 x) to remove unbound 
proteins (as described earlier). The protein of interest (recombinant His tagged protein 
or in vitro-translated 
35
S-labelled protein) was added to the glutathione Sepharose 
beads, the sample made up to 200 µl with buffer A and incubated for 2 hours at 4 °C 
with constant agitation. Glutathione Sepharose beads (with immobilised proteins) were 
washed in buffer A (as described earlier) to remove unbound proteins, beads transferred 
to a new tube (to reduce background) and proteins removed using protein loading 
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buffer. Proteins were then separated on a 12 % SDS-PAGE gel and results visualised 
either by Coomassie blue staining, Western blot analysis or autoradiography.   
 
2.7.4. In vitro protein-protein interaction assays using thioredoxin 
tagged proteins 
 
To perform a protein-protein in vitro interaction assay using thioredoxin tagged proteins 
10 µl of protein A Sepharose beads (GE healthcare) were washed (3 x) in buffer A and 
pelleted by centrifugation, using a Eppendorf minifuge at 300 rpm for 1 minute. The 
washed protein A sepharose beads were made up to 100 µl with buffer A and incubated 
with monoclonal anti-thioredoxin antibodies (Sigma, T0803) at 4 °C, with constant 
agitation. After 1 hour (or overnight) the protein A Sepharose beads were washed (3 x) 
with 1 ml of cold buffer A (as described earlier) and incubated with the thioredoxin 
tagged protein of interest at 4 °C, with constant agitation. After 2 hours the protein A 
Sepharose beads (containing immobilised antibodies and proteins) were washed with 
cold buffer A (as described above) and incubated with the in vitro-translated 
35
S-
labelled protein of interest in a total volume of 200 µl (with buffer A) at 4 °C, with 
constant agitation. After 2 hours the protein A Sepharose beads (containing antibodies 
and proteins) were washed (as described earlier), beads transferred to a new tube (to 
reduce background) and proteins removed from beads using protein loading buffer. 
Proteins were then separated on a 12 % SDS-PAGE gel and results visualised by 
autoradiography.   
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Chapter three  
 
 
 
Development of 
approaches to analyse box 
C/D snoRNP biogenesis  
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3.1. Introduction  
 
The box C/D snoRNPs are stable RNA protein complexes that function in the chemical 
modification of rRNA. There are over 100 different species of box C/D snoRNP that 
(Lestrade and Weber, 2006) in humans are responsible for over 105 specific rRNA 2’-
O-methylation events, which are essential for the structure and function of the ribosome 
(Maden, 1990; Decatur and Fournier, 2002). A minority of box C/D snoRNPs, such as 
the U3 and U8 snoRNPs, do not function in the chemical modification of rRNA but 
rather function as chaperones assisting in pre-rRNA processing.  
 
The box C/D snoRNPs consist of four evolutionary conserved common core proteins 
known as 15.5K, NOP56, NOP58 and fibrillarin (Tyc and Steitz, 1989; Lyman et al, 
1999; Lafontaine & Tollervey, 1999; Lafontaine & Tollervey, 2000; Newman et al, 
2000; Watkins et al, 2000). Fibrillarin is the methyltransferase component of the 
complex responsible for the 2’-O-methylation of target rRNA residues (Tollervey et al, 
1993). The function of the other core proteins is not clear but they are most likely 
required for the structural integrity of the complex and their presence is vital for the 
biogenesis of box C/D snoRNPs (Lafontaine & Tollervey, 2000; Watkins et al, 2000, 
2002). The box C/D snoRNA component of the complex contains conserved C 
(RUGAUGA, where R is purine) and D (CUGA) box motifs located at the 5’ and 3’ 
ends, respectively, which form the C/D box. Some box C/D snoRNAs also contain a 
second set of less conserved internal box motifs known as the C’ and D’ boxes. The 
snoRNA guides 2’-O-methylation by base pairing to complementary rRNA sequences 
using a 10-21 guide sequence located upstream of the D and / or D’ box (Schimmang et 
al, 1989; Tyc and Steitz, 1989; Kiss-Laszlo et al, 1996; Lafontaine & Tollervey, 1999, 
2000; Newman et al, 2000; Watkins et al, 2000).  
 
The box C/D snoRNPs are found in the nucleolus where the synthesis, processing and 
modification of pre-rRNA transcripts occur as well as the bulk of ribosome assembly 
events. The nucleolus contains three sub-compartments, the FC, DFC and GC. As the 
pre-rRNA transcripts migrate through the nucleolus from the FC to the DFC and finally 
the GC they are processed and modified by factors that are specifically localised in 
these sub-compartments. The box C/D snoRNPs that function in the chemical 
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modification of rRNA as well as the box C/D snoRNPs that are involved in chaperoning 
early pre-rRNA processing, such as the U8 snoRNP (Peculis and Steitz, 1993), are 
found in the discreet DFC sub-compartments of the nucleolus (Figure 3.1). However, 
factors such as the U3 box C/D snoRNP, which function in both early and late pre-
rRNA processing, are found throughout the nucleolus in both the DFC and GC (Figure 
3.1; Granneman, et al, 2004). As the vast majority of box C/D snoRNPs are localised in 
the DFC of the nucleolus the core protein fibrillarin is found predominately in the DFC 
(Figure 3.1). In addition to the nucleolus the box C/D snoRNAs and fibrillarin are also 
found in the Cajal bodies and this, more than likely, represents pre-snoRNPs during 
biogenesis (Boulon et al, 2004; Lemm et al, 2006). The fibrillarin visualised in Cajal 
bodies may also represent fibrillarin that has been associated with the Cajal body 
localised scaRNPs (Jady and Kiss, 2001).  
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Nuclear localisation of the box C/D snoRNAs and fibrillarin 
HeLa SS6 cells were grown on coverslips and fixed using paraformaldehyde. To detect 
box C/D snoRNA FISH was performed using fluorescent probes specific for the U3 and 
U8 snoRNAs. To determine fibrillarin localisation HeLa SS6 cells were transfected 
with a plasmid that expressed fibrillarin with an N terminal 2 x FLAG tag 6 x His tag 
and immunofluoresence performed using anti-FLAG antibodies. The top row shows the 
U3, U8 snoRNAs or fibrillarin while the bottom row is a merged image of U3, U8 
snoRNAs or fibrillarin (red) with the DAPI image (blue). The white arrows indicate a 
Cajal body. The bar shown to the bottom right of the panel represents 5 μm.  
 
 
Box C/D snoRNP biogenesis occurs in a large complex known as the pre-snoRNP that 
consists of snoRNA, core proteins and assembly, RNA processing and transport factors 
(Watkins et al, 2004, 2007; McKeegan et al, 2007). The box C/D snoRNAs are 
transcribed from either independent genes or from the introns of housekeeping genes by 
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RNA polymerase II as extended pre-snoRNAs. The pre-snoRNAs are processed by 
numerous RNA processing factors to produce mature length snoRNA (Petfalski et al, 
1998; Villa et al, 1998; Chanfreau et al, 1998; Allmang et al, 1999). The pre-snoRNA of 
independently transcribed box C/D snoRNAs, such as U3, also contains a 5’ m7G cap 
that is hypermethylated by TGS1 to form an m3G cap (Speckmann et al, 2000; 
Verheggen et al, 2002). The assembly factors TIP48, TIP49, BCD1, TAF9, NOP17 and 
NUFIP have been proposed to be involved in the early recruitment of the common core 
proteins to the pre-snoRNP (Peng et al, 2003; Watkins et al, 2004, 2007; Boulon et al, 
2008; Gonzales et al, 2005; McKeegan et al, 2007).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Box C/D snoRNP biogenesis 
A black line represents the box C/D snoRNA with the 5’ m7G cap shown as an orange 
circle and the 3’ extended sequence as an orange rectangle. The core proteins are 
represented by a blue oval. The assembly, RNA processing and transport factors are 
represented by a brown oval. The 5’ m3G cap of mature snoRNA is shown as by a dark 
blue circle. The Cajal body is represented as a grey outlined box while the nucleolus is 
shown as a solid grey box. Grey arrows show the progression of biogenesis. The nuclear 
membrane is shown by black outlined rectangles. Image provided by N.J.Watkins, 
Newcastle University, UK.  
 
 
The cellular localisation(s) where box C/D snoRNP biogenesis occurs is not clear with 
evidence suggesting the nucleoplasm (Terns et al, 1995; Watkins et al, 2004; Boulon et 
al, 2004), Cajal bodies (Verheggen et al, 2001; Boulon et al, 2004; Lemm et al, 2006) 
and cytoplasm (Baserga et al, 1992; Peculis et al, 2001; Watkins et al, 2007). Numerous 
transport factors have been found associated with pre-snoRNPs such as PHAX, CRM1, 
Ran, CBC, Nopp140 and Snurportin1 (Yang et al, 2000; Boulon et al, 2004; Watkins et 
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al, 2004, 2007). These factors, more than likely, transfer the box C/D pre-snoRNPs to 
sub-cellular domains where snoRNP biogenesis occurs.  
 
To investigate box C/D snoRNP biogenesis it was necessary to establish a variety of 
experimental assays, procedures and approaches. To determine the cellular location of 
box C/D snoRNP biogenesis FISH and immunofluorescence were used to identify the 
localisation of snoRNA and the box C/D snoRNP core proteins and assembly factors. 
These assays were also used in conjunction with siRNA mediated depletion to 
determine the effect of the loss of a factor of interest on localisation and biogenesis of 
box C/D snoRNPs. An issue that limited the use of these approaches was that it was not 
possible to discriminate between mature snoRNPs, which had yet to be turned over, and 
snoRNPs that had been synthesised after the siRNA mediated depletion of a factor of 
interest. To address this issue a number of approaches were developed that specifically 
detected newly synthesised box C/D snoRNPs. These included the use of reporter 
plasmids and the development of two box C/D snoRNA inducible cell lines. In addition 
three inducible protein systems were developed, which expressed tagged fibrillarin and 
SMN proteins. Using these systems, in conjunction with siRNA mediated depletion, the 
analysis of box C/D snoRNPs which had been synthesised in the absence of a factor of 
interest was possible. 
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3.2. Results 
 
3.2.1. The role of the common core proteins in box C/D snoRNP 
localisation 
 
Previous studies have shown that loss of the box C/D snoRNP common core proteins 
NOP56, NOP58 and fibrillarin results in a reduction of box C/D snoRNA levels, which 
represents a decrease in snoRNP biogenesis (Lafontaine and Tollervey, 2000; Watkins 
et al, 2004). To further characterise the effect of the loss of the common core proteins 
on box C/D snoRNP biogenesis siRNAs targeting NOP56, NOP58 and fibrillarin 
mRNA were used to deplete the levels of the respective proteins and the localisation of 
box C/D snoRNA analysed by FISH. However, first it was necessary to analyse the 
efficiency of the siRNAs in reducing target protein levels. 
 
The siRNA duplexes used to deplete NOP56, NOP58 and fibrillarin have been 
successfully used by Watkins et al 2004; however, to confirm their efficiency HeLa SS6 
cells were transfected with siRNAs targeting fibrillarin mRNA and the depletion of the 
respective protein analysed. As a control a parallel experiment was performed in which 
HeLa SS6 cells were transfected with a control siRNA. The control siRNA used 
targeted firefly luciferase mRNA, which is not present in human cells, and therefore 
provided a control of the transfection procedure (Elbashir et al, 2002). Sixty hours after 
transfection cells were harvested, proteins separated on a 12 % SDS-PAGE gel and 
Western blot assays performed using antibodies specific for fibrillarin and nucleolin. 
The nucleolin protein levels were used to control sample loading and to determine the 
specificity of the fibrillarin depletion.   
 
In cells transfected with siRNAs targeting fibrillarin mRNA there was a dramatic 
reduction of fibrillarin protein levels (Figure 3.3), which was consistent with the results 
of Watkins et al 2004. The effect of the siRNAs was specific as the levels of nucleolin 
were unaffected. The specificity and the efficiency of the siRNAs targeting NOP56 and 
NOP58 mRNA have all been tested in Watkins et al, 2004 and, as with the fibrillarin 
siRNAs, result in the specific depletion of target protein levels. 
 
 88 
 
 
 
 
  
 
 
 
Figure 3.3: Depletion of fibrillarin  
HeLa SS6 cells were transfected with siRNAs targeting either firefly luciferase (control) 
or fibrillarin mRNA. Cells were harvested sixty hours after transfection, proteins 
separated on a 12 % SDS-PAGE gel and Western blot assays performed using 
antibodies that recognise fibrillarin and nucleolin. Nucleolin provided a control of 
sample loading as well as the specificity of the siRNA depletion. The proteins targeted 
for depletion are indicated above the panel. The antibodies used are indicated to the left 
of the panel.  
 
 
To determine the effect of the depletion of the common core proteins on box C/D 
snoRNA localisation siRNAs targeting either NOP56, NOP58, fibrillarin or firefly 
luciferase (control) were transfected into HeLa SS6 cells. Sixty hours after transfection 
the cells were fixed and FISH performed using fluorescent probes specific for the U3 
box C/D snoRNA and the spliceosomal U2 snRNA. As the U2 snRNA is found in 
nucleoplasmic Cajal bodies and nuclear speckles it provided a marker of these nuclear 
bodies. The U2 snRNA also provided a control of the specificity of the siRNA depletion 
as none of the factors targeted for depletion are known to be involved in snRNP 
biogenesis and therefore the loss of these factors should only affect the U3 snoRNA. 
 
In the control cells the U3 snoRNA was found predominately in the nucleolus but was 
also found in Cajal bodies (Figure 3.4), the typical localisation of U3 box C/D snoRNA. 
The U3 snoRNA was distributed throughout the nucleolus indicating localisation to 
both the DFC and GC (see Figure 3.1 for comparison of nucleolar localisation). The 
distribution and / or level of U2 snRNA did not change with any of the siRNA 
depletions, which indicates that all the effects seen were specific to the U3 snoRNAs.  
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Figure 3.4: The localisation of box C/D snoRNA in cells depleted of the common 
core proteins 
(A) HeLa SS6 cells were transfected with siRNAs targeting either firefly luciferase 
(control) NOP56, NOP58 or fibrillarin. After sixty hours cells were fixed and FISH 
performed using fluorescent probes specific for the U3 box C/D snoRNA and U2 
snRNA. The same exposure time was used for each probe to allow direct comparison of 
RNA levels and distribution. The protein targeted for depletion is indicated at the top of 
each column of images. The labels along the left hand side of the panels indicate the 
FISH probes used. The bottom row shows a merged image of the U3 snoRNA (red) and 
U2 snRNA (green). The white arrows show a selected Cajal body. The bar to the bottom 
right of the panel represents 5 μm.  
(B) An enlargement of a Cajal body from each siRNA depleted cell from Figure 3.4 A. 
The protein targeted for depletion is indicated at the top of each column of images. The 
labels along left hand side of panels indicate FISH probes used. 
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In both NOP56 and fibrillarin depleted cells there was a mild reduction in the levels of 
the nucleolar localised U3 snoRNA compared to the control cells (Figure 3.4). 
However, the relative intensity of the U3 snoRNA signal from the Cajal bodies 
remained unchanged in NOP56 and fibrillarin depleted cells compared to the control 
cells, indicating a retention or accumulation of the U3 snoRNA. The depletion of 
NOP56 and fibrillarin also resulted in the accumulation of the U3 snoRNA in the 
nucleoplasm of the cell. The accumulation of the U3 snoRNA in the nucleoplasm and 
Cajal bodies, more than likely, corresponds to a halt in box C/D snoRNP biogenesis. A 
possible explanation is that pre-snoRNPs were formed, which lacked either NOP56 or 
fibrillarin, and were unable to localise to the nucleolus resulting in their accumulation in 
the nucleoplasm and Cajal bodies. The reduction in nucleolar U3 snoRNA levels most 
likely reflects a decrease in box C/D snoRNP biogenesis.  
 
In cells depleted of NOP58 there was a dramatic reduction in U3 snoRNA levels in the 
nucleolus and Cajal bodies (Figure 3.4). The drop in the U3 snoRNA levels as a result 
of the depletion of NOP58 was, most likely, due to NOP58 being essential for the 
stability of pre-snoRNAs as has been previously proposed (Lafontaine and Tollervey, 
2000; Watkins et al, 2004).    
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3.2.2. Loss of the unrelated protein, hPRP31, does not affect box C/D 
snoRNA localisation 
 
To ensure that the change in the U3 snoRNA localisation and accumulation seen when 
NOP56, NOP58 and fibrillarin were depleted (Figure 3.4) was not due to an indirect 
effect, caused by the loss of an essential protein, an unrelated essential factor was 
depleted and the localisation of the U3 snoRNA analysed by FISH.  
 
The protein targeted for depletion was hPRP31 (61K), a snRNP protein essential for the 
interaction between the U4/U6 di-snRNP and the U5 snRNP to form the U4/U6.U5 tri-
snRNP. The U4/U6.U5 tri-snRNPs are distributed between nuclear speckles and Cajal 
bodies and previous studies have shown that siRNA mediated depletion of hPRP31 
results in the loss of the U4 and U6 snRNPs from nuclear speckles and an accumulation 
in the Cajal bodies (Schaffert et al, 2004). From this observation it was proposed that 
the Cajal bodies were the site where and U4/U6.U5 tri-snRNP is formed (Schaffert et al, 
2004). 
 
HeLa SS6 cells, grown on coverslips, were transfected with siRNAs targeting either 
firefly luciferase (control), NOP58 or hPRP31. Sixty hours later cells were fixed and 
analysed by FISH using fluorescent probes specific for the U3 box C/D snoRNA and 
the spliceosomal U4 snRNA (Figure 3.5). In the control cells the U3 snoRNA was 
localised predominately in the nucleolus but also in the Cajal bodies while the U4 
snRNA was distributed between the nuclear speckles and Cajal bodies. Cells transfected 
with siRNAs targeting NOP58 showed a dramatic reduction in the U3 snoRNA levels 
(as in Figure 3.4) but the U4 snRNA level and distribution were not affected. When the 
U4/U6 snRNP specific hPRP31 protein was depleted the U4 snRNA accumulated in 
Cajal bodies, as was previously described by Schaffert et al 2004. Importantly when 
hPRP31 was depleted there was no change in the localisation or levels of the U3 
snoRNA. This indicated that the effects seen with the U3 snoRNA localisation and 
distribution, when NOP56, NOP58 and fibrillarin were depleted, were specific to the 
functions of these proteins.  
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Figure 3.5: The localisation of box C/D snoRNA in cells depleted of hPRP31 
(A) HeLa SS6 cells were transfected with siRNAs targeting firefly luciferase (control), 
NOP58 or hPRP31. After sixty hours cells were fixed and FISH performed using 
fluorescent probes specific for the U3 box C/D snoRNA and the spliceosomal U4 
snRNA. The same exposure time was used for each probe to allow direct comparison of 
RNA levels and distribution. The protein targeted for depletion is indicated at the top of 
each column of images. The labels along the left hand side of the panels indicate the 
FISH probes used. The bottom row shows a merged image of the U3 snoRNA (red) and 
the U4 snRNA (green). The white arrows indicate a selected Cajal body. The bar shown 
to the bottom right of the panel represents 5 μm.  
(B) An enlargement of a Cajal body from each siRNA depleted cell from Figure 3.4 A. 
The protein targeted for depletion is indicated at the top of each column of images. The 
labels along left hand side of panels indicate FISH probes used. 
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3.2.3. Localisation of the box C/D snoRNP assembly factors 
 
Numerous factors have been implicated in the assembly of the box C/D snoRNPs; 
however, the localisation of many of these factors has not been analysed. The 
identification of the localisation of box C/D snoRNP assembly factors in comparison 
with the distribution of the box C/D snoRNA and common core proteins may shed light 
on the site(s) of box C/D snoRNP biogenesis. 
 
As antibodies were not available for a number of the box C/D snoRNP assembly factors 
plasmids were constructed that expressed the assembly factors fused to an N terminal 2 
x FLAG tag (plasmids provided by K.S.McKeegan, Newcastle University, UK). HeLa 
SS6 cells, grown on coverslips, were transfected with the expression plasmids and 
twenty-four hours later cells were fixed. The localisation of the assembly factors was 
analysed by immunofluorescence using anti-FLAG antibodies. Cells were also 
incubated with either anti-coilin or anti-BMS1 antibodies to detect the Cajal bodies or 
nucleolus, respectively. DAPI staining of DNA was used to determine the localisation 
of the nucleoplasm.  
 
The box C/D snoRNP assembly factors TIP48, TIP49, BCD1, TAF9 and NUFIP, 
expressed from the plasmids, were found distributed throughout the nucleoplasm 
(Figure 3.6 A and B). In addition TIP48 was found in the cytoplasm. None of these 
assembly factors were found enriched in the Cajal bodies, which were indicated by 
coilin (Figure 3.6 A). The localisation of assembly factors in the Cajal bodies cannot, 
however, be excluded as there is no definitive absence of the factors from these nuclear 
bodies. Antibodies raised against BMS1 were used to identify the nucleolus but the 
localisation of assembly factors to this region was not clear-cut (Figure 3.6 B). Cells 
transfected with the NUFIP, BCD1 and TAF9 expression plasmids showed a weak 
nucleolar staining using the anti-FLAG antibody but this was much lower than the 
nucleoplasmic staining and not repeatedly seen. The low levels of assembly factors 
sometimes observed in the nucleolus may be due to some cells being transfected with 
large quantities of the expression plasmids. This could result in over expression and 
accumulation of tagged protein to areas of the cell where it does not normally localise. 
Overall the data indicates that the assembly factors localise to the nucleoplasm. 
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Figure 3.6: The localisation of the box C/D snoRNP assembly factors 
HeLa SS6 cells were transfected with plasmids expressing box C/D snoRNP assembly 
factors fused to N terminal 2 x FLAG tags. Twenty-four hours after transfection HeLa 
SS6 cells were fixed and immunofluorescence performed using anti-FLAG antibodies 
to determine the location of the assembly factors. In addition immunofluorescence was 
performed with (A) anti-coilin antibodies or (B) anti-BMS1 antibodies to indicate the 
locations of the Cajal bodies and nucleolus, respectively. DAPI staining of DNA was 
used to identify the nucleoplasm. The assembly factor transfected is indicated at the top 
of each column of images. Labels along the left hand side of the panels indicate 
antibodies used and DAPI staining. The bottom row shows merged image of FLAG 
tagged assembly factors (red) with coilin or BMS1 (green), as indicated. The bar shown 
to the bottom right of the panel represents 5 μm. The BCD1, TAF9 and NUFIP images 
with BMS1 were kindly provided by K.S.McKeegan, Newcastle University, UK. (A) 
Image below main panel is an enlargement of a Cajal body from each cell of Figure 3.6 
A. The assembly factor transfected is indicated at the top of each column of images. 
Labels along the left hand side of the panels indicate antibodies used.  
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3.2.4. Development of procedures to analyse de novo box C/D snoRNP 
biogenesis in HeLa SS6 cells 
 
One issue with using siRNAs to deplete a protein of interest followed by the analysis of 
the localisation of endogenous box C/D snoRNA was that it was not possible to 
discriminate between snoRNAs synthesised prior to protein depletion and newly formed 
snoRNAs. As box C/D snoRNPs are predicted to be as stable as the snRNPs (Personal 
communication from N.J.Watkins, Newcastle University, UK), which have half-lives of 
between 60 and 88 hours (Fury and Zieve, 1996), it is likely that a high background of 
mature box C/D snoRNPs, synthesised prior to siRNA mediated depletion, are present. 
Due to these issues it was necessary to develop alternative approaches to analyse box 
C/D snoRNP biogenesis.  
 
Previous studies investigating the synthesis of the snRNPs overcame the issues of the 
stability and long half-lives of the snRNPs by developing assays to monitor de novo 
biogenesis. One such study by Shpargel and Matera 2005 used a procedure whereby 
siRNAs were first used to deplete potential snRNP biogenesis factors, in this case SMN, 
then forty-eight hours later the cells were transfected with a GFP-SmB reporter plasmid. 
Analysis of the tagged protein derived from the reporter plasmid ensured that only de 
novo synthesised snRNPs, produced in the absence of SMN were detected. Using this 
approach, Shpargel and Matera 2005 showed that when SMN protein levels were 
depleted the GFP-SmB protein was unable to localise to Cajal bodies. Further 
experiments using this two-step transfection procedure also revealed that in the absence 
of SMN there was reduced binding of GFP-SmB to the snRNAs (Shpargel and Matera, 
2005). Both these experiments supported the role for SMN in snRNP biogenesis. 
Interestingly, Shpargel and Matera 2005 were unable to detect any change in the 
localisation of the endogenous Sm proteins in SMN depleted cells. Therefore, the two 
step-transfection procedure, using a reporter plasmid to monitor de novo biogenesis, 
provided more reliable and accurate data. With this in mind, several procedures were 
developed to analyse de novo box C/D snoRNP biogenesis. 
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One of the procedures developed to analyse de novo box C/D snoRNP biogenesis 
utilised a U3 reporter plasmid (StreptoTag U3, Granneman et al, 2004). This plasmid 
expressed human U3 snoRNA with a Strepto tag in a non-essential 3’ stem loop region 
of RNA (Figure 3.7). The StreptoTag U3 was detectable by FISH and primer extension 
assays using probes specific for the StreptoTag sequence (Granneman et al, 2004). The 
StreptoTag U3 reporter plasmid was incorporated into a two-step transfection procedure 
similar to one used by Shpargel and Matera 2005. In this procedure HeLa SS6 cells 
were transfected with siRNAs to deplete a target protein followed by a secondary 
transfection of the StreptoTag U3 reporter plasmid. This procedure allowed the de novo 
biogenesis of U3 snoRNPs to be specifically monitored in the absence of the protein of 
interest. 
 
  
 
 
 
 
 
 
 
 
Figure 3.7: StreptoTag U3 snoRNA 
Schematic diagram showing location and predicted secondary structure of the U3 box 
C/D snoRNA StreptoTag. The snoRNA is represented as a black line in the left panel. 
In the right panel the snoRNA is shown as black lettering. The locations of GAC box, 5’ 
hinge and 3’ hinge regions shown by black box. Conserved box A, A’, C’, D, B and C 
are indicated (Granneman et al, 2004). 
 
 
To establish the two-step transfection procedure the effect of the loss of NOP56 and 
NOP58 on the localisation of newly synthesised StreptoTag U3 snoRNA was analysed. 
HeLa SS6 cells were transfected with siRNAs targeting either firefly luciferase 
(control), NOP56 or NOP58, and after twenty-four hours transfected with the 
StreptoTag U3 reporter plasmid. Twelve hours later cells were fixed and FISH 
performed using a fluorescent probe specific for the StreptoTag sequence to detect the 
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newly synthesised U3 snoRNA. As a comparison FISH was also performed using a 
fluorescent probe targeting endogenous U3 snoRNA.  
 
In the control cells both the endogenous U3 and the StreptoTag U3 snoRNA were found 
predominately in the nucleolus but also in Cajal bodies, the typical localisations of box 
C/D snoRNAs (Figure 3.8). Endogenous U3 and StreptoTag U3 snoRNAs were 
distributed throughout the nucleolus indicating localisation to both the DFC and GC, 
which was consistent with previous studies (Granneman et al, 2004; see Figure 3.1 for 
comparison of nucleolar localisation). In cells depleted of NOP56 there was an 
accumulation of both the endogenous U3 and the StreptoTag U3 snoRNAs in the 
nucleoplasm. This was, most likely, due to a block in biogenesis with pre-snoRNP 
complexes being formed, which lacked NOP56, resulting in nucleoplasmic 
accumulation. The StreptoTag U3 snoRNA was also present in Cajal bodies in NOP56 
depleted cells; however, it is difficult to determine whether there was an accumulation 
in these bodies without a transfection control. Interestingly, some StreptoTag U3 
snoRNA also accumulated in the nucleolus in NOP56 depleted cells. This indicated that 
either there was a low level production of mature U3 particles in the reduced NOP56 
environment or that snoRNP complexes were formed that lacked NOP56 but maintained 
the ability to localise, albeit inefficiently, to the nucleolus. In NOP56 depleted cells 
there was also a reduction in the levels of nucleolar endogenous U3 snoRNA.  
 
In NOP58 depleted cells there was a dramatic reduction of endogenous U3 levels with 
no visible accumulation in the nucleoplasm or Cajal bodies (Figure 3.8), as seen before 
(Figure 3.4). The StreptoTag U3 expressed in the NOP58 depleted cells did accumulate 
in low levels in the nucleolus but not in either the nucleoplasm or Cajal bodies (Figure 
3.8); however, without a transfection control it is difficult to interpret this data. 
  
Further two-step transfection experiments were performed using the StreptoTag U3 
reporter plasmid and siRNAs targeting fibrillarin and a variety of other assembly 
factors. It was, however, not possible to perform a successful secondary transfection of 
the StreptoTag U3 reporter plasmid. One possible reason for this is that the loss of an 
essential protein may affect the transfection rate of the cells. To overcome the issue of 
poor secondary transfection different methods were tested including electroporation; 
however, these attempts were also unsuccessful.   
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Figure 3.8: The localisation of newly synthesised StreptoTag U3 snoRNA in cells 
depleted of NOP56 and NOP58 
HeLa SS6 cells were transfected with siRNAs targeting either firefly luciferase 
(control), NOP56 or NOP58. Twenty-four hours later cells were transfected with a 
reporter plasmid expressing U3 snoRNA tagged with strepavidin (StreptoTag U3). After 
a total of sixty hours, cells were fixed and analysed by FISH using fluorescent probes 
specific for the U3 snoRNA and the StreptoTag U3 snoRNA. DAPI staining of DNA 
was used to indicate the nucleoplasm. The same exposure time was used for each probe 
to allow direct comparison of RNA levels and distribution. The protein targeted for 
depletion is indicated at the top of each column of images. The labels along the left 
hand side of the panels indicate the FISH probes and DAPI staining. The bar to the 
bottom right of the panel represents 5 μm.  
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3.2.5. Development of inducible box C/D snoRNA cell lines 
 
There was a clear problem with the two-step transfection procedure used to analyse de 
novo box C/D snoRNP biogenesis. In order to remove the need for a second transfection 
Tet-inducible cell lines were developed that expressed either the U3 or the U14 box C/D 
snoRNAs. 
 
A Tet-inducible U3 HEK293 cell line was produced utilising the StreptoTag U3 
reporter plasmid used previously in the two-step transfection procedure (Figure 3.7). 
The use of StreptoTag U3 snoRNA meant that induced U3 snoRNA could be detected 
above endogenous U3 snoRNA by FISH and primer extension assays using probes 
specific for the StreptoTag sequence (Granneman et al, 2004). As the U3 snoRNA is 
transcribed from an independent gene a Tet02 sequence (5´-
TCCCTATCAGTGATAGAG A-3´) was inserted into the U3 promoter region. The 
development of the inducible U3 promoter was based upon a Tet-responsive U6 
promoter that was constructed to express shRNAs (short hairpin RNAs; Lin et al, 2004). 
The Tet-responsive U6 promoter provided a good basis for the development of the Tet-
responsive U3 promoter as the U3 snoRNA and U6 snRNA promoter regions contain 
similar transription elements. A single Tet02 sequence was inserted in a non-essential 
region of the human U3 promoter between the 5’ PSE (Ach and Weiner, 1991; Savino 
et al, 1992) and the transcription start site (Figure 3.9). Two Tet-responsive StreptoTag 
U3 promoters were created that differed slightly in the location of the Tet02 sequence.  
 
Before creating the inducible HEK293 cell line it was first necessary to determine 
whether the insertion of the Tet02 sequence had damaged the function of either of the 
new U3 snoRNA promoters. HeLa SS6 cells were transfected with the StreptoTag U3 
reporter plasmids, containing the inserted Tet02 sequences, and expression determined 
by primer extension assays. As HeLa SS6 cells do not contain the Tet-repressor gene 
the Tet-responsive promoters would not be repressed. These assays showed that only 
one of the StreptoTag U3 reporter plasmids, containing inserted Tet02 sequences, 
retained the ability to express StreptoTag U3 (data not shown). 
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A 
         PSE           U3 snoRNA 
GTTAAAAGTTTGCGGCAGATGTAGACCTAGCAGAGGTGTGCGAGGAGGCCGTTAAGACTATACTTTCAG 
                    
GTTAAAAGTTTGTCCCTATCAGTGATAGAGAAGAGGTGTGCGAGGAGGCCGTTAAGACTATACTTTCAG 
             
GTTAAAAGTTTGCGGCAGATGTAGACCTAGCATCCCTATCAGTGATAGAGATTAAGACTATACTTTCAG 
 
B 
 
 
 
Figure 3.9: Schematic diagram of the Tet-responsive StreptoTag U3 snoRNA 
(A) To create a Tet-responsive StreptoTag U3 promoter a single Tet02 sequence (blue) 
was inserted between the PSE (proximal sequence element; black) and StreptoTag U3 
sequence (red). The top panel shows a section of the U3 box C/D snoRNA gene with 
the PSE (proximal sequence element; white lettering on black background), U3 
snoRNA sequence (white lettering on red background) and intervening sequences (black 
lettering). Middle and bottom panels show the location of the inserted Tet02 operator 
sequences (Blue text). 
(B) Schematic diagram of the location of StreptoTagU3 gene in an intergrated 
pcDNA5/FRT/TO expression cassette. The FRT recombination sites mark the insertion 
site of pcDNA5/FRT/TO expression plasmid in the Flp-In T-Rex HEK293 cells. As the 
StreptoTag U3 gene contains its own promoter with inserted Tet02 sequence it was 
inserted upstream of the CMV/2xTetO2 promoter region between the amplicillin gene 
(Amp) gene and pUC origin. PSV40 represents Simian virus 40 promoter. BGH pA 
represents Bovine growth hormone polyadenylation signal. For further details of 
plasmid see Chapter 2.2.1. 
 
 
To create a Tet-inducible StreptoTag U3 snoRNA cell line the StreptoTag U3 gene, 
with inserted Tet02 sequence, was cloned into a pcDNA5/FRT/TO expression plasmid 
containing a FRT recombination site. The pcDNA5/FRT/TO expression plasmid was 
then inserted into the FRT recombination site of Flp-In T-Rex HEK293 cells through 
homologous recombination. The Flp-In T-Rex HEK293 cells contain a Tet-repressor 
gene that expresses TetR proteins that directly bind Tet02 sequences and prevent their 
expression. The addition of Tet inhibits the function of the TetR proteins and therefore 
induces expression from promoters containing Tet02 sequences. 
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To test the expression of StreptoTag U3 snoRNA from the Tet-inducible StreptoTag U3 
HEK293 cell line varying quantities of Tet was added to the cells and primer extension 
assays performed using primers specific for the StreptoTag sequence. Unfortunately, 
only very low levels of StreptoTag U3 were detected, which were not sufficient for this 
cell line to be used in further experiments (data not shown).  
 
In addition to the Tet-inducible StreptoTag U3 HEK293 cell line a Tet-inducible mouse 
U14 (mU14) HEK293 cell line was constructed. The induced mU14 snoRNA can be 
specifically detected above endogenous U14 snoRNA by primer extension assays due to 
sequence differences between mouse and human U14. As U14 is an intronic RNA, 
encoded within the introns of the hsc70 gene, to create the Tet-inducible mU14 it was 
not necessary to design a new promoter region, as the Tet-responsive CMV promoter 
contained within the pcDNA5/FRT/TO expression plasmid was suitable. A section of 
the mouse hsc70 gene containing exons 5 and 6 with intron 5 (containing U14) was 
cloned from a mouse U14 expression plasmid (Watkins et al, 1996) and inserted into a 
pcDNA5/FRT/TO expression plasmid (Figure 3.10 A). The cell line was then created as 
described earlier.  
 
To determine the level of mU14 snoRNA expression from the Tet-inducible mU14 
HEK293 cell line various concentrations of Tet were added to the cells and, after forty-
eight or seventy-two hours, cells harvested. RNA extraction was performed on the 
samples followed by primer extension assays using primers specific for mU14 snoRNA. 
As a control of sample loading a primer extension assay was also performed with each 
sample using a primer specific for human U3 snoRNA. The samples were then 
separated by electrophoresis on an 8 % acrylamide gel containing 7 M urea and results 
viewed by autoradiography (Figure 3.10 B).  
The U3 primer extensions performed show that equal quantities of RNA were loaded 
from each sample (Figure 10 B). In the absence of Tet no mU14 snoRNA was 
expressed (Figure 10 B; lane 1); however, when the mU14 HEK293 cells were grown in 
the presence of 2 μg/ml of Tet for forty-eight or seventy-two hours (Figure 3.10; lanes 2 
and 3) a weak signal was present which indicates that there was a low level of mU14 
snoRNA expression. When cells were grown in a lower concentration of Tet (1 μg/ml; 
Figure 3.10 B; lane 4 and 5) it took at least seventy-two hours for a detectable amount 
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of mU14 snoRNA to be expressed. Unfortunately, the expression levels of mU14 were 
very low and therefore the Tet-inducible mU14 HEK293 cells were not suitable for use 
in assays to analyse box C/D snoRNP biogenesis.  
 
A  
 
  
 
 
 
 
 
B 
 
 
 
 
Figure 3.10: Development of a Tet-inducible mU14 snoRNA HEK293 cell line  
(A) Schematic diagram of the Tet-inducible mU14 in an Flp-In T-Rex HEK293 
incorporated pcDNA5/FRT/TO expression cassette. FRT marks insertion site. The 
expression of mouse hsc70, which contained U14, was under the control of the 
CMV/2xTetO2 promoter. PSV40 represents Simian virus 40 promoter. BGH pA 
represents Bovine growth hormone polyadenylation signal. For further details of 
plasmid see Chapter 2.2.1  
(B) Primer extension assays showing expression of mU14 snoRNA from the Tet-
inducible mU14 HEK293 cell line. The mU14 HEK293 cells were induced by the 
addition of varying quantities of Tet for different lengths of time. After induction cells 
were harvested, RNA extracted and primer extension assays performed using primers 
specific for the mU14 and U3 snoRNAs. The U3 primer extension assay was performed 
as a control of sample loading. The samples were separated by electrophoresis on 8 % 
acrylamide gel containing 7 M urea gel and results viewed by autoradiography. Labels 
left of panel indicate primer extension probes used. Labels above panel, 1 = no Tet; 2 = 
2 μg/ml Tet, 48 hours; 3 = 2 μg/ml Tet, 72 hours; 4 = 1 μg/ml Tet, 48 hours; 5 = 1 μg/ml 
Tet, 72 hours; 6 = 0. 5 μg/ml Tet, 72 hours.  
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3.2.6. Inducible protein systems 
 
To further study box C/D snoRNP biogenesis systems that enabled the controlled 
expression of a tagged protein of interest were constructed. These included two Tet-
inducible HEK293 cell lines, expressing tagged fibrillarin or SMN, and a reporter 
plasmid system expressing tagged fibrillarin. These inducible proteins systems provide 
further methods of analysing box C/D snoRNP biogenesis by determining the 
localisation and interactions of newly synthesised fibrillarin and SMN.  
 
Tet-inducible tagged fibrillarin and SMN HEK293 cell lines were produced as 
described earlier in Chapter 3.2.5 and 2.2.3. In order for the induced fibrillarin and 
SMN to be specifically detected they were expressed with N terminal 2 x FLAG and 6 x 
His fusion tags (Figure 3.11). A control HEK293 cell line was also developed that only 
expressed the 2 x FLAG and 6 x His fusion tags, which was utilised as a negative 
control in some experiments. Before these cells lines were used to analyse box C/D 
snoRNP biogenesis it was necessary to ensure that the expressed protein behaved in a 
similar manner to the respective endogenous protein.  
 
 
 
 
 
 
 
 
Figure 3.11: Schematic diagram of the Tet-responsive fibrillarin and SMN 
HEK293 expression cassette 
Schematic diagram of the Tet-inducible 2 x FLAG 6 x His tagged SMN and fibrillarin 
pcDNA5/FRT/TO expression cassette. The FRT recombination site indicates the 
insertion site of the pcDNA5/FRT/TO expression plasmid into the Flp-In T-Rex 
HEK293 cells. The expression of SMN or fibrillarin is under the control of the 
CMV/2xTetO2 promoter. PSV40 represents Simian virus 40 promoter. BGH pA 
represents Bovine growth hormone polyadenylation signal. For further details of 
plasmid see Chapter 2.2.3.  
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To determine the time required for 2 x FLAG 6 x His fibrillarin (FLAG-fibrillarin) 
expression the FLAG-fibrillarin HEK293 cells were induced by 1 μg/ml of Tet. As a 
control FLAG-fibrillarin HEK293 cells were grown without the addition of Tet (0 
hour). After six, twelve and twenty-four hours cells were harvested, proteins separated 
on a 12 % SDS-PAGE gel and Western blot assays performed using anti-fibrillarin 
antibodies. It was possible to distinguish between endogenous and FLAG-fibrillarin 
using anti-fibrillarin antibodies as the induced FLAG-fibrillarin migrated significantly 
slower than endogenous fibrillarin on SDS-PAGE gels. A Western blot assay was also 
performed using anti-nucleolin antibodies to ensure equal sample loading. In the 
absence of Tet FLAG-fibrillarin was not expressed; however, six hours after the 
addition of Tet FLAG-fibrillarin was expressed at a slightly lower level than 
endogenous fibrillarin (Figure 3.12). In cells incubated with Tet for twenty-four hours 
there was an increase in the levels of FLAG-fibrillarin; however, the levels were still 
not quite as high as the endogenous fibrillarin. This experiment showed that FLAG-
fibrillarin was expressed as early as six hours after the addition of 1 μg/ml of Tet at 
levels comparable to endogenous fibrillarin. This was also an important control to show 
that the addition of 1 μg/ml of Tet did not result in over expression of FLAG-fibrillarin.  
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Figure 3.12: Tet-inducible FLAG-fibrillarin HEK293 cell line controls  
(A) Western blot assay showing the Tet induction of FLAG-fibrillarin HEK293 cells. 
FLAG-fibrillarin HEK293 cells were induced by addition of 1 µg/ml of Tet. As a 
control FLAG-HEK293 cells that had not been induced were harvested (0 hrs). At 
several time points (indicated above gel) cells were harvested, proteins separated on a 
12 % SDS-PAGE gel and Western blot assays performed using anti-nucleolin and anti-
fibrillarin antibodies (indicated left of panel). The migration of proteins is shown to the 
right of the panel.  
(B) Co-precipitation of the U3 snoRNA with FLAG-fibrillarin. Whole cell extracts were 
produced from induced HEK293 cells that expressed FLAG-fibrillarin or just the FLAG 
tag (control). Immunoprecipitation assays were performed using anti-FLAG antibodies 
and co-precipitating RNA extracted, separated by electrophoresis on an 8 % acrylamide 
gel containing 7 M urea and analysed by Northern blot hybridisation using a 
radiolabelled probe specific for the U3 box C/D snoRNA. Results were visualised by 
autoradiography. Input represents 10 % of the amount of extract used in assay.  
(C) Immunofluorescence of induced FLAG-fibrillarin HEK293 cells. FLAG-fibrillarin 
cells, grown on coverslips, were induced by the addition of 1 µg/ml of Tet. Forty-eight 
hours after induction cells were fixed and immunofluorescence performed using anti-
FLAG antibodies to identify the localisation of FLAG-fibrillarin. Anti-coilin and anti-
BMS1 antibodies were used to indicate the location of Cajal bodies and nucleolus, 
respectively. DAPI staining of DNA was used to indicate the nucleoplasm. Antibodies 
and markers used are indicated to the left and right of the panel. The bottom row of 
images is a merged image of FLAG-fibrillarin (red) with either coilin (green) or BMS1 
(green) as indicated and DAPI (blue). The white arrows indicate the location of a Cajal 
body. The bar to the bottom right of the panel represents 5 μm.  
(D) Enlarged nucleolus from Figure 3.12 C. Antibodies used are indicated to the right of 
the panel. The bottom row is a merged image of FLAG-fibrillarin (red) and BMS1 
(green).   
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To determine whether FLAG-fibrillarin associated with the box C/D snoRNPs the 
FLAG-fibrillarin HEK293 cells were induced by the addition of 1 μg/ml of Tet. As a 
negative control 1 μg/ml Tet was also added to the control HEK293 cell line. After 
forty-eight hours cells were harvested and whole cell extracts produced. To perform 
immunoprecipitation assays anti-FLAG antibodies were bound to protein A Sepharose 
beads and incubated with the cell extract of interest. The beads were washed, RNA 
extraction performed and co-precipitating RNAs separated by electrophoresis on an 8 % 
acrylamide gel containing 7 M urea. RNA was analysed by Northern blot hybridisation 
using a radiolabelled probe specific for the U3 box C/D snoRNA and results visualised 
by autoradiography. Anti-FLAG antibodies successfully co-precipitated U3 snoRNA 
from FLAG-fibrillarin HEK293 cell extracts but not from the control HEK293 cell 
extracts (Figure 3.12 B). In comparison to the 10 % input it appears that 20-30 % of the 
total cell U3 snoRNA was co-precipitated from the FLAG-fibrillarin HEK293 cell 
extract. This indicates that the FLAG-fibrillarin can efficiently associate with the box 
C/D snoRNPs.  
 
To determine if the FLAG-fibrillarin localised correctly FLAG-fibrillarin HEK293 
cells, grown on cover slips, were induced by the addition of 1 μg/ml Tet. Forty-eight 
hours later cells were fixed and analysed by immunofluorescence. Anti-FLAG 
antibodies were used to detect FLAG-fibrillarin. Anti-coilin and anti-BMS1 antibodies 
were used to determine locations of the Cajal bodies and nucleolus, respectively. BMS1 
was distributed throughout the nucleolus, indicating localisation to both the DFC and 
GC, which was representative of its role in both early and late pre-rRNA processing 
(Figure 3.12 D; Wegierski et al, 2001). FLAG-fibrillarin was only found in discreet sub-
compartments of the nucleolus, indicating it was localised specifically to the DFC. 
FLAG-fibrillarin also co-localised with coilin, which indicates it was present in the 
Cajal bodies (Figure 3.12 C). Therefore, FLAG-fibrillarin shows the same localisation 
profile as endogenous fibrillarin (see Figure 3.1; Tollervey et al, 1991). Based on these 
controls it appears that induced FLAG-fibrillarin behaves in the same manner as 
endogenous fibrillarin. 
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It was also necessary to analyse the Tet-inducible SMN HEK293 cell line. First the 
level of expression of 2 x FLAG 6 x His tagged SMN (FLAG-SMN) was analysed. To 
determine the time required for expression FLAG-SMN HEK293 cells were grown in 
the presence of 1 μg/ml of Tet. As a control FLAG-SMN HEK293 cells that had not 
been induced were also harvested (0 hour). After six, twelve and twenty-four hours 
incubation with Tet cells were harvested, proteins separated on a 12 % SDS-PAGE gel 
and Western blot assays performed using anti-SMN antibodies. It was possible to 
distinguish between the FLAG-SMN and endogenous SMN using only anti-SMN 
antibodies as the induced FLAG-SMN migrated significantly slower than endogenous 
SMN on SDS-PAGE gels. In the absence of Tet no FLAG-SMN was expressed; 
however, twelve hours after the addition of Tet there was a detectable accumulation of 
FLAG-SMN which continued to increase up to twenty-four hours (Figure 3.13 A). The 
level of FLAG-SMN detected after twenty-four hours was similar to the level of 
endogenous SMN. This also showed that the 1 μg/ml of Tet did not result in the over 
expression of FLAG-SMN.  
 
As SMN has previously been shown to bind to pre-snRNAs during snRNP biogenesis 
(Pellizzoni et al, 2002; Wehner et al, 2002; Yong et al, 2002, 2004) an 
immunoprecipitation assay was performed to determine whether the FLAG-SMN was 
also able to associate with snRNA. In this experiment FLAG-SMN and control HEK293 
cells were induced by the addition of 1 μg/ml of Tet. After forty-eight hours whole cell 
extracts were produced and immunoprecipitation assays performed using anti-FLAG 
antibodies as described earlier. Co-precipitating RNAs were separated by 
electrophoresis on an 8 % acrylamide gel containing 7 M urea, Northern blot 
hybridisation performed using a radiolabelled probe specific for the U1 snRNA and 
results visualised using autoradiography. Anti-FLAG antibodies successfully co-
precipitated the U1 snRNA from FLAG-SMN HEK293 cell extracts but not from the 
control HEK293 cell extracts (Figure 3.13 B). In relation to the 10 % input it appears 
that 2-3 % of the total cell U1 snRNA has been co-precipitated from the FLAG-SMN 
HEK293 cell extract. The small percentage of total cell snRNA precipitated was 
expected as SMN only interacts with pre-snRNA and is not stably associated into the 
snRNP. This experiment showed that the FLAG-SMN was able to associate with 
snRNA, which is characteristic of endogenous SMN. 
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Immunofluorescence was performed to determine whether the localisation of FLAG-
SMN was the same as endogenous SMN. FLAG-SMN HEK293 cells, grown on cover 
slips, were induced by 1 μg/ml of Tet. After forty-eight hours cells were fixed and 
immunofluorescence performed using anti-FLAG antibodies to determine the 
localisation of FLAG-SMN. Anti-coilin and anti-BMS1 antibodies were used to detect 
the Cajal bodies and nucleolus, respectively. FLAG-SMN was found in the cytoplasm 
and enriched in Cajal bodies, which is characteristic of endogenous SMN (Liu and 
Dreyfuss, 1996). Taken together all the data indicates that the FLAG-SMN was 
comparable to endogenous SMN. 
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Figure 3.13: Tet-inducible FLAG-SMN HEK293 cell line controls 
 (A) Western blot assay showing Tet induction of FLAG-SMN HEK293 cells. FLAG-
SMN HEK293 cells were induced by addition of 1 µg/ml of Tet. As a control FLAG-
HEK293 cells that had not been induced were harvested (0 hrs). At several time points 
cells were harvested, proteins separated on an 12 % SDS-PAGE gel and Western blot 
assays performed using anti-SMN antibodies to detect both FLAG-SMN and 
endogenous SMN (indicated left of panel). The time periods are shown above panel. 
The migration of proteins is shown to the right of the panel.  
(B) Co-precipitation of U1 snRNA with FLAG-SMN. Whole cell extracts were 
produced from induced HEK293 cells that expressed FLAG-SMN or just the FLAG tag 
(control). Immunoprecipitation assays were performed using anti-FLAG antibodies and 
co-precipitating RNA extracted, separated by electrophoresis on an 8 % acrylamide gel 
containing 7 M urea and analysed by Northern blot hybridisation using a probe specific 
for the U1 snRNA. Results were visualised by autoradiography. Input represents 10 % 
of the amount of extract used in assay.   
(C) Immunofluorescence of induced FLAG-SMN HEK293 cells. FLAG-SMN cells, 
grown on coverslips, were induced by the addition of 1 µg/ml of Tet. Forty-eight hours 
after induction cells were fixed and immunofluorescence performed using anti-FLAG 
antibodies to identify the localisation of FLAG-SMN. Anti-coilin and anti-BMS1 
antibodies were used to indicate the location of Cajal bodies and nucleolus, 
respectively. DAPI staining of DNA was used to indicate the nucleoplasm. Antibodies 
and markers used indicated left and right of panel. The bottom row is a merged image of 
FLAG-SMN (red) with either coilin (green) or BMS1 (green) and DAPI (blue). The 
White arrows indicate the location of a Cajal body. The bar shown to the bottom right of 
the panel represents 5 μm. 
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One of the experiments the Tet-inducible FLAG-SMN HEK293 cell line was created to 
be used in was siRNA rescue assays. In these experiments endogenous SMN was to be 
depleted by siRNAs and the effect of the loss of SMN on box C/D snoRNP biogenesis 
rescued by induction of FLAG-SMN expression. In order to maintain the levels of the 
induced FLAG-SMN siRNAs were designed against the 3’UTR of endogenous SMN 
mRNA, which was not present in the FLAG-SMN mRNA. Even though the siRNA 
target sequence was not present in the FLAG-SMN mRNA it was still necessary to 
determine, experimentally, whether induced FLAG-SMN was able to accumulate in 
cells transfected with the siRNAs targeting SMN. For this control FLAG-SMN 
HEK293 cells were transfected with siRNAs targeting either firefly luciferase (control) 
or SMN and simultaneously induced by the addition of 1 μg/ml of Tet. Cells were 
harvested after twenty-four, forty-eight and seventy-two hours. Proteins were separated 
on a 12 % SDS-PAGE gel and Western blot assays performed using anti-SMN 
antibodies to identify both FLAG-SMN and endogenous SMN as described earlier. A 
Western blot was also performed using anti-nucleolin antibodies as a control of sample 
loading.  
 
 
 
 
 
 
 
 
 
Figure 3.14: Depletion of endogenous SMN in induced FLAG-SMN HEK293 cells 
FLAG-SMN HEK293 cells were transfected with siRNAs targeting either firefly 
luciferase (control) or SMN and induced by the addition of 1 μg/ml of Tet. Cells were 
harvested after twenty-two, forty-eight and seventy-two hours, proteins separated on a 
12 % SDS-PAGE gel and Western blot assays were performed using anti-SMN 
antibodies to identify both endogenous SMN and FLAG-SMN. A Western blot was also 
performed using anti-nucleolin antibodies as a control of sample loading. The protein 
targeted for depletion is indicated above the panel. Antibodies used in the Western blot 
are shown to the left of the panel. The migration of proteins is shown to the right of the 
panel. 
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In cells transfected with siRNAs targeting SMN mRNA there was a reduction in the 
level of endogenous SMN, compared to the control cells, after as little as twenty-four 
hours (Figure 3.14). The level of the induced FLAG-SMN was unaffected in cells 
transfected with siRNAs targeting SMN, which indicates that the SMN siRNAs are 
unable to target the FLAG-SMN mRNA for degradation. 
 
 
 
 
 
 
 
Figure 3.15: Depletion of SMN in HeLa SS6 cells 
HeLa SS6 cells were transfected with siRNAs targeting firefly luciferase (control) or 
SMN. After sixty hours cells were harvested, proteins separated on a 12 % SDS-PAGE 
gel and Western blot assays performed using antibodies that recognised SMN. A 
Western blot assay was also performed using anti-fibrillarin antibodies as a control of 
sample loading. The protein targeted for depletion is indicated above the panel. The 
antibodies used are indicated to the left of the panel. 
 
 
The depletion of endogenous SMN in the FLAG-SMN HEK293 cells (Figure 3.14) was 
not as efficient as was seen when the same siRNA duplex was used to deplete SMN in 
HeLa SS6 cells (Figure 3.15). To determine whether it was possible to use siRNAs to 
efficiently deplete target proteins in HEK293 cells siRNAs targeting NOP56, NOP58 
and fibrillarin were transfected into basic HEK293 cells and the localisation of the U3 
box C/D snoRNA was analysed by FISH as previously described (Chapter 3.2.1). In 
HeLa SS6 cells the depletion of NOP58 resulted in the dramatic reduction in the level of 
the U3 snoRNA while the depletion of NOP56 and fibrillarin resulted in the 
accumulation of the U3 snoRNA in the nucleoplasm and Cajal bodies (Figure 3.4). 
However, in HEK293 cells transfected with siRNAs targeting NOP56, NOP58 and 
fibrillarin there was no change in the levels or distribution of the U3 box C/D snoRNA 
(data not shown). A possible explanation for the lack of effect on the U3 snoRNA levels 
and localisation in HEK293 cells is that the siRNA mediated depletion was not as 
efficient in HEK293 cells as in HeLa SS6 cells. To try and overcome this issue both 
chemical and electroporation transfection protocols were employed; however, these 
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proved equally unsuccessful. Due to these issues the use of the inducible HEK293 cells 
in experiments, which incorporated siRNA depletion, was not possible.  
 
As siRNA mediated depletion proved difficult in HEK293 cells an inducible fibrillarin 
reporter plasmid was designed for use in HeLa SS6 cells. This system used a pPTuner 
reporter plasmid (Clontech) containing a degradation domain (DD) tag that when 
expressed targets the protein, to which it is fused, for proteosomal-mediated 
degradation. However, when the stabilising agent Shield1 is added the DD is no longer 
targeted to the proteosome and the protein, it is fused with, accumulates (Banaszynski et 
al, 2006). To create this system fibrillarin cDNA with N terminal 2 x FLAG 6 x His 
sequences was cloned into the pPTuner plasmid. The pPTuner plasmid (Figure 3.16) 
also contained an internal ribosome entry site 2 (IRES2) element upstream of a GFP 
coding sequence that when expressed provides a marker for transfected cells.  
 
 
 
 
 
Figure 3.16: Organisation of DD-fibrillarin plasmid 
Fibrillarin cDNA with 2 x FLAG and 6 x His N terminal tags was cloned into a 
pPTuner IRES2 GFP plasmid (Clontech). The pPTuner plasmid contains a CMV 
(cytomegalo virus) promoter, N terminal degradation domain (DD), internal ribosome 
entry site 2 (IRES2) and a green florescent protein (GFP) tag. Arrow indicates 
transcription start site. 
 
 
The DD fibrillarin reporter plasmid (DD-fibrillarin) was developed to be co-transfected 
into HeLa SS6 cells with siRNAs. Once target protein levels had been depleted the 
addition of shield1 would result in the accumulation of DD-fibrillarin and the 
incorporation of DD-fibrillarin into newly synthesized snoRNPs and its localisation 
could be analysed. The use of this procedure removed the requirement for multiple 
transfections as only a single transfection of both siRNA and reporter plasmid was 
required. 
 
Before using the DD-fibrillarin reporter plasmid to analyse box C/D snoRNP biogenesis 
it was necessary to first characterise its expression and accumulation. To determine the 
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quantity of shield1 required to induce stabilisation HeLa SS6 cells were transfected with 
the DD-fibrillarin reporter plasmid and incubated with various levels of shield1. After 
twenty-four hours cells were harvested, proteins separated on a 12 % SDS-PAGE and 
Western blot assays performed using anti-FLAG antibodies to detect DD-fibrillarin. In 
addition a Western blot assay was performed using anti-fibrillarin antibodies as a 
control of sample loading. These assays showed that in the absence of shield1 there was 
some accumulation of DD-fibrillarin; however, when 50 nM to 1000 nM of shield1 was 
added there was a dramatic accumulation of DD-fibrillarin (Figure 3.17 A). 
Interestingly, there was very little difference in the accumulation of DD-fibrillarin when 
50 nM or 1000 nM of shield1 was added.  
 
To determine the relative level of DD-fibrillarin accumulation in comparison to 
endogenous fibrillarin further analysis of the Western blot in Figure 3.17 A was 
performed. Using only anti-fibrillarin antibodies it was possible to distinguish between 
DD-fibrillarin and endogenous fibrillarin as the DD-fibrillarin migrated slower on SDS-
PAGE gels. In the absence of shield1 there was a low level accumulation of DD-
fibrillarin (Figure 3.17 B). When 250 nM shield1 was added there was a higher 
accumulation of DD-fibrillarin; however, the level of DD-fibrillarin was still much 
lower than the level of endogenous fibrillarin. This was an important control that 
showed DD-fibrillarin was not over expressed. 
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Figure 3.17: Control experiments of DD-fibrillarin accumulation 
 (A) Western blot assay showing quantity of shield1 required for stabilisation and 
accumulation of DD-fibrillarin. HeLa SS6 cells were transfected with the DD-fibrillarin 
reporter plasmid and incubated with various concentrations of shield1 for twenty-four 
hours. Proteins were separated on a 12 % SDS-PAGE and analysed by Western blot 
assays using anti-FLAG antibodies. A Western blot assay was also performed using 
anti-fibrillarin antibodies as a control of sample loading. The quantity of shield1 used is 
indicated above the panel. The antibodies used in the Western blot are shown to the left 
of the panel.  
(B) Western blot showing the level of DD-fibrillarin accumulation in comparison to 
endogenous fibrillarin. Longer exposure and larger section of the Western blot 
performed in Figure 3.17 A with both DD-fibrillarin and endogenous fibrillarin visible 
using only anti-fibrillarin antibodies (indicated left of panel). The quantity of shield1 
used is indicated above the panel.  
(C) Western blot showing time course of DD-fibrillarin stabilisation and accumulation. 
HeLa SS6 cells were transfected with the DD-fibrillarin reporter plasmid and incubated 
with 250 nM of shield1. As a control cells transfected with the DD-fibrillarin plasmid 
were extracted before the addition of shield1 (0 hours). Cells were extracted after one, 
three, six, twelve, twenty-four and forty-eight hours, proteins separated on a 12 % SDS-
PAGE and analysed by Western blot assays using anti-FLAG antibodies to identify DD-
fibrillarin. A Western blot assay was also performed using anti-nucleolin antibodies to 
control sample loading. The incubation time is indicated above the panel. The 
antibodies used in the Western blot are shown to the left of the panel. 
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A time course of DD-fibrillarin accumulation in the presence of shield1 was also 
performed. HeLa SS6 cells were transfected with the DD-fibrillarin reporter plasmid 
and twelve hours later shield1 was added to a final concentration of 250 nM. This 
concentration of shield1 was selected as it has previously shown to produce a clear 
accumulation of DD-fibrillarin (Figure 3.17 A). As a control cells transfected with the 
DD-fibrillarin reporter plasmid were harvested before the addition of shield1 (0 hours). 
Cells supplemented with shield1 were harvested after one, three, six, twelve, twenty-
four and forty-eight hours. Proteins were separated on a 12 % SDS-PAGE gel and 
Western blot assays performed using anti-FLAG antibodies to detect DD-fibrillarin. As 
a control of sample loading a Western blot assay was also performed with anti-nucleolin 
antibodies. In the absence of shield1 there was a slight accumulation of DD-fibrillarin; 
however, as little as one hour after the addition of shield1 there was a much larger 
accumulation of DD-fibrillarin (Figure 3.17 C). The level of DD-fibrillarin 
accumulation did not appear to change after one hour and even after forty-eight hours 
the level of DD-fibrillarin remained approximately the same.   
 
Immunofluorescence was performed to determine whether the DD-fibrillarin localised 
the same as endogenous fibrillarin. Two sets of HeLa SS6 cells were transfected with 
the DD-fibrillarin reporter plasmid and to one set 250 nM of shield1 was added and to 
the control cells no shield1 was added. Both sets of cells were then incubated for 
another six hours, fixed and immunofluorescence performed using anti-FLAG 
antibodies to detect DD-fibrillarin. Anti-coilin and anti-BMS1 antibodies were used to 
detect the location of the Cajal bodies and nucleolus, respectively. 
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Figure 3.18: Immunofluorescence of DD-fibrillarin 
(A) HeLa SS6 cells, grown on coverslips, were transfected with the DD-fibrillarin 
reporter plasmid. Twelve hours later shield1 was added to a concentration of 250 nM. 
Six hours after the induction of stabilisation cells were fixed and immunofluorescence 
performed. Anti-FLAG antibodies were used to detect DD-fibrillarin. Anti-coilin and 
anti-BMS1 antibodies were used to indicate the locations of the Cajal bodies and the 
nucleolus, respectively. DAPI staining of DNA was used to determine the location of 
the nucleoplasm. Antibodies used indicated left and right of the panel. The bottom row 
is a merged image of DD-fibrillarin (red), Coilin or BMS1 (green) and DAPI (blue). 
The white arrows indicate a Cajal body. The bar shown to the bottom right of the panel 
represents 5 μm. 
(B) Enlarged nucleolus from Figure 3.18 A. The antibodies used are indicated above 
panels. The right hand panel is a merged image of FLAG-fibrillarin (red) and BMS1 
(green). 
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In the cells where shield1 was added DD-fibrillarin localised to the nucleolus and the 
Cajal bodies as was shown by the co-localisation with BMS1 and coilin, respectively 
(Figure 3.18). BMS1 was distributed throughout the nucleolus in both the DFC and GC, 
which was representative of its role in both early and late pre-rRNA processing 
(Wegierski et al, 2001). DD-fibrillarin was found in discreet sub-compartments of the 
nucleolus, which indicated it was localised specifically to the DFC where the majority 
of box C/D snoRNPs are found (Figure 3.18 B; see Figure 3.1 for comparison of 
nucleolar localisation). This experiment showed that DD-fibrillarin localised to the 
same sub-cellular domains as endogenous fibrillarin (Tollervey et al, 1993). In the 
control cells a low level background of DD-fibrillarin was visible but the signal was too 
low to obtain images (data not shown). The results were therefore in line with the 
Western blot analysis with cells not supplemented with shield1 producing a low level 
background of DD-fibrillarin but an accumulation of DD-fibrillarin once shield1 was 
added (Figure 3.17).  
 
One major issue that became apparent from initial experiments with the DD-fibrillarin 
reporter plasmid was that the GFP marker, translated from the IRES2 element, was not 
expressed at high enough levels to provide an indication of the level of transfection. The 
cause of the low GFP expression was due to the fact that proteins encoded after the 
IRES2 element are translated at a rate three to four times lower than the gene of interest 
(personal communication from Clontech). To try and amplify the GFP signal 
immunofluorescence was performed using rabbit anti-GFP antibodies in conjunction 
with GFP conjugated anti-rabbit antibodies; however, still no GFP signal was visible. 
The GFP marker was a vital control for experiments utilising siRNA mediated depletion 
experiments to ensure that when analysing the localisation of DD-fibrillarin, cells with a 
similar level of transfection could be selected.  
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Figure 3.19: The localisation of DD-fibrillarin in NOP56 depleted cells 
HeLa SS6 cells were transfected with the DD-fibrillarin reporter plasmid and siRNAs 
targeting either firefly luciferase (control) or NOP56. Forty-eight hours later the 
stabilising agent, shield1, was added to a concentration of 250 nM. After six hours cells 
were fixed and immunofluorescence performed. Anti-FLAG antibodies were used to 
detect DD-fibrillarin and anti-BMS1 antibodies used to identify the nucleolus. DAPI 
staining of the DNA was used to determine the location of the nucleoplasm. The same 
exposure time was used for each probe to allow direct comparison of protein 
distribution and levels. The protein targeted for depletion is indicated at the top of each 
column of images. The antibodies used are indicated to the left of the panel. The bottom 
row is a merged image of DD-fibrillarin (red), BMS1 (green) and DAPI (blue). The bar 
to the bottom right of the panel represents 5 μm. 
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To determine whether the co-transfection of siRNAs and the DD-fibrillarin reporter 
plasmid would work HeLa SS6 cells were co-transfected with the DD-fibrillarin 
reporter plasmid and siRNAs targeting firefly luciferase (control) or NOP56. Forty-
eight hours later shield1 was added to a final concentration of 250 nM. After another six 
hours the HeLa SS6 cells were fixed and analysed by immunofluorescence using anti-
FLAG antibodies to detect DD-fibrillarin and anti-BMS1 antibodies to identify the 
nucleolus. 
 
In the control cells DD-fibrillarin was found in the nucleolus, as was shown by the co-
localisation with the BMS1 (Figure 3.19). In cells depleted of NOP56 DD-fibrillarin 
was still found in the nucleolus; however, DD-fibrillarin also accumulated in the 
nucleoplasm. The accumulation in the nucleoplasm could be due the formation of pre-
snoRNP complexes that contained DD-fibrillarin but lacked NOP56 and therefore were 
unable to localise to the nucleolus.  
 
The co-transfection of the DD-fibrillarin reporter plasmid with siRNAs was only 
successful using siRNAs targeting NOP56, and even with this depletion only a few cells 
expressed a detectable amount of DD-fibrillarin. A number of siRNAs targeting other 
snoRNP factors were tested; however, these resulted in the complete lack of DD-
fibrillarin accumulation. A possible explanation for the lack of DD-fibrillarin expression 
may be that in the absence of the box C/D snoRNP factors DD-fibrillarin was turned 
over rapidly. Due to an inability to obtain detectable expression of the GFP transfection 
marker and the issues with DD-fibrillarin accumulation in cells depleted of factors of 
interest the use of the DD-fibrillarin reporter plasmid was limited.    
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3.3. Discussion 
 
In this chapter a variety of assays, procedures and approaches were developed to 
investigate box C/D snoRNP biogenesis. These included inducible cell lines, procedures 
to analyse de novo snoRNP biogenesis and the use of more basic assays including FISH 
and immunofluorescence to determine the localisation of the box C/D snoRNA, 
common core proteins and assembly factors. 
 
Box C/D snoRNAs are transcribed in the nucleoplasm and formation of the snoRNP has 
been predicted to occur in the nucleoplasm, Cajal bodies and cytoplasm (Terns et al, 
1995; Boulon et al, 2004; Watkins et al, 2004, 2007; Lemm et al, 2006; McKeegan et al, 
2007). One approach used to shed more light on the site(s) of box C/D snoRNP 
biogenesis was to determine the cellular localisation of the box C/D snoRNP assembly 
factors. Immunofluorescence analysis revealed that the box C/D snoRNP assembly 
factors TIP48, TIP49, BCD1, TAF9 and NUFIP localise throughout the nucleoplasm 
and are not enriched in any nuclear body (Figure 3.6 A and B). The nucleoplasmic 
localisation of the assembly factors fits with box C/D snoRNP biogenesis occurring in 
the nucleoplasm (Terns et al, 1995; Boulon et al, 2004; Watkins et al, 2004). As no 
assembly factors were found enriched in the Cajal bodies this suggests that the assembly 
factors do not function in box C/D snoRNP biogenesis at this site. It was not, however, 
possible to entirely rule out the presence of assembly factors in the Cajal bodies.  
 
As many of the box C/D snoRNP assembly factors are involved in other processes in 
the nucleoplasm it is difficult to draw a firm conclusion on the site(s) of box C/D 
snoRNP biogenesis by analysing their localisation alone. For instance TAF9 is a TATA 
binding protein and therefore functions in RNA polymerase II transcription in the 
nucleoplasm (Milgrom et al, 2005). NUFIP is a zinc finger transcription factor and so is 
also localised to the nucleoplasm (Cabart et al, 2004). TIP48 and TIP49 have roles in 
chromatin-modifying complexes (Shen et al, 2000) and transcription activating 
complexes (Cho et al, 2001) that require these proteins to be localised again to the 
nucleoplasm. No additional functions outside of box C/D snoRNP biogenesis have been 
found for BCD1 and therefore, in this case, the nucleoplasmic localisation may solely 
reflect its role in box C/D snoRNP biogenesis.  
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Another approach used to analyse box C/D snoRNP biogenesis was the use of siRNA 
mediated depletion followed by analysing the localisation of box C/D snoRNA. To 
establish this approach siRNAs were used to deplete the box C/D snoRNP common core 
proteins NOP56, NOP58 and fibrillarin and FISH used to determine the localisation of 
the U3 box C/D snoRNA. In the control cells the U3 snoRNA localised predominately 
to the nucleolus and was also found in the Cajal bodies (Figure 3.4), the typical 
distribution of U3 snoRNA (Granneman et al, 2004). In cells depleted of NOP56 or 
fibrillarin there was a slight reduction in the levels of nucleolar U3 snoRNA, more than 
likely, due to a reduction in the rate of box C/D snoRNP biogenesis. In NOP56 and 
fibrillarin depleted cells U3 snoRNA accumulated in the nucleoplasm and Cajal bodies, 
providing further evidence that box C/D snoRNP biogenesis occurs at these sites. The 
accumulation of box C/D snoRNA in the nucleoplasm when fibrillarin and NOP56 were 
depleted is in agreement with studies in yeast (Verheggen et al, 2001). A possible 
explanation is that as only mature box C/D snoRNPs, containing all the common core 
proteins, are predicted to localise to the nucleolus (Verheegen et al, 2001), pre-snoRNPs 
lacking either fibrillarin or NOP56 accumulated in the nucleoplasm and Cajal bodies. In 
cells depleted of NOP58 there was a dramatic reduction in nucleolar U3 snoRNA levels 
with no accumulation in the nucleoplasm or Cajal bodies (Figure 3.4). The dramatic 
drop in the U3 snoRNA levels indicates that NOP58 is essential for the stability of the 
snoRNA, which is agreement with previous studies (Lafontaine and Tollervey, 2000; 
Watkins et al, 2004). As distinctive phenotypes were observed by the siRNA mediated 
depletion of the common core proteins this indicates that this procedure could be use to 
analyse the function of other proteins in box C/D snoRNP biogenesis. 
 
One issue with using siRNAs to deplete the common core proteins followed by analysis 
of the localisation of endogenous box C/D snoRNA was that it was not possible to 
discriminate between snoRNAs synthesised prior to protein depletion and newly formed 
snoRNAs. This is an issue when analysing the box C/D snoRNPs as these are stable 
complexes, which have been predicted to have long half-lives (personal communication 
from N.J.Watkins, Newcastle University, UK). Similar issues had to be addressed in 
studies analysing snRNP biogenesis as these complexes are also very stable and have 
half-lives of between 60 and 88 hours (Fury and Zieve, 1996). A study by Shparagel 
and Matera 2005 addressed this issue by developing a number of procedures to 
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specifically monitor the de novo biogenesis of the snRNPs. These included the use of an 
in vitro assembly assay and a two-step transfection procedure whereby cells were first 
transfected with siRNAs followed by a secondary transfection of a reporter plasmid, 
once target protein levels had been depleted. A variety of approaches were therefore 
developed in this study to analyse the de novo biogenesis of box C/D snoRNPs. 
 
An assembly assay was developed to analyse box C/D snoRNP biogenesis based upon a 
snRNP assembly assay (Shparagel and Matera, 2005). In this assay an active cell 
extract, produced from HeLa SS6 cells that had been depleted of a protein of interest 
using siRNAs, was incubated with radiolabelled U14 box C/D snoRNA. To assess 
protein association onto the radiolabelled U14 snoRNA immunoprecipitation assays 
were performed using antibodies that recognised the box C/D snoRNP common core 
proteins. Unfortunately, despite the use of a variety of cell extraction protocols it was 
not possible to immunoprecipitate any newly formed box C/D snoRNPs, even using 
HeLa SS6 cell extract that had not been subjected to siRNA mediated depletion.        
 
A two-step transfection procedure was developed to analyse de novo box C/D snoRNP 
biogenesis in this study. This involved HeLa SS6 cells being first transfected with 
siRNAs followed by the secondary transfection of a plasmid that expressed tagged U3 
snoRNA (StreptoTag U3; Figure 3.8). In cells depleted of NOP56 the newly synthesised 
StreptoTag U3 snoRNA accumulated in the nucleolus, nucleoplasm and Cajal bodies, 
which further implicates the nucleoplasm and Cajal bodies as sites of box C/D snoRNP 
biogenesis. In cells depleted of NOP58 there was no accumulation of the StreptoTag U3 
snoRNA in the nucleoplasm or Cajal bodies. Interestingly, even with this de novo 
procedure the StreptoTag U3 snoRNA still accumulated in the nucleolus of cells 
depleted of NOP56 and NOP58, which indicate that a low level of box C/D snoRNP 
biogenesis was still occurring. An issue with this assay is that without an internal 
marker of transfection, such as a GFP marker co-expressed from the plasmid, it is 
difficult to compare the relative levels of the StreptoTag U3 snoRNA between cells 
making analysis problematic.  
 
A variety of other siRNAs targeting fibrillarin and box C/D snoRNP assembly factors 
were tested using this two-step transfection procedure; however, these experiments were 
not successful. The main issue that limited the use of this system was the poor rate of 
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secondary transfection of the StreptoTag U3 reporter plasmid. A number of different 
transfection protocols were utilised to try and overcome this issue but these proved 
unsuccessful. While it was not possible to use this procedure to further study box C/D 
snoRNP biogenesis it provided clarification that the results seen with the endogenous 
U3 snoRNA after NOP56 and NOP58 depletion are accurate (Figure 3.4).    
 
To remove the need for multiple transfections Tet-inducible box C/D snoRNA HEK293 
cell lines were created that expressed the StreptoTag U3 or mU14 snoRNAs. These cell 
lines allowed a single transfection of siRNAs to be performed followed by induction of 
box C/D snoRNA once target protein levels have been depleted. Both these cell lines 
expressed the respective snoRNA by the addition of Tet and could be specifically 
detected above endogenous snoRNA. However, despite the use of varying quantities of 
Tet and numerous incubation times neither of the box C/D snoRNA HEK293 cell lines 
expressed sufficient levels of the respective snoRNA to be comfortably detected, 
therefore the use of these cell lines was limited. One possible explanation for the low 
level of the StreptoTag U3 and mU14 snoRNA expression from the Tet-inducible 
HEK293 cells is that in nature multiple copies of these RNAs are present in the genome, 
which could reflect that each copy is only expressed at low levels. For example in rat, 
human and mouse hsc70, three copies of the U14 snoRNA are expressed from introns 5, 
6 and 8 (Sorger and Pelhma, 1987; Dworniczak and Mirault, 1987; Lui and Maxwell, 
1990). Furthermore, two copies of the U14 snoRNA are expressed from ribosomal 
protein genes (Kenmochi et al, 1996). In regards the U3 snoRNA there are four to six 
copies in the human genome (Mazan et al, 1993). One potential method of increasing 
the expression levels of the inducible snoRNAs is to insert tandem repeats of the 
snoRNA genes into the Tet-inducible HEK293 expression cassettes. Tandem repeats of 
snoRNA genes was used successfully by Darzacq et al 2008 to create an E3 box H/ACA 
inducible U2OS stable cell line that expressed inducible E3 snoRNA at a level 
comparable with endogenous E3. As the U3 snoRNA is encoded as an independent 
gene tandem repeats of the entire U3 gene could be inserted into the expression cassette. 
As mU14 snoRNA is an intronic RNA to increase its expression tandem repeats of the 
hsc70 gene incorporating U14 i.e. intron 5 with sections of the surrounding exons, 
would need to be inserted into the HEK293 expression cassette.    
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Two Tet-inducible tagged protein cell lines were also created to study box C/D snoRNP 
biogenesis, the FLAG-SMN and FLAG-fibrillarin HEK293 cell lines. These cell lines 
expressed their tagged proteins at levels that were similar to the respective endogenous 
proteins (Figure 3.12 and 3.13). Immunofluorescence showed that FLAG-SMN 
localised to the cytoplasm and Cajal bodies, and FLAG-fibrillarin localised to the 
nucleolus and Cajal bodies (Figure 3.1). Immunoprecipitation assays using anti-FLAG 
antibodies confirmed that FLAG-SMN was able to bind snRNA and the FLAG-
fibrillarin could associate with box C/D snoRNPs (Figures 3.12 and 3.13). This 
indicates that both FLAG-SMN and FLAG-fibrillarin function in a similar manner to 
their respective endogenous proteins (Tollervey et al, 1993; Liu and Dreyfuss, 1996; 
Yong et al, 2002, 2004). While the controls showed that the inducible proteins 
functioned as endogenous proteins and were expressed at usable levels an issue become 
apparent when siRNAs were used to deplete target proteins in HEK293 cells. 
Comparative analysis of the levels of the SMN protein in HEK293 and HeLa SS6 cells 
transfected with siRNAs targeting SMN revealed that siRNA depletion of proteins was 
not as efficient in HEK293 as in HeLa SS6 cells. Furthermore, the transfection of 
siRNAs targeting NOP56, NOP58 and fibrillarin in HEK293 cells did not result in a 
change in levels or cellular localisation of the U3 snoRNA as was shown in HeLa SS6 
cells (Figure 3.4). To overcome this issue numerous transfection protocols were 
employed including electroporation; however, these were unsuccessful. Even though the 
use of siRNA mediated depletion was not possible these Tet-inducible cell lines can still 
be used to analyse the incorporation of the FLAG-SMN or FLAG-fibrillarin into newly 
synthesised complexes by immunoprecipitation using anti-FLAG or anti-His antibodies. 
At the time of writing, numerous shRNAs are being developed by the lab to create a 
more efficient protein depletion system for use in HEK293 cells. 
 
To overcome the issues of siRNA mediated depletion in HEK293 cells the inducible 
DD-fibrillarin reporter plasmid was developed that could be co-transfected with siRNAs 
into HeLa SS6 cells. Using this system it was shown that the depletion of NOP56 
resulted in the accumulation of newly synthesied DD-fibrillarin in the nucleoplasm 
(Figure 3.19). A possible explanation for this is that DD-fibrillarin was incorporated 
into pre-snoRNP complexes that were unable to localise to the nucleolus, due to the lack 
of NOP56, resulting the subsequent accumulation in the nucleoplasm. This is also 
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indicated by the fact that the depletion of NOP56 resulted in the accumulation of U3 
box C/D snoRNA in the nucleoplasm (Figure 3.4). 
 
The siRNA mediated depletions of other box C/D snoRNP factors was attempted using 
the DD-fibrillarin co-transfection procedure; however, the use of this procedure was 
limited due to the lack of DD-fibrillarin accumulation in all but the NOP56 depletion 
experiments. Another issue that limited the use of the DD-fibrillarin reporter plasmid 
was that the GFP transfection marker did not express at high enough levels to determine 
the level of transfection and expression of DD-fibrillarin between cells, a necessary 
control.  
 
In this chapter a variety of assays, procedures and approaches were developed to 
analyse box C/D snoRNP biogenesis; however, not all proved viable. Despite this the 
use of siRNA mediated depletion of target proteins followed by FISH to detect 
endogenous box C/D snoRNA localisation provided a method to study potential box 
C/D snoRNP factors. While the use of siRNA depletion of target proteins in HEK293 
cells proved problematic the inducible FLAG-SMN and FLAG-fibrillarin HEK293 cell 
lines can be used to analyse the incorporation of the FLAG-SMN or FLAG-fibrillarin 
into newly synthesised complexes by immunoprecipitation using anti-FLAG or anti-His 
antibodies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 130 
Chapter four 
 
 
 
Analysis of the localisation 
and interactions of 
fibrillarin  
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4.1. Introduction 
 
Fibrillarin is the methyltransferase component of the box C/D snoRNPs responsible for 
the 2’-O-methylation of rRNA residues (Tollervey et al, 1993). The box C/D snoRNPs 
contain three other common core proteins known as 15.5K, NOP56 and NOP58, which 
with fibrillarin, are stably associated onto the box C/D snoRNA. In humans, the box 
C/D snoRNPs are responsible for 105 specific rRNA methylation events, which are 
essential for the structure and function of the ribosome (Maden, 1990; Decatur and 
Fournier, 2002). The box C/D snoRNAs guide modification of rRNA by binding target 
sequences using a 1-20 nucleotide guide sequence that positions the rRNA residue to be 
modified at the fibrillarin active site (Kiss-Laszlo et al, 1996, 1998). Fibrillarin 
functions by transferring a methyl group from the co-factor AdoMet to the donor site 
located on the ribose sugar (Figure 4.1).   
  
 
 
 
 
 
 
 
Figure 4.1: The chemical modification of rRNA by the box C/D snoRNPs 
The 2’-O-methylation of the ribose sugar backbone of rRNA. Blue circles represent 
nitrogen. Oxygen is shown as red circles. Joined black lines indicate carbon. Black lines 
indicate covalent bonds.  
 
Fibrillarin is a conserved protein that, in humans, contains 321 amino acids, which can 
be divided into the RGG motif containing domain (amino acids 1-81), the N terminal 
domain (amino acids 82-141) and the C terminal domain (amino acids 142-321) (Figure 
4.2). The C terminal domain of fibrillarin houses the methyltransferase component that 
interacts with AdoMet (Wang et al, 2000; Figure 4.2 and 4.3). Interestingly, the 
methylated RGG motif containing domain of fibrillarin appears to be specific to 
eukaryotes being absent from archaea, the organism from which fibrillarin was 
crystallised and structure determined (Wang et al, 2000; Figure 4.3).  
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Protein sequence aligments of fibrillarin from Homo sapiens (H. sapiens) Caenorhabditis elegans (C. elegans), Saccharomyces cerevisiae (S. 
cerev), Methanococcus jannaschii (M. jannaschii) and Methanococcus thermophiles (M. thermo) (indicated to the left of the sequences). 
Sequences were aligned by clustalW. Identical amino acids marked by black boxes and similar amino acids marked by grey boxes. Black lines 
above sequence show location of β-sheets and α-helices as indicated from the archaea M. jannaschii fibrillarin crystal structure (Wang et al, 
2000; see Figure 4.3). 
 
H.sapiens      (1) --MKPGFSPRGGGFGGRGGFGDR--GGRGGRGGFGGG-------------------RGRGGGFRGRGRGGGGGGGGGGGG 
C.elegans      (1) -MGRPEFNRGGGGGGFRGGRGGDRGGSRGGFGGGGRGGYGGGDRGSFGGGDRGGFRGGRGGGDRGGFRGGRGGGDRGGFG 
S.cerev        (1) MSFRPGSRGGSRGGSRGGFGGRG--GSRGGARGGSRGG-----------------FGGRGGS-RG----GARGGSRGGFG 
 
                                                             ß-1’    _ß-2’      ß-3’             ß-4’   
H.sapiens     (58) GR----GGGGFHS-GGNRGRG-----RGGKRGNQSGKNVMVEPHRHEGVFICRGKEDALVTKNLVPGESVYGEKRVSISE 
C.elegans     (80) GRGSPRGGFGGRG-SPRGGRGSPRGGRGGAGGMRGGKTVVVEPHRLGGVFIVKGKEDALATKNMVVGESVYGEKRVSVDD 
S.cerev       (57) GRGG--SRGGARG-GSRGGRG------GAAGGARGGAKVVIEPHRHAGVYIARGKEDLLVTKNMAPGESVYGEKRISVEE 
M.jannaschii   (1) ----------------------------------MEDIKIKEIFENIYEVDLGDGLKRIATKSIVKGKKVYDEKIIKIGD 
M.thermo       (1) ------------------------------------MYAVKEVKGMDGVFIMNNSLLTINPN---PGVKVYGERIIDWGG 
 
                    _____ß-5’_______    __a-0___             _ß-1_     ___a-1___     _ß-2__  __a-2__ 
H.sapiens    (128) GD-------DKIEYRAWNPFRSKLAAAILGGVDQIHIKPGAKVLYLGAASGTTVSHVSDIVGPDGLVYAVEFSHRSGRDL 
C.elegans    (159) GAG-------SIEYRVWNPFRSKLAASIMGGLENTHIKPGTKLLYLGAASGTTVSHCSDVVGPEGIVYAVEFSHRSGRDL 
S.cerev      (128) PSKEDGVPPTKVEYRVWNPFRSKLAAGIMGGLDELFIAPGKKVLYLGAASGTSVSHVSDVVGPEGVVYAVEFSHRPGREL 
M.jannaschii  (47) E-----------EYRIWNPNKSKLAAAIIKGLKVXPIKRDSKILYLGASAGTTPSHVADIADK-GIVYAIEYAPRIMREL 
M.thermo      (42) R-----------EYRVWDPRRSKLAAAILNGLRGFSLNSDSRVLYLGASAGTTASHISDIVTD-GRVYCIEFSPRMMREL 
 
                  __       _ß-3_     _a-3      _ß-4_      ____a-4_____ ____ß-5_____ a5      ______ 
H.sapiens    (201) INLAKKRTNIIPVIEDARHPHKYRMLIAMVDVIFADVAQPDQTRIVALNAHTFLRNGGHFVISIKANCIDSTASAEAVFA 
C.elegans    (232) LGVAKKRPNVVPIVEDARHPHKYRMLVGMVDVIFSDVAQPDQARIVALNAQNFLRNGGHAVISIKANCIDSTAEPEAVFA 
S.cerev      (208) ISMAKKRPNIIPIIEDARHPQKYRMLIGMVDCVFADVAQPDQARIIALNSHMFLKDQGGVVISIKANCIDSTVDAETVFA 
M.jannaschii (115) LDACAERENIIPILGDANKPQEYANIVEKVDVIYEDVAQPNQAEILIKNAKWFLKKGGYGXIAIKARSIDVTKDPKEIFK 
M.thermo     (110) LGVCESRKNMAPLLEDASRPLSYLRMVEAADLVYCDVAQPDQTRLFIENMDCFLKRDGYGLIMIKARSIDVTRSPRKIFR 
 
                   a-6_____   ____ß-6__    __ß-7____ 
H.sapiens    (281) SEVKKMQQENMKPQEQLTLEPYERDHAVVVGVYRPPPKVKN---- 
C.elegans    (312) GEVNKLKEEKFKPLEQVTLEPYERDHAVVVAVYRPVKGKKV---- 
S.cerev      (288) REVQKLREERIKPLEQLTLEPYERDHCIVVGRYMRSGLKK----- 
M.jannaschii (195) EQKEILEAGGFKIVDEVDIEPFEKDHVMFVGIWEGK--------- 
M.thermo     (190) EEVGKLESSGFRIIDQVGLNPYEKDHMAVLVKRDV---------- 
 
Figure 4.2: Protein sequence alignment of fibrillarin from various organisms 
1
3
2
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Figure 4.3: Crystal structure of archaeal fibrillarin 
Ribbon diagram of fibrillarin from the archaea Methanococcus jannaschii with 
secondary structures assigned by PROCHECK and ribbon representation by 
MOLSCRIPT. β-sheets in the C terminal domain (β1–β7) and in the N terminal domain 
(β1′–β5′) are shown in magenta and red, respectively. The C terminal domain α-helices 
(α1–α6) are shown in green while the helix (α0) that connects the N and C terminal 
domains is shown in blue. Image taken from Wang et al, 2000.  
 
 
Fibrillarin is found in the DFC sub-compartments of nucleolus where, as a stable 
component of the box C/D snoRNPs, it functions in the 2’-O-methylation of rRNA 
residues (Figure 4.1 and 4.4). The nucleolus contains three sub-compartments, the FC, 
DFC and GC, and is the site where synthesis and processing of pre-rRNA as well as the 
bulk of ribosome assembly events occur. The pre-rRNA is transcribed at the FC DFC 
border and, as the pre-rRNA migrates from the FC to the DFC and finally the GC, it is 
processed and modified. Factors that function in both early and late pre-rRNA 
processing, such as BMS1, are distributed throughout the nucleolus in both the DFC and 
GC (Wegierski et al, 2001; Figure 4.4).  
 
Fibrillarin is also found in the Cajal bodies, which could represent box C/D snoRNPs 
during biogenesis (Verheggen et al, 2001; Boulon et al, 2004; Lemm et al, 2006) or box 
C/D scaRNPs that are localised in the Cajal bodies (Jady and Kiss, 2001)  
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Figure 4.4: Differential nucleolar localisation of fibrillarin and BMS1 
HeLa SS6 cells were grown on coverslips, transfected with plasmids that express 2 x 
flagged tagged fibrillarin and immunofluorescence performed using anti-FLAG 
antibodies. Immunofluoresecnce was also performed using antibodies against BMS1 to 
detect the nucleolus. The proteins visualised are indicated above the panel. Merged 
image shows fibrillarin (red) with BMS1 (green). The bar to the bottom right of the 
panel represents 5 μm. 
 
 
A mutational study of human fibrillarin revealed that amino acids 133-306, which 
closely corresponds to the C terminal domain (amino acids 142-321), were essential for 
the localisation to both the nucleolus and the Cajal bodies (Snaar et al, 2000). The same 
study also showed that the fibrillarin RGG motif containing domain (amino acids 1-80) 
and amino acids 81-133, which corresponds closely to the N terminal domain (amino 
acids 82-141), were not essential for fibrillarin localisation (Snaar et al, 2000). 
However, the mechanisms that result in the localisation of fibrillarin to the DFC and 
Cajal bodies are not clear. The region of fibrillarin spanning amino acids 133-306 could 
contain nucleolar and Cajal body localisation signals or alternatively be essential for 
association into the box C/D snoRNPs which then localise to the Cajal bodies and 
nucleolus.    
 
The biogenesis of box C/D snoRNPs is a complex process that has been proposed to 
occur in the nucleoplasm (Terns et al, 1995; Watkins et al, 2004; Boulon et al, 2004), 
Cajal bodies (Verheggen et al, 2001; Boulon et al, 2004; Lemm et al, 2006) and 
cytoplasm (Baserga et al, 1992; Peculis et al, 2001; Watkins et al, 2007). Box C/D 
snoRNP biogenesis proceeds in a large, dynamic complex known as the pre-snoRNP 
that consists of the snoRNA, common core proteins and assembly, transport and RNA 
processing factors (Boulon et al, 2004; Watkins et al, 2004, 2007; McKeegan et al, 
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2007). The assembly factors TIP48, TIP49, BCD1, TAF9, NOP17 and NUFIP are vital 
for box C/D snoRNP biogenesis and have been shown to extensively interact with the 
common core proteins (McKeegan et al, 2007). It has been proposed that the box C/D 
snoRNP assembly factors function in the early recruitment of the common core proteins 
to the pre-snoRNP (Watkins et al, 2004, 2007; McKeegan et al, 2007; Boulon et al, 
2008). Fibrillarin interacts with all of the above assembly factors; however, the specific 
function of the assembly factors is not known.  
 
The importance of the interactions between fibrillarin and the box C/D snoRNP 
assembly factors for association with the box C/D snoRNP has not been analysed. 
Furthermore, the contribution of the various domains of fibrillarin for incorporation into 
the box C/D snoRNP has not been fully characterised. To gain a greater understanding 
of the association of fibrillarin with the box C/D snoRNPs a series of fibrillarin deletion 
mutants were produced and a variety of experimental approaches utilised. These 
included assays to determine which domains of fibrillarin were required for localisation, 
association with snoRNPs and interactions with the box C/D snoRNP assembly factors. 
By further analysing the roles of the various domains of fibrillarin the association with 
the box C/D snoRNP could be further defined.  
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4.2. Results 
 
4.2.1. Construction of human fibrillarin deletion mutants  
 
To further characterise the association of fibrillarin with the box C/D snoRNP a series 
of human fibrillarin deletion mutants were constructed. These deletion mutants were 
used in a variety of experiments to further define the roles and interactions of the 
individual domains of fibrillarin.  
 
The fibrillarin deletion mutants were constructed based, in part, upon analysis of the 
crystal structure of the archaea, Methanococcus jannaschii (M. jannaschii), fibrillarin 
(Wang et al, 2000; see Figure 4.3). Analysis of the crystal structure revealed two main 
globular domains, the N terminal and C terminal domains, which are separated by alpha 
helix 0. The N terminal domain consists of five β-sheets while the larger C terminal 
domain has seven β-sheets and seven α-helices (Wang et al, 2000; see Figure 4.3). 
Sequence alignments were performed between human and M. jannaschii fibrillarin, 
which showed that there was a high degree of identity between these two proteins 
(Figure 4.2). The locations of the fibrillarin secondary structures, as shown by the M. 
jannaschii fibrillarin crystal structure, were then assigned to the human fibrillarin 
sequence (Figure 4.2). One major difference between archaea and eukaryotic fibrillarin 
was the presence of an RGG motif containing domain located upstream of the N 
terminal domain in the eukaryotic protein.  
  
Based upon the identification of the locations of the N and C terminal domains and the 
additional eukaryotic specific RGG containing domain five fibrillarin deletion mutants 
were constructed by PCR amplification of human fibrillarin cDNA. These included an 
N and C terminal domain mutant that lacked the RGG domain (N-C-fibrillarin; amino 
acids 82-321), an RGG domain and N terminal domain mutant that lacked the C 
terminal domain (R-N-fibrillarin; amino acids 1-141), a RGG domain mutant that 
lacked both the N and C terminal domains (R-fibrillarin; amino acids 1-81) and a N 
terminal domain mutant that lacked the RGG domain and C terminal domain (N-
fibrillarin; amino acids 82-141) (see Figure 4.5). In addition a full length fibrillarin was 
produced to be used as a positive control. The amplified cDNA of fibrillarin and the 
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deletion mutants was cloned into plasmids that inserted N terminal GFP tags (for 
mammalian expression) and pET plasmids for expression in E. coli and to produce in 
vitro-translated [
35
S] methionine-labelled proteins from reticulocyte lysate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Fibrillarin deletion mutants 
Schematic representation of human fibrillarin deletion mutants. The full length 
fibrillarin is composed of a RGG motif containing domain (RGG; amino acids 1-81), N 
terminal domain (N; amino acids 82-141) and C terminal domain (C; amino acids 142-
321), which are indicated above the panel. Secondary structures are indicated by 
coloured blocks, which correspond to Figure 4.3. β-sheets in the C terminal domain (β1–
β7) and in the N terminal domain (β1′–β5′) are shown in magenta and red, respectively. 
The C terminal domain α-helices (α1–α6) are shown in green while the α-helix (α0), 
which connects the N and C terminal domains, is shown in blue. Numerical values 
above panel correspond to amino acid number. The five fibrillarin deletion mutants are 
shown below the full length fibrillarin. Name of deletion mutant is shown to the left of 
the panel.    
 
 
4.2.2. Analysis of the localisation and association, with the box C/D 
snoRNPs, of the fibrillarin deletion mutants 
 
To determine which domains of fibrillarin are required for correct cellular localisation 
HeLa SS6 cells were transfected with plasmids that expressed full length fibrillarin and 
the deletion mutants with N terminal GFP fusion tags. Twenty-four hours after 
transfection the cells were fixed and the localisation of the GFP tagged fibrillarin and 
deletion mutants was viewed by widefield microscopy.  
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Figure 4.6: The localisation of GFP-fibrillarin deletion mutants 
HeLa SS6 cells were transfected with plasmids encoding GFP fusions of full length 
fibrillarin and the deletion mutants. After twenty-four hours cells were fixed and stained 
with DAPI to identify the nucleoplasm. The GFP-fibrillarin deletion mutant plasmid 
transfected is shown above each lane (see Figure 4.5). Top row shows the GFP-
fibrillarin deletion mutant proteins, the middle row shows the DAPI image and the 
bottom row is a merged image of GFP-fibrillarin mutant proteins (green) with the DAPI 
image (blue). The white arrows indicate a Cajal body. The bar to the bottom right of the 
panel represents 5 μm. 
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The full length GFP-fibrillarin was found predominately in discrete sub-compartments 
of the nucleolus, indicating localisation to the DFC (Figure 4.6 (Figure 4.4). All of the 
fibrillarin deletion mutants tested also localised to the nucleolus; however, only the 
GFP-N-C-fibrillarin deletion mutant was found specifically in the DFC (Figure 4.6). 
The GFP-R-N-fibrillarin and GFP-R-fibrillarin deletion mutants were distributed 
throughout the nucleolus, which suggests localisation to both the DFC and GC.  
 
The full length GFP-fibrillarin was also found enriched in Cajal bodies (Figure 4.5), 
which is characteristic of wild type fibrillarin. Of the deletion mutants only the GFP-N-
C-fibrillarin was found in Cajal bodies. While the GFP-R-N-fibrillarin and GFP-R-
fibrillarin deletion mutants were not seen in Cajal bodies they were distributed 
throughout the nucleoplasm, which was not seen with full length GFP-fibrillarin. The 
localisation of GFP-R-N-fibrillarin and GFP-R-fibrillarin deletion mutants to the 
nucleoplasm could, however, be due to the over expression of these proteins resulting in 
non-specific accumulation.   
 
Unfortunately, it was not possible to determine the localisation of the N-fibrillarin 
deletion mutant due to the inability to successfully clone the cDNA into the GFP 
expression plasmid. It was also not possible to determine the localisation of the GFP-C-
fibrillarin deletion mutant; however, this was due to the expression level being too low 
to be detected by either widefield microscopy or even Western blot analysis using anti-
GFP or anti-fibrillarin antibodies (data not shown).  
 
The fibrillarin deletion mutants were also created to establish which domains of 
fibrillarin are essential for association with the box C/D snoRNPs. To determine this the 
GFP tagged fibrillarin deletion mutants were expressed in HeLa SS6 cells, whole cell 
extracts produced, immunoprecipitation assays performed using anti-GFP antibodies 
and co-precipitating factors, such as box C/D snoRNA, analysed. These experiments 
were, however, unsuccessful and no co-precipitation of box C/D snoRNA was 
witnessed even with the full length GFP-fibrillarin control. Two possible explanations 
are that the anti-GFP antibodies were inefficient at immunoprecipitating the GFP tagged 
full length fibrillarin and deletion mutants and / or the expression level of the GFP 
tagged full length fibrillarin and deletion mutants was too low to result in the 
precipitation of enough material to be detected.  
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4.2.3. Fibrillarin interacts directly with the box C/D snoRNP assembly 
factors  
 
Previous studies have shown that fibrillarin interacts with the box C/D snoRNP 
assembly factors TIP48, TIP49, BCD1, NOP17, TAF9 and NUFIP (McKeegan et al, 
2007). However, one issue with the in vitro interaction assays used to determine these 
interactions was the use of in vitro-translated 
35
S-labelled fibrillarin. As the 
35
S-labelled 
fibrillarin was produced from reticulocyte lysate it is possible that additional factors, 
that could bridge interactions, may be present in the assays making it difficult to 
determine if the interactions between fibrillarin and the box C/D snoRNP assembly 
factors are direct.  
 
To determine whether fibrillarin interacts directly with the box C/D snoRNP assembly 
factors in vitro interaction assays were performed using recombinant human fibrillarin, 
expressed and purified from E. coli. Unfortunately, due to solubility issues, it was not 
possible to express and purify full length fibrillarin fused to an N terminal 6 x His tag 
(His) efficiently. It was possible, however, to express and purify the N-C-fibrillarin 
deletion mutant fused with an N terminal His tag and this protein was used in the in 
vitro interaction assays (His-N-C-fibrillarin). The N terminal His tag allowed N-C-
fibrillarin to be specifically identified in a Western blot assay using anti-His antibodies.  
 
The box C/D snoRNP assembly factors TIP48, TIP49, NOP17 and NUFIP were all 
expressed and purified with N terminal GST fusion tags from E. coli (GST-TIP48, 
GST-TIP49, GST-NOP17 and GST-NUFIP; McKeegan et al, 2007; Figure 4.7 A). 
Unfortunately, it was not possible to express and purify full length BCD1 and therefore 
a BCD1 deletion mutant, consisting of amino acids 1-360 was expressed and purified 
fused to an N terminal GST tag. As the GST-BCD1 deletion mutant was previously 
used to identify the interaction with fibrillarin (McKeegan et al, 2007) there was no 
issue with using this protein to analyse the interaction with fibrillarin.  
 
The GST tagged assembly factors or GST alone (negative control) were immobilised on 
glutathione Sepharose beads and incubated with His-N-C-fibrillarin. After two hours 
incubation at 4
◦
C the glutathione Sepharose beads were washed, bound proteins 
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separated on a 12 % SDS-PAGE gel and Western blot assays performed using anti-His 
antibodies (Figure 4.7 B). 
 
 
 
A 
 
 
 
 
 
 
 
 
  
 
 
 
 
B 
 
 
 
 
 
 
 
Figure 4.7: Interaction assay between fibrillarin and the box C/D snoRNP 
assembly factors NUFIP, BCD1 and NOP17 
(A) Recombinant GST, GST-BCD1 (deletion mutant amino acids 1-360), GST-NOP17, 
GST-NUFIP, GST-TIP48 and GST-TIP49 proteins were separated on a 12 % SDS-
PAGE gel and visualised by Coomassie blue staining. The identity of the protein loaded 
is indicated at the top of the panel. The migration of individual proteins is indicated to 
the right of the panel. M: molecular marker. The size of the molecular marker is shown 
to the left of the panel in kilodaltons. The asterisk indicates the full length protein where 
appropriate  
(B) Interaction of fibrillarin with box C/D snoRNP assembly factors. GST, GST-
NUFIP, GST-BCD1 and GST-NOP17 were immobilised on glutathione Sepharose 
beads and incubated with His-N-C-fibrillarin. Bound proteins were separated on a 12 % 
SDS-PAGE gel and His-N-C-fibrillarin detected by Western blot analysis using anti-His 
antibodies. Input represents 10 % of His-N-C-fibrillarin used in interaction assay. The 
immobilised GST proteins used are shown above the panel. 
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Immobilised GST-BCD1 and GST-NOP17 retained His-N-C-fibrillarin at levels above 
GST alone (Figure 4.7). His-N-C-fibrillarin was also retained by immobilised GST-
NUFIP above the levels seen with GST alone; however the retention was low. The weak 
retention of His-N-C-fibrillarin by GST-NUFIP was repeatedly seen, which suggests a 
weak interaction between these proteins. These experiments indicate that fibrillarin 
interacts directly with the box C/D snoRNP assembly factors BCD1, NOP17 and 
NUFIP. 
 
In vitro interaction assays were also performed to determine whether the interaction of 
fibrillarin with the box C/D snoRNP assembly factors TIP48 and TIP49 were direct. 
The assays were performed as described above, however, unlike the previous 
experiment the interactions were visualised by direct Coomassie blue staining of the 
SDS-PAGE gel. Assay shown in Figure 4.8 performed by K.S.McKeegan, Newcastle 
University, UK.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Interaction assay between fibrillarin and the box C/D snoRNP 
assembly factors TIP48 and TIP49 
GST, GST-TIP48 and GST-TIP49 were immobilised on glutathione Sepharose beads 
and incubated with His-N-C-fibrillarin. Bound proteins were separated on a 12 % SDS-
PAGE gel and interactions visualised by Coomassie blue staining. The immobilised 
GST proteins are shown above the panel. The migration of individual proteins used is 
indicated to the right of panel. Result kindly provided by K.S. McKeegan, Newcastle 
University, UK. 
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Immobilised GST-TIP48 and GST-TIP49 both retained His-N-C fibrillarin above the 
levels seen with GST alone (Figure 4.8). This indicates that fibrillarin interacts directly 
with both TIP48 and TIP49.  
 
4.2.4. The box C/D snoRNP assembly factors interact with the C 
terminal domain of fibrillarin 
 
To determine which domains of fibrillarin the box C/D snoRNP assembly factors 
NUFIP, BCD1, NOP17, TIP48 and TIP49 interact with in vitro protein interaction 
assays were performed using the fibrillarin deletion mutants. Unfortunately, it was not 
possible to express and purify all the fibrillarin deletion mutants as recombinant 
proteins due to solubility issues. Therefore, full length fibrillarin and the deletion 
mutants were expressed using reticulocyte lysate in the presence of [
35
S] methionine. 
The GST tagged assembly factors were immobilised on gluthathione Sepharose beads 
and incubated with the in vitro-translated 
35
S-labelled full length fibrillarin and deletion 
mutant proteins. Bound proteins were separated on a 12 % SDS-PAGE gel and results 
visualised by autoradiography.  
 
Immobilised GST-NUFIP retained in vitro-translated 
35
S-labelled full length fibrillarin 
and all the deletion mutant proteins above the levels seen with GST alone (Figure 4.9). 
GST-NUFIP retained the full length fibrillarin and the N-C-fibrillarin and C-fibrillarin 
deletion mutants at a higher level than the R-N-fibrillarin and N-fibrillarin, which 
indicates that NUFIP interacts most strongly with the C terminal domain of fibrillarin. 
As GST-NUFIP retains R-N-fibrillarin and N-fibrillarin above the levels of GST alone, 
albeit at a low intensity, this suggests that NUFIP may interact weakly with N terminal 
domain of fibrillarin.    
 
Immobilised GST-BCD1 retained in vitro-translated 
35
S-labelled full length fibrillarin 
and the N-C-fibrillarin and C-fibrillarin deletion mutants above the levels seen with 
GST alone (Figure 4.9). As GST-BCD1 only retained fibrillarin deletion mutants that 
contained the C terminal domain this indicates that BCD1 interacts with this domain. As 
the retention of the N-C-fibrillarin and C-fibrillarin deletion mutants by GST-BCD1 
 144 
was lower than with full length fibrillarin this suggests that the whole fibrillarin protein 
is required for an efficient interaction.  
 
Immobilised GST-NOP17 retained in vitro-translated 
35
S-labelled full length fibrillarin 
and the N-C-fibrillarin and C-fibrillarin deletion mutants above the levels of GST alone 
(Figure 4.9). As GST-NOP17 did not retain fibrillarin deletion mutants that lacked the C 
terminal domain this indicates that NOP17 interacts specifically with the C terminal 
domain of fibrillarin. 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Interaction assay between the fibrillarin deletion mutants and BCD1, 
NOP17 and NUFIP 
GST, GST-NUFIP, GST-BCD1 and GST-NOP17 were immobilised to glutathione 
Sepharose beads and incubated with in vitro-translated 
35
S-labelled full length fibrillarin 
and deletion mutant proteins. Bound proteins were separated on a 12 % SDS-PAGE gel 
and visualised by autoradiography. Input represents 10 % of in vitro-translated 
35
S-
labelled protein used in interaction assay. The identity of GST tagged proteins used is 
indicated above each lane. The identity of the radiolabelled proteins used is indicated to 
the left of the panel. A single exposure was used for each in vitro-translated 
35
S-labelled 
protein. 
 
 
Immobilised GST-TIP48 and GST-TIP49 retained the in vitro-translated 
35
S-labelled N-
C-fibrillarin and C-fibrillarin deletion mutant proteins above levels seen with GST alone 
(Figure 4.10). There is a low level retention of the N-R-fibrillarin deletion mutant 
protein by GST-TIP48 and GST-TIP49 and no retention of the N-fibrillarin. As both 
immobilised GST-TIP48 and GST-TIP49 only efficiently retained the in vitro-translated 
35
S-labelled fibrillarin deletion mutant proteins containing the C domain this indicates 
that TIP48 and TIP49 interact with the C terminal domain of fibrillarin. 
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Figure 4.10: Interaction assay between the fibrillarin deletion mutants and the box 
C/D snoRNP assembly factors TIP48 and TIP49 
GST, GST-TIP48 and GST-TIP49 were immobilised onto glutathione Sepharose beads 
and incubated with the in vitro-translated 
35
S-labelled full length fibrillarin and deletion 
mutant proteins. Bound proteins were separated on a 12 % SDS-PAGE gel and 
visualised by autoradiography. Input represents 10 % of in vitro-translated 
35
S-labelled 
protein used in interaction assay. The identity of GST tagged proteins and radiolabelled 
proteins used are indicated above each lane. A single exposure is used for each in vitro-
translated 
35
S-labelled protein. The asterisk indicates the full length proteins.  
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4.3. Discussion 
 
In this chapter a series of human fibrillarin deletion mutants were constructed to further 
analyse fibrillarin and the interactions necessary for its association with the box C/D 
snoRNPs. The fibrillarin deletion mutants were constructed based upon analysis of the 
crystal structure of M. jannaschii fibrillarin (Wang et al, 2000), which contained two 
main globular domains, the N and C terminal domains. Protein sequence alignments 
were performed between human and M. jannaschii fibrillarin and the secondary 
structures assigned to human fibrillarin. As eukaryotic fibrillarin contains an additional 
domain containing an RGG motif upstream of the N terminal domain deletion mutants 
were also created based on the location of this domain.  
 
To determine which domains of fibrillarin were required for correct cellular localisation 
the fibrillarin deletion mutants were expressed with N terminal GFP tags in HeLa SS6 
cells and their localisation viewed by widefield microscopy (Figure 4.6). The GFP-N-C-
fibrillarin deletion mutant localised to the DFC of the nucleolus and to the Cajal bodies. 
This is the typical localisation of wild type fibrillarin and indicates that the missing 
RGG containing domain (amino acids 1-81) of GFP-N-C-fibrillarin is not essential for 
localisation. Interestingly, the GFP-R-fibrillarin, which only consists of the RGG 
containing domain, localised throughout the nucleolus and the nucleoplasm. The GFP-
N-C-fibrillarin and GFP-R-fibrillarin data is in agreement with previous studies which 
show that while the fibrillarin RGG motif containing domain localises to the nucleolus 
on its own it is not required for fibrillarin localisation (Snaar et al, 2000).  
 
The GFP-R-N-fibrillarin deletion mutant, which lacked the C terminal domain, did not 
localise to Cajal bodies and was found throughout the nucleoplasm and nucleolus 
(Figure 4.6). As fibrillarin localisation has previously been shown not to require the 
RGG motif containing domain this indicates that the C terminal domain is required for 
localisation. This is in agreement with previous studies that have shown that a region of 
fibrillarin spanning amino acids 133-306, which corresponds closely with the C 
terminal domain used in this study (amino acids 142-321), is essential for localisation 
(Snaar et al, 2000). Unfortunately, it was not possible to obtain localisation data for the 
C-fibrillarin and N-fibrillarin deletion mutants, which prevented further analysis of the 
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contribution of the N and C terminal domains to cellular localisation. Whether the C 
terminal domain of fibrillarin contains localisation signals or is important for 
association of fibrillarin with the box C/D snoRNPs is not clear using this approach 
alone and further study is required.   
 
Another approach used to analyse fibrillarin association with the box C/D snoRNPs was 
to investigate which domains of fibrillarin are required to interact with the box C/D 
snoRNP assembly factors. Fibrillarin has previously been shown to interact with the box 
C/D snoRNP biogenesis factors, BCD1, NOP17, TAF9, NUFIP, TIP48 and TIP49 
(McKeegan et al 2007); however, this was determined using in vitro-translated 
35
S-
labelled fibrillarin. Before determining which domains of fibrillarin these assembly 
factors interact with it was first necessary to confirm that these interactions were direct. 
In vitro interaction assays were performed between recombinant His-N-C-fibrillarin and 
GST-BCD1, GST-NOP17 GST-NUFIP, GST-TIP48 and GST-TIP49. It was not 
possible to test whether the interaction between fibrillarin and TAF9 was direct as GST-
TAF9 could not be expressed and purified at a satisfactory level. These in vitro 
interaction assays showed that fibrillarin interacts directly with BCD1, NOP17, NUFIP, 
TIP48 and TIP49 (Figure 4.7 and 4.8). The fibrillarin deletion mutants were then used 
in a series of in vitro interaction assays to map the box C/D snoRNP assembly factor 
binding domains. As it was not possible to express and purify the fibrillarin deletion 
mutants as recombinant proteins they were expressed as in vitro-translated 
35
S-labelled 
proteins. These assays indicate that the box C/D snoRNP assembly factors interact with 
the C terminal domain of fibrillarin. There were a couple of exceptions, for instance in 
addition to the C terminal domain NUFIP also interacts, albeit weakly, with the N 
terminal domain of fibrillarin. Furthermore, while BCD1 only interacts with fibrillarin 
deletion mutants containing the C terminal domain the interaction was not as strong as 
with full length fibrillarin.  
 
The crystal structure of the interaction of the archaeal homologue of NOP56 and 
NOP58 (Nop5) with fibrillarin revealed that this interaction is mediated by α-helices 2-3 
and β-sheet 3 of fibrillarin, which are all located in the fibrillarin C terminal domain 
(Aittaleb et al 2003). As human fibrillarin has been shown to interact with NOP56 
(McKeegan et al, 2007) in vitro interaction assays were performed using the in vitro-
translated 
35
S-labelled fibrillarin deletion mutants and recombinant NOP56. These 
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assays, however, did not produce consistent results. Based on the Nop5 interaction data 
(Aittaleb et al 2003) it is possible that the C terminal domain of fibrillarin mediates the 
interaction between fibrillarin and NOP56.  
 
To determine which domains of fibrillarin are essential for the association with the box 
C/D snoRNPs the GFP tagged fibrillarin deletion mutants were expressed in HeLa SS6 
cells, cell extracts produced, and anti-GFP antibodies used in immunoprecipitation 
assays. Co-precipitating factors such as box C/D snoRNA were then analysed. These 
experiments were, however, unsuccessful due either to poor expression of the GFP 
tagged full length fibrillarin and deletion mutants and / or the anti-GFP antibodies used 
were not suitable for immunoprecipitation assays. In order to overcome these issues Tet 
inducible fibrillarin deletion mutant HEK293 cell lines were designed and are currently 
being developed by the lab. A HEK293 cell line that expresses full length fibrillarin 
with a N terminal 2 x FLAG 6 x His tag (FLAG-fibrillarin) has already been developed 
and successfully used in immunoprecipitation and immunofluorescence assays in this 
study (Chapter 3.2.6). The use of inducible 2 x FLAG 6 x His tagged fibrillarin deletion 
mutant HEK293 cell lines should overcome the issues experienced with 
immunoprecipitation assays using the GFP-fibrillarin deletion mutants.  
 
Overall the data presented indicates that the C terminal domain of fibrillarin is essential 
for both fibrillarin localisation and for interactions with the box C/D snoRNP assembly 
factors. It is possible that the interaction of the C terminal domain of fibrillarin with the 
assembly factors mediates the association with the box C/D snoRNPs, which then 
localise to the Cajal bodies and the nucleolus. Further experiments are, however, 
required to confirm that the C terminal domain of fibrillarin is essential for the 
association of fibrillarin with the box C/D snoRNPs.  
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Chapter five 
 
 
 
The role of the SMN 
complex in box C/D 
snoRNP biogenesis 
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5.1. Introduction  
 
The multiprotein SMN complex functions in the assembly of the snRNPs (Yong et al, 
2002, 2004) and has also been implicated in the biogenesis of telomerase RNPs 
(Bachand et al, 2002), miRNPs (Mourelatos et al, 2002) and snoRNPs (Jones et al, 
2001; Pellizzoni et al, 2001). The SMN complex has been under intense investigation as 
mutation of the gene encoding the SMN protein is linked to the neurodegenerative 
disease SMA. 
 
A              B 
 
 
  
 
 
 
 
Figure 5.1: The SMN complex  
(A) Schematic diagram of the SMN complex. SMN complex components are shown as 
green ovals. It is possible that multiple SMN proteins self oligomerise to form larger 
complexes.  
(B) Schematic diagram of the domain organisation of the SMN protein. SMN contains 
an N terminal domain K-rich (lysine) sequence, a central Tudor domain and C terminal 
domain P-rich (proline) sequences and YG-box (tyrosine glycine). Numerical values 
above the panel indicate the amino acid numbers.  
 
 
The SMN complex is composed of SMN, Gemins2-8 and the UNRIP factor. The SMN 
protein is the central component of the SMN complex and interacts directly with 
Gemin2, 3, 5, 7 and 8 (Figure 5.1 A). Not all the SMN complex proteins, however, 
interact with the SMN protein, for instance Gemin4 and 6 associate with the SMN 
complex through interactions with Gemin3 and 7. UNRIP associates with the complex 
by interacting with Gemin6 and 7 and is exclusively found in cytoplasmic SMN 
complexes (Carissimi et al, 2005). Gemin8 also interacts with Gemin6 and 7. The exact 
stoichiometry of the SMN complex is not clear and it has been proposed that the SMN 
protein self oligomerises to form a much larger complex (Paushkin et al, 2002). The 
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SMN complex is found throughout the cytoplasm and in the nucleus enriched in Cajal 
bodies and Gems (Liu and Dreyfuss, 1996).  
 
The human SMN protein is of 294 amino acids in size and contains a number of 
conserved motifs (Figure 5.1 B). These include an N terminal domain RNA binding K-
rich sequence and a central Tudor domain that mediates interactions with RGG motifs 
of proteins including coilin and Sm proteins (Selenko et al, 2001; Whitehead et al, 
2002). In addition the SMN protein contains an YG-box, which has been implicated in 
self oligomerisation (Lorson et al, 1998). The Gemin and UNRIP proteins also contain 
evolutionary conserved motifs, for instance Gemin3 contains a DEAD box RNA 
helicase motif (Charroux et al, 1999) while Gemin5 contains 13 WD repeats in the N 
terminal domain and coiled-coil motifs in the C terminal domain (Gubitz et al, 2002). 
Gemin7 contains several RGG motifs (Baccon et al, 2002) and UNRIP contains a 
number of GH-WD motifs (Carissimi et al, 2005).  
 
The most characterised role of the SMN complex is in the biogenesis of the snRNPs, 
which function in pre-mRNA splicing as part of the spliceosome. The SMN complex 
has a number of proposed roles and the best defined of these is the association of the Sm 
core proteins (B/B’, D1, D2, D3, E, F and G) onto pre-snRNA to form a stable 
heptameric ring known as the Sm core (Figure 5.2; Charroux et al, 1999; Friesen et al, 
2001; Brahms et al, 2001; Gubitz et al, 2002). In the cytoplasm the SMN complex 
functions in Sm core formation by binding preformed Sm protein complexes (D3/B, 
D1/D2 and E/F/G), which are associated with plCln (a component of PRMT5 complex), 
and then catalysing the formation of the Sm core on pre-snRNA (Chari et al, 2008).  
 
The SMN complex has also been implicated in the nuclear import of pre-snRNPs. The 
nuclear import of the pre-snRNPs occurs through the utilisation of one of two NLS that 
are formed in the cytoplasm, the m3G cap and Sm core. The SMN complex has known 
roles in the formation of the Sm core but has also been implicated in the recruitment of 
the hypermethylase TGS1 that converts the snRNA 5’ m7G cap into an m3G cap 
(Mouaikel et al, 2003). In the m3G dependent import pathway Snurportin1 interacts 
with the m3G cap of the pre-snRNA and the import factor importin β, which results in 
the nuclear import of the pre-snRNP (Huber et al, 1998). SMN has been proposed to 
function in the Sm core dependent import pathway as SMN has also been shown to 
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interact with importin β and can mediate nuclear import in the absence of Snurportin1 
(Narayanan et al, 2002).  
 
 
 
 
 
 
 
 
 
Figure 5.2: The role of the SMN complex in snRNP biogenesis 
A dark grey line represents the snRNA with the 5’ m7G cap shown as an orange circle 
and the 3’ extended sequence as an orange rectangle. The Sm core proteins are 
represented by a yellow oval. The SMN complex is represented by a green oval. TGS1 
is shown as a red oval. The 5’ m3G cap of mature snRNA is shown as by a dark grey 
circle. The Cajal body is represented as a grey outlined box. The nuclear membrane is 
shown by black outlined rectangles. Grey arrows indicate the progression of biogenesis. 
Figure adapted from image provided by N.J.Watkins, Newcastle University, UK.   
 
 
The SMN complex has also been linked to the biogenesis of the box C/D snoRNPs, 
which predominately function in the chemical modification of rRNA (Kiss-Laszlo et al, 
1996). However, a few box C/D snoRNPs, such as U3 and U8, assist in the processing 
of pre-rRNA (Sharma and Tollervey, 1999; Kiss et al, 2002). The box C/D snoRNPs are 
stable RNA protein complexes which consist of four evolutionary conserved common 
core proteins known as 15.5K, NOP56, NOP58 and fibrillarin. The fibrillarin core 
protein is the methyltransferase component of the complex, which is responsible for the 
2’-O-methylation of target rRNA residues (Tollervey et al, 1993).  
 
The box C/D snoRNPs are found in the nucleolus where the synthesis, processing and 
modification of pre-rRNAs occur, as well as the bulk of ribosome assembly events. The 
nucleolus contains three sub-compartments, the FC, DFC and GC. The box C/D 
snoRNPs that function in the chemical modification of rRNA and early pre-rRNA 
processing, such as the U8 snoRNP (Peculis and Steitz, 1993), are found in the discreet 
DFC sub-compartments of the nucleolus (Figure 5.3). On the contrary, factors that 
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function in both early and late pre-rRNA processing such as the U3 box C/D snoRNP 
are found distributed throughout the nucleolus in both the DFC and GC (Filipowisz et 
al, 1999; Lafontaine and Tollervey, 2001; Granneman, et al, 2004). Box C/D snoRNA is 
also found in the Cajal bodies and this, more than likely, represents pre-snoRNPs during 
biogenesis (Verheggen et al, 2001; Boulon et al, 2004; Lemm et al, 2006).  
 
 
 
 
 
 
 
 
 
Figure 5.3: Differential nucleolar localisation of the box C/D snoRNPs 
HeLa SS6 cells were grown on coverslips, fixed and FISH performed using fluorescent 
probes specific for the U3 and U8 box C/D snoRNAs. DAPI staining of DNA was used 
to indicate the nucleoplasm. The top row shows the U3 or U8 snoRNA and the bottom 
row a merged image of U3 or U8 (red) with the DAPI staining (blue). The white arrow 
indicates a Cajal body. The bar to the bottom right of the panel represents 5 μm. 
 
 
The box C/D snoRNAs are transcribed in the nucleoplasm by RNA polymerase II and 
form a large, multiprotein pre-snoRNP complexes that contain snoRNA, common core 
proteins and assembly, RNA processing and transport factors (Watkins et al, 2004, 
2007; McKeegan et al, 2007; Boulon et al, 2004, 2008). Numerous interactions between 
the box C/D snoRNP assembly factors BCD1, NOP17, NUFIP, TAF9, TIP48 and 
TIP49 and the common core proteins have been identified and it has been proposed that 
these interactions are required for the recruitment and association of the common core 
proteins with the box C/D snoRNA (Watkins et al, 2004, 2007; McKeegan et al, 2007). 
The site(s) of box C/D snoRNP biogenesis is not clear with the nucleoplasm (Watkins et 
al, 2004; 2007; McKeegan et al, 2007), Cajal bodies (Boulon et al, 2007; Verheggen et 
al, 2002) and cytoplasm (Baserga et al, 1992; Peculis et al, 2001; Watkins et al, 2007) 
all implicated. 
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The SMN complex was first linked to box C/D snoRNP biogenesis in a yeast two-
hybrid screen, which indicated that the SMN protein interacts with the box C/D snoRNP 
common core protein fibrillarin (Liu and Dreyfuss, 1996; Jones et al, 2001). Further in 
vitro investigations revealed that SMN interacts with the RGG domain of fibrillarin 
(Pellizzoni et al, 2001; Jones et al, 2001). The fibrillarin interaction domain of SMN is 
not clear with data indicating the YG-box (Pellizzoni et al, 2001) and the Tudor domain 
(Jones et al, 2001; Whitehead et al, 2002). Immunoprecipitation assays from human cell 
extracts confirmed the fibrillarin and SMN interact in vivo (Pellizzoni et al, 2001; Jones 
et al, 2001). An interaction was also found between the SMN protein and the box 
H/ACA snoRNP common core protein GAR1 (Pellizzoni et al, 2001; Whitehead et al, 
2002), which suggests that the SMN complex might be involved in the biogenesis of 
both box C/D and H/ACA snoRNPs.  
 
The role of SMN in box C/D snoRNP biogenesis was further investigated by analysing 
the localisation of box C/D snoRNP factors in the absence of functional SMN. The 
expression of the dominant negative SMN, which was not functional in snRNP 
biogenesis, resulted in the accumulation of fibrillarin, the U3 box C/D snoRNA and the 
dominant negative SMN outside the nucleolus (Pellizzoni et al, 2001). Furthermore, in 
cells depleted of SMN the core proteins fibrillarin and NOP56 accumulated outside of 
the nucleolus in small nuclear bodies (Lemm et al, 2006). This indicates that SMN is 
required for the correct localisation of box C/D snoRNP factors, which suggests that 
SMN is required for box C/D snoRNP biogenesis.  
 
The significance of the interaction of SMN with fibrillarin is not clear and while the 
SMN protein is required for the correct localisation of box C/D snoRNP components it 
is not known what effect this has on box C/D snoRNP biogenesis. Furthermore, it is not 
known whether other components of the SMN complex are involved in box C/D 
snoRNP biogenesis. To gain a greater understanding of the role of the SMN complex in 
box C/D snoRNP biogenesis the interactions of all the components of the SMN complex 
with the box C/D snoRNP common core proteins and assembly factors was 
characterised. A number of approaches were also used to determine whether the SMN 
protein interacts with the pre-snoRNP complex. In addition components of the SMN 
complex were depleted using siRNAs and the localisation and levels of box C/D 
snoRNAs analysed.  
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5.2. Results  
 
5.2.1. Fibrillarin interacts with SMN but not with any of the other 
components of the SMN complex 
 
It has been previously shown that the SMN protein binds to the RGG domain of 
fibrillarin (Pellizzoni et al, 2001; Jones et al, 2001); however, it was not known whether 
any of the other components of the SMN complex also interact with fibrillarin. To 
determine whether the SMN complex components Gemins2-8 or UNRIP interact with 
fibrillarin in vitro interaction assays were performed.  
 
Fibrillarin and a fibrillarin deletion mutant (amino acids 82-321), which lacked the 
RGG containing domain, were expressed and purified from E. coli fused to N terminal 
GST tags (GST-fibrillarin and GST-N-C-fibrillarin; Figure 5.4 A; McKeegan et al, 
2007). SMN, Gemins2-8 and UNRIP were expressed using reticulocyte lysate in the 
presence of [
35
S] methionine to create in vitro-translated 
35
S-labelled proteins 
(expression plasmids provided by U.Fischer, University of Wurtzberg, Germany). To 
perform the interaction assays GST-fibrillarin, GST-N-C-fibrillarin or GST alone 
(negative control) were immobilised to glutathione Sepharose beads and incubated with 
the in vitro-translated 
35
S-labelled protein of interest. After two hours incubation at 4
◦
C 
the glutathione Sepharose beads were washed, bound proteins separated on a 12 % 
SDS-PAGE gel and results visualised by autoradiography.  
 
Immobilised GST-fibrillarin retained in vitro-translated 
35
S-labelled SMN above the 
levels seen with the GST protein alone (Figure 5.4 B). This indicates, in agreement with 
previous studies (Pellizzoni et al, 2001; Jones et al, 2001), that fibrillarin interacts with 
the SMN. Immobilised GST-N-C-fibrillarin, which lacked the RGG domain, also 
retained the in vitro-translated 
35
S-labelled SMN protein above the levels seen with 
GST alone. The retention of SMN by GST-N-C-fibrillarin, however, was lower than 
with full-length fibrillarin, which indicates that the RGG domain of fibrillarin is of 
importance for the interaction with SMN in agreement with previous studies (Pellizzoni 
et al, 2001; Jones et al, 2001). 
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A     B 
 
 
 
 
 
 
 
 
 
    
            
Figure 5.4: Interaction assay between fibrillarin and components of the SMN 
complex 
(A) 12 % SDS-PAGE of GST, GST-fibrillarin and GST-N-C-fibrillarin visualised by 
Coomassie blue staining. The protein loaded is indicated at the top of each lane. M: 
molecular marker in kilodaltons. The migration of proteins is indicated to the right of 
the panel. Asterisk indicates the full-length protein where appropriate.  
(B) Interaction assay of fibrillarin with SMN complex components. GST, GST-
fibrillarin or GST-N-C-fibrillarin were immobilised to glutathione Sepharose beads and 
incubated with in vitro-translated 
35
S-labelled SMN, Gemins2-8 or UNRIP. Bound 
proteins were separated on a 12 % SDS-PAGE gel and results visualised by 
autoradiography. Input represents 10 % of in vitro-translated 
35
S-labelled protein used. 
The identity of GST tagged protein used is indicated above each lane. The identity of 
the radiolabelled protein used is indicated to the left of the panel. A single exposure was 
used for each in vitro-translated 
35
S-labelled protein.  
 
 
 
Immobilised GST-fibrillarin and GST-N-C-fibrillarin both failed to retain any of the in 
vitro-translated 
35
S-labelled Gemin or the UNRIP proteins above the levels seen with 
GST alone (Figure 5.4 B). This indicates that fibrillarin does not interact with Gemins2-
8 or UNRIP.  
 
The ability of the other box C/D snoRNP common core proteins to interact with the 
SMN protein was also investigated. To determine whether 15.5K interacts with SMN 
B 
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GST-15.K, expressed and purified from E. coli (McKeegan et al, 2007), was 
immobilised to glutathione Sepharose beads and incubated with in vitro-translated 
35
S-
labelled SMN. No interaction was seen between SMN and 15.5K (data not shown).  
 
To determine if SMN interacts with NOP56 and NOP58 these common core proteins 
were expressed and purified from E. coli with an N terminal thioredoxin tag and C 
terminal His tag (His-NOP56, His-NOP58; McKeegan et al, 2007). Due to solubility 
issues deletion mutants of NOP56 (1-458) and NOP58 (1-435) had to be used; however, 
the C terminal charged regions that were removed have been shown not to be required 
for box C/D snoRNP formation in yeast (Gautier et al, 1997; Lafontaine and Tollervey, 
2000). The His-NOP56 and His-NOP58 proteins were immobilised to protein A 
Sepharose beads, using anti-thioredoxin antibodies, incubated with in vitro-translated 
35
S-labelled SMN and interactions visualised as described earlier. Immobilised His-
NOP56 and His-NOP58 failed to retain in vitro-translated 
35
S-labelled SMN above the 
levels of the control beads (data not shown). As His-NOP56 and His-NOP58 have been 
successfully used in other interaction assays (McKeegan et al, 2007; Figure 6.1) the lack 
of retention of in vitro-translated 
35
S-labelled SMN indicates that NOP56 and NOP58 
do not interact with SMN. 
 
5.2.2. SMN interacts with the box C/D snoRNP assembly factors BCD1 
and NUFIP 
 
Box C/D snoRNP biogenesis proceeds in a large, multiprotein pre-snoRNP complex, 
which consists of snoRNA, common core proteins and assembly (BCD1, NOP17, 
NUFIP, TAF9, TIP48 and TIP49) RNA processing and transport factors (Watkins et al, 
2004; 2007, Boulon et al, 2004; McKeegan et al, 2007). To determine whether the SMN 
complex interacts any of the box C/D snoRNP assembly factors, which could also 
indicate that it associates with the pre-snoRNP, in vitro interaction assays were 
performed. 
 
The box C/D assembly factors NUFIP, NOP17, TIP48 and TIP49 were expressed and 
purified from E. coli fused to N terminal GST tags (GST-NUFIP, GST-NOP17, GST-
TIP48 and GST-TIP49; Figure 4.7 A; McKeegan et al, 2007). There were issues with 
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producing recombinant full length BCD1; however, it was possible to efficiently 
express and purify a BCD1 deletion mutant (amino acids 1-360) with an N terminal 
GST tag and this was used in the interaction assay (GST-BCD1; McKeegan et al, 2007). 
The SMN complex components were expressed as in vitro-translated 
35
S-labelled 
proteins as described earlier. The interaction assays were performed as described 
previously when using GST tagged and in vitro-translated 
35
S-labelled proteins. As a 
positive control an interaction assay was performed between GST-fibrillarin and in 
vitro-translated 
35
S-labelled SMN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5:  Interaction assay between components of the SMN complex and the 
box C/D snoRNP assembly factors  
GST, GST-fibrillarin, GST-BCD1, GST-NOP17, GST-NUFIP, GST-TIP48 or GST-
TIP49 were immobilised to glutathione Sepharose beads and incubated with in vitro-
translated 
35
S-labelled SMN, Gemins2-8 and UNRIP. Bound proteins were separated on 
an SDS-PAGE gel and results visualised by autoradiography. Input represents 10 % of 
in vitro-translated 
35
S-labelled protein used. The identity of the GST tagged proteins 
used is indicated above each lane. The identity of the radiolabelled protein used is 
indicated to the left of the panel. 
 
 
Immobilised GST-fibrillarin retained in vitro-translated 
35
S-labelled SMN, but not any 
of the other SMN complex proteins, above the levels seen with GST alone (Figure 5.5). 
This indicated that SMN interacts with fibrillarin as has previously been shown (Figure 
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5.4). Immobilised GST-BCD1 and GST-NUFIP both retained in vitro-translated 
35
S-
labelled SMN above the levels seen when using GST alone; however, the retention of 
SMN was lower than with immobilised GST-fibrillarin. This indicates that the 
interaction of SMN with BCD1 and NUFIP was weaker than was seen with fibrillarin. 
Immobilised GST-BCD1 and GST-NUFIP failed to retain the in vitro-translated 
35
S-
labelled Gemins2-8 or UNRIP which indicates that no interactions occur between these 
proteins.  
 
Immobilised GST-NOP17, GST-TIP48 and GST-TIP49 failed to retain in vitro-
translated 
35
S-labelled SMN, Gemins2-8 or UNRIP above the levels seen with GST 
alone (Figure 5.5). This suggests that NOP17, TIP48 and TIP49 do not interact with the 
SMN complex.  
 
5.2.3. There is an overlap in the sedimentation of SMN, fibrillarin and 
the box C/D snoRNAs  
 
It was not clear whether SMN interacts with the box C/D pre-snoRNP with previous 
studies providing contradictory results (Wehner et al, 2002; Watkins et al, 2004). To 
analyse the potential association of the SMN complex with the box C/D pre-snoRNP 
glycerol gradient centrifugation was performed. The co-migration of SMN and pre-
snoRNP factors could suggest that they are present in the same complex. 
 
HeLa SS6 nuclear extract was separated on a 10-30 % glycerol gradient and 
fractionated (fraction number one being the uppermost fraction of the gradient). RNA 
was extracted from each fraction, separated by electrophoresis on an 8 % acrylamide gel 
containing 7 M urea gel, Northern blot hybridisation performed using radiolabelled 
probes specific for the U3 and U8 box C/D snoRNAs and the results visualised by 
autoradiography. In addition proteins from each fraction were separated on a 12 % SDS-
PAGE and analysed by Western blot assays using antibodies that recognise fibrillarin 
and SMN. 
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Figure 5.6: Glycerol gradient analysis of HeLa SS6 nuclear extract 
(A) HeLa SS6 nuclear extract was separated on a 10-30 % glycerol gradient. RNA was 
extracted from individual fractions, separated on an 8 % acrylamide gel containing 7 M 
urea and analysed by Northern blot hybridisation using radiolabelled probes specific for 
the U3 and U8 box C/D snoRNAs. Results were visualised by autoradiography. The 
position of U8 precursors (I to IV) and U3 precursors (P) as well as mature length 
snoRNAs (M) are indicated to the left of the panel (B) Proteins from individual 
fractions was separated on a 12 % SDS-PAGE and Western blot analysis performed 
using antibodies that recognise fibrillarin and SMN (indicated left of the panel).  
 
 
Both precursor and mature U3 and U8 box C/D snoRNAs are visible on the glycerol 
gradient and exhibit different sedimentation behaviours (Figure 5.6 A). The precursor 
and mature U3 snoRNA sedimented in a board peak, between fractions 1 to 9, with the 
majority of mature U3 snoRNA in fraction 5. Unlike the U3 snoRNA, which only has 
one length of precursor, there are numerous intermediate U8 precursors (I to IV), which 
indicate a more complex 3’ RNA processing pathway than the U3 snoRNA (Watkins et 
al, 2007). The U8 snoRNA sedimented in a broad peak between fractions 1 to 9; 
however, the two longest U8 intermediates (I and II) were found mostly in fractions 1 to 
5, while the U8 intermediate III precursors were predominately in fractions 3 to 6. The 
shortest U8 intermediate (IV) was mostly found in fractions 3 to 6 while the mature 
length U8 snoRNA was predominately in fractions 3 and 4.  
 
The box C/D snoRNP common core protein fibrillarin co-sedimented with both U3 and 
U8 snoRNAs in fractions 1 to 9 and was predominately found in fractions 3 and 4 
(Figure 5.6 B). As fractions 3 and 4 contain mature U8 snoRNA and fibrillarin these 
fractions, most likely, represent mature U8 snoRNPs. Fraction 5 contains both fibrillarin 
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and mature U3 snoRNA and therefore, more than likely, represents mature U3 
snoRNPs. 
 
The SMN protein was present in fractions 4 to 9 but predominately in fractions 6, 7 and 
8 (Figure 5.6 B). SMN did not co-sediment with the box C/D snoRNA and / or 
fibrillarin; however, there was some degree of overlap between fractions 4 and 10. It is 
therefore possible that SMN, fibrillarin and the box C/D snoRNA are in the same 
complex; however, this cannot be deduced by this technique alone.  
 
5.2.4. SMN is not a stable component of the U3 and U8 box C/D pre-
snoRNPs  
 
SMN has been shown to interact with the box C/D snoRNP common core protein 
fibrillarin both in vitro and in vivo (Figure 5.4; Pellizzoni et al, 2001; Jones et al, 2001). 
It is, however, not clear whether SMN associates with the box C/D pre-snoRNP 
(Wehner et al, 2002; Watkins et al, 2004). To determine whether SMN interacts with 
the box C/D pre-snoRNP and also to confirm the in vivo interaction of SMN and 
fibrillarin immunoprecipitation assays were performed on extracts produced from cells 
that express FLAG tagged SMN or fibrillarin.  
 
Whole cell, nucleoplasmic and nucleolar extracts were produced from induced FLAG-
SMN, FLAG-fibrillarin and control HEK293 cell lines. The control HEK293 cell line 
provides a negative control as it only expresses the FLAG and His tags. Anti-FLAG 
antibodies were immobilised onto protein A Sepharose beads and incubated with the 
cell extract of interest. The protein A Sepharose beads were then washed and co-
precipitated RNA extracted. The RNA samples were separated by electrophoresis on an 
8 % acrylamide gel containing 7 M urea, Northern blot hybridisation performed using a 
radiolabelled probes specific for the U3 and U8 box C/D snoRNAs and the 
spliceosomal U1 snRNA, and the results visualised by autoradiography. In addition co-
precipitated proteins were separated on a 12 % SDS-PAGE gel and Western blot 
analysis performed using antibodies that recognise fibrillarin. As FLAG-fibrillarin 
migrates significantly slower than endogenous fibrillarin on SDS-PAGE gels both 
forms are distinguishable using only anti-fibrillarin antibodies.  
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Figure 5.7: Immunoprecipitation of FLAG-SMN and FLAG-fibrillarin from 
HEK293 cell extracts 
(A) Nucleolar, (B) nucleoplasmic and (C) whole cell extracts were produced from 
HEK293 cells that expressed FLAG tagged fibrillarin (fib), SMN or just the FLAG tag 
(control). Immunoprecipitation assays were performed using anti-FLAG antibodies and 
co-precipitating RNA extracted, separated by electrophoresis on an 8 % acrylamide gel 
containing 7 M urea and analysed by Northern blot hybridisation using radiolabelled 
probes specific for the U3 and U8 box C/D snoRNAs and the spliceosomal U1 snRNA. 
Results were visualised by autoradiography. Co-precipitating proteins were separated 
on a 12 % SDS-PAGE gel and analysed by Western blot assays using antibodies that 
recognised fibrillarin. The cell lines used are indicated above each lane. Input represents 
10 % of the amount of extract used in immunoprecipitation assay. The factors probed 
for are indicated to the left of the panels. The migration of U8 precursors (I to IV) and 
the U3 precursor (P) as well as mature length snoRNAs (M) is indicated to the right of 
the panels. The migration of endogenous and FLAG-fibrillarin are shown to the right of 
the panels.  
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Anti-FLAG antibodies successfully co-precipitated both the U3 and U8 box C/D 
snoRNAs from all the FLAG-fibrillarin HEK293 cell extracts but not from any of the 
control HEK293 cell extracts (Figure 5.7 A, B and C). This indicates that FLAG-
fibrillarin associated with box C/D snoRNAs in both the nucleoplasm and nucleolus. As 
mature box C/D snoRNPs are found in the nucleolus (Verheggen et al, 2001) the co-
precipitation of the U3 and U8 snoRNA from FLAG-fibrillarin nucleolar extracts 
(Figure 5.7 A) suggests that the FLAG-fibrillarin was incorporated into mature box C/D 
snoRNPs. The co-precipitation of U3 and U8 pre-snoRNAs from the FLAG-fibrillarin 
cell extracts also indicates that FLAG-fibrillarin associated with the box C/D snoRNPs 
before mature length snoRNA was produced (Figure 5.7 C).    
 
Interestingly anti-FLAG antibodies did not co-precipitate endogenous fibrillarin from 
any of the FLAG-fibrillarin HEK293 cell extracts (Figure 5.7 A, B and C). This was 
surprising, as box C/D snoRNPs have been predicted to contain two copies of fibrillarin 
(Cahill et al, 2002; Aittaleb et al, 2003) and therefore the co-precipitation of 
endogenous fibrillarin, associated in the same box C/D snoRNP complex as the FLAG-
fibrillarin, was expected. The lack of co-precipitation of endogenous fibrillarin could 
indicate that box C/D snoRNPs only contain one copy of fibrillarin.  
 
Anti-FLAG antibodies successfully co-precipitated U1 snRNA from FLAG-SMN 
HEK293 whole cell extract, but not from the control whole cell extract (Figure 5.7 C). 
In addition, the anti-FLAG antibodies did not co-precipitate U1 snRNA from either the 
FLAG-SMN HEK293 nucleoplasmic or nucleolar extracts (Figure 5.7 A and B). This 
indicates that FLAG-SMN interacted with the U1 snRNA specifically in the cytoplasm, 
which was in agreement with SMN facilitating the association of the Sm core with 
snRNA in the cytoplasm (Pellizzoni et al, 2002; Yong et al, 2002, 2004; Wehner et al, 
2002). Anti-FLAG antibodies did not co-precipitate the U3 or U8 box C/D snoRNAs 
from any of the FLAG-SMN HEK293 cell extracts (Figure 5.7 A, B and C). This 
indicated that FLAG-SMN did not stably associate with the box C/D pre-snoRNP. 
Surprisingly anti-FLAG antibodies did not co-precipitate fibrillarin from any of the 
FLAG-SMN HEK293 cell extracts, which indicated that FLAG-SMN did not interact 
with fibrillarin. This is not in agreement with previous studies that show fibrillarin can 
be co-precipitated using anti-SMN antibodies (Pellizzoni et al, 2001; Jones et al, 2001).  
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5.2.5. Gemin5 is essential for the accumulation of box C/D snoRNA 
 
Previous studies have shown that in the absence of the box C/D snoRNP assembly 
factors there is a reduction of box C/D snoRNA levels, most likely, due to a decrease in 
box C/D snoRNP biogenesis (Peng et al, 2003; Watkins et al, 2004, 2007; McKeegan et 
al, 2007; Boulon et al, 2008) To determine whether the SMN complex is essential for 
box C/D snoRNP biogenesis SMN and the Gemin proteins were depleted using siRNAs 
and the levels of box C/D snoRNA analysed. It was, however, first necessary to assess 
the efficiency of the siRNA duplexes.  
 
The siRNAs that were used to target SMN, Gemin2, 5, 6 and 7 have all been shown to 
deplete the levels of the respective mRNAs (data not shown, control experiments 
performed by I.Lemm and R.Luhrmann, Max Planck Institute for Biophysical 
Chemistry, Germany). Unfortunately, it was not possible to obtain siRNA duplexes 
which efficiently depleted the levels of Gemin3, 4, 8 or UNRIP. To confirm the 
efficiency of the siRNAs with the transfection protocol used in this study HeLa SS6 
cells were transfected with siRNAs targeting SMN or Gemin2 mRNA. These two 
siRNAs were selected as antibodies were not available for the other SMN complex 
proteins. As a control, HeLa SS6 cells were transfected with functional siRNAs that 
targeted firefly luciferase mRNA, which is not present in human cells (Elbashir et al, 
2002). After sixty hours cells were harvested, proteins were separated on a 12 % SDS-
PAGE gel and Western blot analysis performed using antibodies that recognise SMN, 
Gemin2 and, as a control, fibrillarin.  
 
In cells transfected with siRNAs targeting SMN there was dramatic depletion of SMN 
protein levels compared to the control cells (Figure 5.8). The level of fibrillarin was 
unaffected in cells transfected with the SMN siRNA, which indicates that the depletion 
of SMN was specific and also that the levels of SMN do not effect fibrillarin levels. In 
cells transfected with siRNAs targeting Gemin2 there was a significant reduction in 
Gemin2 protein levels compared to the control cells. The level of SMN was unaffected 
by the depletion of Gemin2 which indicates that not only were the Gemin2 siRNAs 
specific but that the loss of Gemin2 does not affect the level of SMN.  
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Figure 5.8: Depletion of SMN and Gemin2 
HeLa SS6 cells were transfected with siRNAs targeting either firefly luciferase 
(control), SMN or Gemin2 mRNA. After sixty hours cells were harvested, proteins 
separated on a 12 % SDS-PAGE gel and Western blot assays performed using 
antibodies that recognised SMN, fibrillarin or Gemin2. The siRNA duplexes used are 
indicated above each panel. Antibodies used in Western blot assays are indicated to the 
left of the panels.  
 
 
 
To determine whether the SMN complex is required for box C/D snoRNP biogenesis 
HeLa SS6 cells were transfected with siRNAs targeting firefly luciferase (control), 
SMN, Gemin2, 5, 6 and 7. As a positive control siRNAs targeting NOP58, which is 
essential for box C/D snoRNA accumulation, were also transfected (Watkins et al, 
2004). After sixty hours cells were harvested and RNA (derived from an equal numbers 
of cells) separated by electrophoresis on a 8 % acrylamide gel containing 7 M urea. 
Northern blot hybridisation was then performed using radiolabelled probes specific for 
the U3, U8, U14 box C/D snoRNAs, the spliceosomal U1 snRNA and the ncRNA 
component of SRP, 7SL. 7SL was chosen as a internal control of RNA levels as it has 
no known function with any of the proteins targeted for depletion. The results were 
visualised by autoradiography (Figure 5.9 A), quantified, adjusted based upon the 7SL 
levels (which were unaffected by any of the siRNA depletions) and represented as a 
percentage change compared to cells transfected with the control siRNA (Figure 5.9 B).   
 
 
 
 
 
 
 
 166 
0
20
40
60
80
100
120
Control NOP58 SMN Gemin2 Gemin5 Gemin6 Gemin7
Protein targeted for depletion
p
e
r
c
e
n
ta
g
e
 c
h
a
n
g
e
U3
U8
u14
U1
 
A 
 
 
 
 
 
 
B  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: Box C/D snoRNA levels after depletion of components of the SMN 
complex  
HeLa SS6 cells were transfected with siRNAs targeting either firefly luciferase 
(control), NOP58, SMN, Gemin2, 5, 6 or 7. After sixty hours cells were harvested, 
RNA extracted, separated by electrophoresis on 8 % acrylamide gel containing 7 M urea 
and Northern blot hybridisation performed using radiolabelled probes specific for the 
U3, U8, U14 box C/D snoRNAs, the U1 snRNA and 7SL. Results were visualised by 
autoradiography. (A) Northern blot with protein targeted for depletion indicated above 
the panel. The radiolabelled RNA probes used are indicated to the left of each panel. (B) 
Quantification of RNA levels of Figure 5.9 A. The Levels of box C/D snoRNA and 
snRNA were all adjusted relative to the level of the internal control, 7SL, and 
represented as a percentage change.   
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In cells depleted of NOP58 there was a dramatic reduction in the levels of U3 box C/D 
snoRNA to 32 % of that in the control cells (Figure 5.9 B). Similar reductions were seen 
for all the box C/D snoRNAs in cells depleted of NOP58, which was in agreement with 
previous studies that have shown that NOP58 is essential for box C/D snoRNA 
accumulation (Lafontaine and Tollervery, 2000; Watkins et al, 2004). The depletion of 
NOP58 did not result in a change in the levels of U1 snRNA, which was expected, as 
NOP58 is not known to be involved in snRNP biogenesis.  
 
Depletion of Gemin5 resulted in the reduction of all the box C/D snoRNAs; U3 levels 
were reduced to 49 %, U8 levels to 40 % and U14 levels to 65 % of that in the control 
cells (Figure 5.9 B). This indicates that Gemin5 was essential for box C/D snoRNA 
accumulation and suggests that it may be involved in box C/D snoRNP biogenesis. In 
cells depleted of Gemin5 the U1 snRNA levels were reduced to 65 %, compared to the 
control cells, which indicates that Gemin5 was essential for snRNA accumulation and 
suggests it functions in snRNP biogenesis.   
 
The loss of SMN did not result in a significant change in the levels of the box C/D 
snoRNAs (Figure 5.9 B). This indicates that SMN was not essential for box C/D 
snoRNA accumulation. In cells depleted of SMN there was a reduction in the levels of 
U1 snRNA to 68 % of that in the control cells. This showed that SMN was required for 
snRNA accumulation, which was expected as SMN has a known role in the biogenesis 
of snRNPs (Pellizzoni et al, 2002; Wehner et al, 2002; Yong et al, 2002; 2004). In cells 
depleted of Gemin2, 6 and 7 there was no change in the levels of any of the box C/D 
snoRNAs or U1 snRNA (Figure 5.9 B), showing that these proteins were not required 
for their accumulation.  
 
The results presented here show that out of the SMN complex only Gemin5 was 
essential for box C/D snoRNA accumulation and could indicate that it is involved in 
box C/D snoRNP biogenesis.  
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5.2.6. The SMN complex is essential for the correct localisation of box 
C/D snoRNA 
 
Previous studies have shown that expression of non-functional SMN effects the 
localisation of box C/D snoRNA and fibrillarin (Pellizzoni et al, 2001). Furthermore, 
the depletion of SMN results in the mislocalisation of the box C/D snoRNP common 
core proteins fibrillarin and NOP56 (Lemm et al, 2006). As the localisation of box C/D 
snoRNP factors is an indication of biogenesis SMN, Gemin2, 5, 6 and 7 were depleted 
and the localisation of box C/D snoRNA analysed. 
 
HeLa SS6 cells, grown on coverslips, were transfected with siRNAs targeting firefly 
luciferase (control), SMN, Gemin2, 5, 6 or 7. After sixty hours cells were fixed and 
FISH performed using fluorescent probes specific for either the U3 or U8 box C/D 
snoRNAs, or the spliceosomal U2 snRNA. The U2 snRNA provided a marker of the 
nucleoplasmic Cajal bodies and the nuclear speckles. In addition, as depletion of SMN 
results in the loss of the U2 snRNA from Cajal bodies (Shpargel and Matera, 2005; 
Lemm et al, 2006) it provided a positive control for the siRNA mediated depletion of 
SMN.  
 
 
In the control cells the U3 box C/D snoRNA was found in Cajal bodies but 
predominately in the nucleolus (Figure 5.10 A), the typical distribution of U3 snoRNA 
(Figure 5.3). In cells depleted of SMN, while the U3 snoRNA was still present in the 
nucleolus, there was an accumulation in the nucleoplasm and also in the cytoplasm. 
There was also a loss of the U3 snoRNA localised to Cajal bodies; however, it is 
difficult to interpret this as in SMN depleted cells there is a reduction in Cajal body 
numbers (Shpargel and Matera, 2005; Lemm et al, 2006).  
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Figure 5.10: Box C/D snoRNA localisation in SMN depleted cells  
HeLa SS6 cells were transfected with siRNAs targeting either firefly luciferase (control) 
or SMN. After sixty hours cells were fixed and FISH performed using florescent probes 
specific for the (A) U3 or (B) U8 box C/D snoRNAs, and the U2 snRNA. The same 
exposure time was used for each probe to allow direct comparison of RNA levels and 
distribution. The protein targeted for depletion is indicated at the top of each column of 
images. The labels along the left hand side of the panels indicate the FISH probes used. 
The bottom row shows a merged image of U3 or U8 snoRNA (red) and U2 snRNA 
(green). The white arrows show a selected Cajal body. The bar to the bottom right of 
panels represents 5 μm. Figure 5.10 B provided by N.J.Watkins, Newcastle University, 
UK. 
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To determine whether SMN was required for the localisation of other box C/D 
snoRNAs the U8 box C/D snoRNA was also analysed in SMN depleted cells (Figure 
5.10 B). In the control cells the U8 snoRNA was predominately localised to the 
nucleolus but also found in the Cajal bodies. In the SMN depleted cells the U8 snoRNA 
accumulated in the nucleoplasm, cytoplasm and was lost from Cajal bodies, as was seen 
for the U3 box C/D snoRNA (Figure 5.10 A). This indicates that SMN is required for 
the localisation of box C/D snoRNAs and is involved in box C/D snoRNP biogenesis.   
 
In cells depleted of Gemin2 the U3 box C/D snoRNA was predominately found in the 
nucleolus; however, there was an accumulation in nucleoplasm (Figure 5.11). Unlike 
cells depleted of SMN no U3 box C/D snoRNA accumulated in the cytoplasm and both 
the U3 snoRNA and U2 snRNA were found in Cajal bodies. In cells deleted of Gemin5 
the U3 snoRNA was again found in the nucleolus, however, there was an accumulation 
in both the nucleoplasm and cytoplasm. Also with the depletion of Gemin5 there was a 
loss of both the U3 snoRNA and U2 snRNA from Cajal bodies. This could indicate that 
either Gemin5 is essential for localisation of U3 snoRNA and U2 snRNA to the Cajal 
bodies or that Gemin5 is required for the integrity of Cajal bodies, as is the case for 
SMN (Shpargel and Matera, 2005; Lemm et al, 2006). The depletion of Gemin6 
resulted in the accumulation of the U3 snoRNA outside the nucleolus in the 
nucleoplasm and cytoplasm and the loss of the U3 snoRNA and U2 snRNA from Cajal 
bodies. In cells depleted of Gemin7 the U3 snoRNA was found in the nucleolus but also 
accumulated in the nucleoplasm. The depletion of Gemin7 also caused a loss of U3 
snoRNA and U2 snRNA from Cajal bodies.   
 
The loss of any of the Gemin proteins tested resulted in an accumulation of U3 box C/D 
snoRNA in the nucleoplasm and in some cases the cytoplasm. This indicates that the 
Gemin2, 5, 6 and 7 are required for the correct localisation of box C/D snoRNA, which 
suggests that they are involved in box C/D snoRNP biogenesis. The Loss of Gemin5, 6 
and 7 also resulted in the loss of U3 box C/D snoRNA from Cajal bodies; however, as 
the U2 snRNA was also lost from Cajal bodies it is difficult to interpret these results.  
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To ensure that the accumulation of box C/D snoRNA in the nucleoplasm and cytoplasm 
was due to specific effects of SMN depletion and not due to a general cell defect caused 
by the loss of an essential factor the localisation of the unrelated 7SL RNA was 
analysed in cells depleted of SMN. As a comparison the localisation of 7SL was also 
analysed in cells depleted of the box C/D core protein NOP58.   
 
In the control cells 7SL was found to be predominately in the cytoplasm and to a lesser 
extent the nucleoplasm (Figure 5.12). 7SL was not found in the nucleolus of the control 
cells, which were indicated by the U3 box C/D snoRNA. In the cells depleted of NOP58 
there was a dramatic reduction in the levels of the U3 snoRNA, as shown earlier (Figure 
5.9 B), but the level and distribution of 7SL was unchanged (Figure 5.12). This 
indicates that the depletion of NOP58 specifically affected the U3 snoRNA. In the SMN 
depleted cells the U3 snoRNA accumulated in the nucleoplasm and cytoplasm; 
however, the level and distribution of 7SL was unaffected. This suggests that the 
accumulation of box C/D snoRNA in the nucleoplasm and cytoplasm in SMN depleted 
cells was due to the loss of box C/D snoRNP specific functions of SMN. 
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Figure 5.12: The localisation of 7SL in SMN depleted cells 
HeLa SS6 cells were transfected with siRNA targeting either firefly luciferase (control), 
NOP58 or SMN. Cells were fixed after sixty hours and analysed by FISH using 
fluorescent probes specific for the U3 box C/D snoRNA and 7SL. DAPI staining was 
used to show the nucleoplasm. The same exposure time was used for each probe to 
allow direct comparison of RNA levels and distribution. The protein targeted for 
depletion is indicated at the top of each column of images. The labels along the left 
hand side of the panels indicate the FISH probes used and DAPI staining of the 
nucleoplasm. The bottom row shows a merged image of the U3 snoRNA (red), with 
7SL (green) and DAPI (blue). The bar to the bottom right of the panel represents 5 μm.  
 
 
 
 
 
 
 
 174 
5.3. Discussion  
 
The SMN protein has been implicated in box C/D snoRNP biogenesis in a number of 
studies (Pellizzoni et al, 2001; Jones et al, 2001; Whitehead et al, 2002; Lemm et al, 
2006); however, the precise role of SMN and whether it functions in box C/D snoRNP 
biogenesis as part of the SMN complex is not clear.  
 
Previous studies using Yeast-2-hybrid screens, in vitro interaction assays and 
immunoprecipitation assays have shown that the box C/D snoRNP common core 
protein fibrillarin interacts with the SMN protein. The N terminal RGG domain of 
fibrillarin mediates the interaction with SMN; however, the interaction domain of SMN 
is not clear (Pellizzoni et al, 2001; Jones et al, 2001). In this study in vitro interaction 
assays were performed between fibrillarin and all the components of the SMN complex 
to determine if other interactions existed. These assays revealed that fibrillarin only 
interacts with the SMN protein and that the RGG domain of fibrillarin is important for 
this interaction (Figure 5.4). Further in vitro interaction assays showed that there were 
no interactions between the SMN protein and the other box C/D snoRNP common core 
proteins. The interaction between fibrillarin and SMN was also investigated in vivo 
using immunoprecipitation assays, utilising extract from cells that expressed FLAG-
SMN (Figure 5.7). It was, however, not possible to co-precipitate fibrillarin with anti-
FLAG antibodies. The lack of a detectable in vivo interaction suggests that weak and / 
or transient interactions occur between SMN and fibrillarin. 
 
The biogenesis of box C/D snoRNPs occurs in a dynamic, multiprotein complex known 
as the pre-snoRNP, which consists of snoRNA, common core proteins and assembly, 
transport and RNA processing factors (Watkins et al, 2004; McKeegan et al, 2007). To 
determine whether the SMN complex interacts with the pre-snoRNP a number of 
approaches were utilised. In vitro interaction assays were performed between the box 
C/D snoRNP assembly factors and components of the SMN complex. These assays 
showed that the SMN protein interacts with the box C/D snoRNP assembly factors 
BCD1 and NUFIP (Figure 5.5), which could indicate that SMN associates with the pre-
snoRNP. Another approach used to determine if SMN interacts with the pre-snoRNP 
was to separate HeLa SS6 nuclear extract on a glycerol gradient and analyse the 
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sedimentation of SMN and components of the box C/D snoRNPs (Figure 5.6). The 
glycerol gradient revealed that there was some degree of overlap in sedimentation of 
SMN, fibrillarin and box C/D snoRNA, which could indicate that SMN interacts with 
the box C/D pre-snoRNP. Immunoprecipitation assays were also performed to 
determine whether SMN interacts with the box C/D pre-snoRNP. As previous studies 
have produced conflicting data regarding the co-precipitation of box C/D snoRNA with 
anti-SMN antibodies (Wehner et al, 2002; Watkins et al, 2004) immunoprecipitation 
experiments were performed using anti-FLAG antibodies and extracts from cells that 
expressed FLAG-SMN (Figure 5.7). No co-precipitation of box C/D snoRNA with anti-
FLAG antibodies was detected, indicating that FLAG-SMN did not interact with the 
box C/D pre-snoRNP. Overall the data suggests that if the SMN complex does interact 
with the box C/D pre-snoRNP, as is indicated by the in vitro interaction of SMN with 
fibrillarin, BCD1 and NUFIP, then it is not a stable component.  
 
To determine whether the SMN complex is required for box C/D snoRNP biogenesis 
SMN, Gemin2, 5, 6 and 7 were depleted using siRNAs and the level of box C/D 
snoRNA analysed. Unfortunately, it was not possible to efficiently deplete Gemin3, 4 or 
UNRIP and so these proteins were not analysed. Of all the SMN complex factors 
analysed only the depletion of Gemin5 resulted in the reduction in the levels of box C/D 
snoRNA (Figure 5.10). As Gemin5 is essential for the accumulation of box C/D 
snoRNA this indicates that it may be involved in box C/D snoRNP biogenesis. Gemin5 
was not shown to interact with any of the box C/D snoRNP factors tested; however, 
Gemin5 has shown to interact directly with the snRNAs (Battle et al, 2006, 2007). It is 
therefore possible that the RNA binding capabilities of Gemin5 could extend to box 
C/D snoRNAs. Gemin5 could be essential for box C/D snoRNA accumulation through 
functions that are required for the stability of RNA, such as the association of common 
core proteins or direct binding of Gemin5 to the box C/D snoRNA preventing 
degradation. Alternatively the loss of Gemin5 could result in a decrease in the rate of 
box C/D snoRNP biogenesis leading to a reduction in box C/D snoRNA levels. 
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The level of the U1 snRNA was also analysed in cells depleted of the SMN, Gemin2, 5, 
6 and 7 (Figure 5.9). Only the depletion of SMN and Gemin5 resulted in a reduction in 
snRNA levels, which shows that these proteins are essential for snRNA accumulation 
and suggests that they are involved in snRNP biogenesis. The SMN complex has a 
defined role in snRNP biogenesis; however, the extent to which the different 
components function in snRNP biogenesis is not clear. Recently a minimal complex 
consisting of just SMN and Gemin2 has been shown to be sufficient for snRNP 
biogenesis (Kroiss et al, 2008; Chari et al, 2008). This could imply that the other Gemin 
proteins have redundant functions or are involved in processes outside of snRNP 
biogenesis.  
 
Another approach used to analyse the role of the SMN complex in box C/D snoRNP 
biogenesis was to determine whether it was essential for the localisation of box C/D 
snoRNPs. Previous studies have shown that in the absence of functional SMN there is 
an accumulation of box C/D snoRNP factors outside the nucleolus; however, the 
importance of the Gemin proteins was not addressed (Pellizoni et al, 2001; Lemm et al, 
2006). In cells depleted of SMN there was an accumulation of both the U3 and U8 box 
C/D snoRNAs in the nucleoplasm and also the cytoplasm (Figure 5.10). In cells 
depleted of Gemin5 and 6 the U3 snoRNA accumulated in the nucleoplasm and the 
cytoplasm of cells (Figure 5.11). In cells depleted of Gemins2 and 7 the U3 snoRNA 
accumulated in the nucleoplasm. Together this data indicates that SMN and Gemin2, 5, 
6 and 7 are vital for the correct localisation of box C/D snoRNA and suggests that all 
these factors are involved in box C/D snoRNP biogenesis. A possible explanation for 
the accumulation of the U3 box C/D snoRNA in the nucleoplasm and cytoplasm is that 
in the absence of SMN and Gemin2, 5, 6 and 7 there is a block in box C/D snoRNP 
biogenesis resulting in the formation of pre-snoRNP complexes which cannot localise to 
the nucleolus. This could be due to the SMN complex functioning as a transport factor 
or the SMN complex is involved in the recruitment and / or association of common core 
proteins, which is essential for nucleolar localisation (Figure 3.4; Verheggen et al, 2001, 
2002).  
 
The depletion of SMN, Gemin5, 6 and 7 also resulted in the loss of box C/D snoRNA 
from Cajal bodies; however, as the U2 snRNA was also absent from the Cajal bodies in 
these cells. The fact that in SMN depleted cells there is a reduction in the number of 
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Cajal bodies (Shparagel and Matera, 2005; Lemm et al, 2006) makes this data is 
difficult to interpret. Interestingly, the depletion of Gemin2 did not prevent the 
localisation of either the U3 snoRNA or U2 snRNA to the Cajal bodies. This is in 
agreement with previous studies that the depletion of Gemin2 does not result in a 
significant reduction in the number of Cajal bodies (Shpargel and Matera, 2005). This 
also suggests that Gemin2 is not required in processes that result in the localisation of 
snRNA and box C/D snoRNA to the Cajal bodies.  
 
The data presented here further implicates the SMN complex in box C/D snoRNP 
biogenesis. In regards to the function of the SMN complex in box C/D snoRNP 
biogenesis that is still not clear; however, based on the data it is possible that the SMN 
complex either functions as a transport factor or in the association of fibrillarin with the 
box C/D snoRNP. An issue, however, with the later proposal is that unlike the siRNA 
mediated depletion of fibrillarin, which results in a mild reduction in box C/D snoRNA 
levels (Figure 3.4; Watkins et al, 2004), the depletion of the SMN protein has no effect 
on box C/D snoRNA levels. However, an explanation for these differences could be that 
if the decline in fibrillarin association caused by the loss of SMN is not significant then 
the levels of box C/D snoRNA may only be slightly affected. Another issue with this 
proposal is that siRNA mediated depletion of fibrillarin results in the accumulation of 
box C/D snoRNA in the nucleoplasm and Cajal bodies (Figure 3.4) while the depletion 
of SMN results in the accumulation of box C/D snoRNA in the nucleoplasm and 
cytoplasm (Figure 5.10). This indicates that SMN does not function in association of 
fibrillarin with the box C/D snoRNP and it is more likely that the SMN complex 
functions as a transport factor in box C/D snoRNP biogenesis. However, further 
investigation is required to determine the role of the SMN complex in box C/D snoRNP 
biogenesis. 
 
The immunoprecipitation assays performed using extracts from inducible FLAG-
fibrillarin HEK293 cells provide evidence as to the stoichiometry of the box C/D 
snoRNP complex. As it has been predicted that box C/D snoRNPs contain two copies of 
fibrillarin, one copy at the C/D box and another at the C’/D’ box (Cahill et al, 2002; 
Aittaleb et al, 2003; Rashid et al, 2003; Tran et al, 2003), it was expected that 
endogenous fibrillarin would be co-precipitated from FLAG-fibrillarin HEK293 cell 
extracts using anti-FLAG antibodies. No endogenous fibrillarin was, however, co-
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precipitated despite the fact that the data indicated that the FLAG-fibrillarin associates 
with box C/D snoRNPs (Figure 5.7). The lack of co-precipitation of endogenous 
fibrillarin could suggest that only one copy of fibrillarin associates with the box C/D 
snoRNPs. As the C’/D’ box is not as conserved as the C/D box it is possible that not all 
box C/D snoRNPs contain two copies of fibrillarin and there may be species 
differences. One issue with this immunoprecipitation assay, however, is that it is 
possible that the FLAG-fibrillarin was expressed at a higher rate than endogenous 
fibrillarin. It is therefore feasible that there was an excess of FLAG-fibrillarin produced 
during the time frame of the experiment resulting in the formation of box C/D snoRNPs 
containing two copies of FLAG-fibrillarin, preventing the association of endogenous 
fibrillarin. This would therefore inhibit the co-precipitation of endogenous fibrillarin 
with FLAG-fibrillarin. Further investigations are required to determine the 
stoichiometry and arrangement of common core proteins on box C/D snoRNPs. 
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Chapter six 
 
 
 
Analysis of the interaction 
of Snurportin1 with the 
box C/D pre-snoRNP  
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6.1. Introduction 
 
The biogenesis of the box C/D snoRNPs and snRNPs share many similarities despite 
their differing roles in the cell. The box C/D snoRNPs function in the chemical 
modification of rRNA or assist in pre-rRNA processing, while the snRNPs operate in 
pre-mRNA splicing as part of the spliceosome. The biogenesis of the snRNPs is more 
defined than that of the box C/D snoRNPs and therefore provides a useful paradigm for 
understanding how box C/D snoRNPs are formed.  
 
The RNA component of the box C/D snoRNPs and snRNPs (with the exception of the 
U6 snRNA) is transcribed by RNA polymerase II in the nucleoplasm as a precursor 
with 3’ extended sequences. All the snRNAs are transcribed from independent genes 
and co transcriptionally acquire 5’ m7G caps; however, this is not the case for box C/D 
snoRNAs. In vertebrates the majority of box C/D snoRNAs are encoded within the 
introns of house keeping genes and are released by endonucleases, resulting in intronic 
box C/D snoRNAs containing 5’-phosphate terminals (Tollervey and Kiss, 1997). A 
few vertebrate box C/D snoRNAs, such as the U3 and U8 snoRNAs, are encoded as 
independent genes and these have a co transcriptionally added 5’ m7G cap (Speckmann 
et al, 2000; Girard et al, 2007). 
 
The 5’ m7G cap of both snRNAs and independently transcribed box C/D snoRNAs is 
converted to an m3G cap by the hypermethylase TGS1 (Huber et al, 1998; Speckmann 
et al, 2000; Mitrousis et al, 2008). While the 5’ m7G cap of snRNA is converted into an 
m3G cap in the cytoplasm where this is occurs with the box C/D pre-snoRNAs is not 
clear with both the Cajal bodies and cytoplasm implicated (Verheggen et al, 2002; 
Watkins et al, 2007).  
 
The box C/D snoRNPs also associate with numerous snRNP transport factors such as 
CBC, CRM1, PHAX and Snurportin1; however, the function of these is best defined for 
the snRNPs (Yang et al, 2000; Boulon et al, 2004; Watkins et al, 2004, 2007). In snRNP 
biogenesis these factors are essential for the localisation of the pre-snRNA and 
biogenesis (Figure 6.1). For instance CBC, CRM1 PHAX interact with nuclear pre-
snRNA via the m
7
G cap, which with RanGTP results in the nuclear export of the pre-
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snRNA (Ohno et al, 2000; Kitao et al, 2008). In the cytoplasm the SMN complex, 
which has also been linked to snoRNP biogenesis (Pellizzoni et al, 2001; Jones et al 
2001; see Chapter 5), facilitates the formation of the protein Sm core and recruits TGS1 
resulting in the formation of the 5’ m3G cap (Ohno et al, 2000; Pellizzoni et al, 2002; 
Yong et al, 2002; 2004). The nuclear import protein, Snurportin1, associates with the 5’ 
m3G cap of the snRNA and mediates an interaction with importin β resulting in the 
nuclear import of the pre-snRNP complex (Huber et al, 1998; Mitrousis et al, 2008). 
Interestingly, SMN has also been shown to function in the nuclear import of the snRNPs 
in the absence of Snurportin1 (Narayanan et al, 2002. 2004). Once in the nucleus the 
pre-snRNP localises to the Cajal bodies where type specific snRNP core proteins are 
proposed to associate and the snRNPs form U4/U6 di-snRNPs and U4/U6.U5 tri-
snRNPs (Stanek et al, 2003; Schaffert et al, 2004).  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: The transport of snRNPs during biogenesis 
A dark grey line represents the snRNA with the 5’ m7G cap shown as an orange circle 
and the 3’ extended sequence as an orange rectangle. A yellow circle represents the 
export factors CBC, CRM1, PHAX and RanGTP. The Sm core proteins are represented 
by a light yellow oval. The SMN complex is represented by a green oval. TGS1 is 
shown as a red oval. Snurportin1 is represented as a blue oval. The 5’ m3G cap of 
mature snRNA is shown as by a dark grey circle. The Cajal body is represented as a 
grey outlined box. The nuclear membrane is shown by black outlined rectangles. Grey 
arrows indicate the progression of biogenesis. Figure adapted from image provided by 
N.J.Watkins, Newcastle University, UK.   
 
 
Box C/D snoRNP biogenesis proceeds in a large dynamic complex known as the pre-
snoRNP that consists of snoRNA, the common core proteins (fibrillarin, NOP56, 
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NOP58 and 15.5K), RNA processing and assembly factors (TIP48, TIP49, BCD1, 
NOP17, TAF9 and NUFIP; Watkins et al, 2004, 2007; McKeegan et al, 2007). The 
CBC, CRM1, PHAX and Snurportin1 factors that associate with box C/D pre-snoRNPs, 
most likely, function in the transport of this complex (Watkins et al, 2004; 2007, Boulon 
et al, 2004). However, the location(s) where box C/D snoRNP biogenesis occurs is not 
clear with data suggesting the nucleoplasm (Watkins et al, 2004, 2007; McKeegan et al, 
2007), Cajal bodies (Boulon et al, 2007; Verheggen et al, 2002) and also the cytoplasm 
(Baserga et al, 1992; Peculis et al, 2001; Watkins et al, 2007). 
 
Snurportin1 was first implicated in box C/D snoRNP biogenesis when it was found 
associated with U8 pre-snoRNPs in the cytoplasm of human cells, which contained m3G 
capped pre-U8 snoRNA (Watkins et al, 2007). As Snurportin1 interacts with the m3G 
cap of snRNA (Huber et al, 1998; Mitrousis et al, 2008) it is conceivable that the same 
interaction occurs with m3G capped U8 snoRNA. Further evidence of the involvement 
of Snurportin1 in box C/D snoRNP biogenesis was shown by siRNA mediated 
depletion of Snurportin1 which resulted in the accumulation of U8 snoRNA outside the 
nucleolus in the nucleoplasm and cytoplasm (Watkins et al, 2007). The accumulation of 
U8 snoRNA in the cytoplasm indicates that Snurportin1 may function in the nuclear 
import of box C/D pre-snoRNPs.  
 
The mechanism by which Snurportin1 associates with the cytoplasmic U8 box C/D pre-
snoRNP is not known. It is possible that Snurportin1 interacts with the U8 snoRNA 5’ 
m3G cap; however, other interactions may also occur. To determine whether 
Snurportin1 interacts with other components of the box C/D pre-snoRNP a series of in 
vitro interaction assays were performed between Snurportin1 and box C/D snoRNP 
common core proteins and assembly factors. As only independently transcribed box 
C/D snoRNAs such as U3, U8 and U13 contain 5’ m3G caps by characterising the 
interaction of Snurportin1 with pre-snoRNP proteins it will be possible to speculate as 
to the involvement of Snurportin1 in the biogenesis of intronic box C/D snoRNPs. In 
addition, as the SMN complex has been implicated in box C/D snoRNP biogenesis 
(Pellizzoni et al, 2001; Jones et al, 2001) and as Snurportin1 has been shown to 
associate in pre-snRNP cytoplasmic complexes, containing SMN (Narayanan et al, 
2002), in vitro interaction assays were performed to determine whether Snurportin1 and 
the SMN complex interact. 
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6.2. Results 
 
6.2.1. Snurportin1 interacts with the box C/D snoRNP common core 
protein NOP56 
 
The box C/D pre-snoRNP is formed through an intricate network of interactions 
between the various components. Snurportin1 associates with cytoplasmic U8 pre-
snoRNPs; however, the interaction with the pre-snoRNP has not been characterised. To 
determine whether Snurportin1 interacts with any box C/D snoRNP common core 
proteins in vitro interaction assays were performed.  
 
Human Snurportin1 was expressed and purified, from E. coli, with an N terminal GST 
tag (GST-SPN1, expression plasmid provided by A.Dickmanns, Max Planck Institute of 
Biophysical Chemistry, Göttingen, Germany). The human box C/D snoRNP common 
core protein 15.5K was expressed and purified, from E. coli, fused to an N terminal His 
tag (His-15.5K, expression plasmid provided by E.S.Maxwell, North Carolina State 
University, USA). Due to solubility issues deletion mutants of NOP56 (1-458) and 
NOP58 (1-435), that lack the C terminal charged region, were expressed and purified 
from E.coli with an N terminal thioredoxin tag and C terminal His tag (His-NOP56, 
His-NOP58; McKeegan et al, 2007). The C terminal charged region of NOP56 and 
NOP58, which was removed in the deletion mutants, has been shown not to be required 
for box C/D snoRNP formation in yeast (Lafontaine and Tollervey, 2000). 
Unfortunately, it was also not possible to express and purify full length fibrillarin; 
however, it was possible to express and purify a deletion mutant, which lacked the N 
terminal RGG motif, fused to an N terminal His tag (His-N-C-fibrillarin (amino acids 
81-321); see Chapter 4.2.1).  
 
GST-Snurportin or GST alone (negative control) were immobilised on glutathione 
Sepharose beads and incubated with His tagged proteins. After two hours incubation the 
glutathione Sepharose beads were washed and bound proteins analysed by separation on 
a 12 % SDS-PAGE gel followed either by Coomassie blue staining of the gel (Figure 
6.2 A) or Western blot assays using anti-His antibodies (Figure 6.2 B). 
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Figure 6.2: Interaction assay between Snurportin1 and the box C/D snoRNP 
common core proteins 
GST-Snurportin1 (GST-SPN1) or GST alone was immobilised on glutathione 
Sepharose beads and incubated with His-N-C-fibrillarin, His-NOP56, His-NOP58 and 
His-15.5K. Bound proteins were separated on a 12 % SDS-PAGE followed by either 
(A) Coomassie blue staining or (B) Western blot analysis using anti-His antibodies. 
Where appropriate full length proteins are indicated by an asterisk. Inputs represent 10 
% of protein used in the interaction assay. The molecular markers (M) sizes are shown 
to the left of the panel in kilodaltons. The identity of the GST and His tagged proteins 
used is indicated at the top of each lane. The migration of the individual proteins is 
indicated to the right of the panel.   
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Immobilised GST-Snurportin1 only retained the His-NOP56 above the levels of the 
GST control (Figure 6.2 B). There was retention of His-NOP58 by GST-Snurportin1; 
however, this as not above the background levels seen with the GST control. This 
indicates that out of thec common core proteins Snurportin1 specifically interacts with 
NOP56. As the interaction of Snurportin1 and NOP56 was only detectable using the 
more sensitive Western blot assay (Figure 6.1 B) this suggests that the interaction is 
either weak and / or transient.  
 
6.2.2. Snurportin1 interacts with the box C/D snoRNP assembly factors 
TIP48 and TIP49 
 
To further analyse the interactions of Snurportin1 with the box C/D pre-snoRNP in vitro 
interaction assays were performed between Snurportin1 and the box C/D snoRNP 
assembly factors TIP48 and TIP49. GST-Snurportin and GST alone were immobilised 
on glutathione Sepharose beads and incubated with recombinant human TIP48 and 
TIP49, which were expressed and purified with an N terminal His tag from E. coli (His-
TIP48 and His-TIP49; McKeegan et al, 2007). In addition, as TIP48 and TIP49 are 
ATPases, the interaction assays were also performed in the presence of 100 mM ATP or 
ADP to determine whether nucleotides were required for interactions.  
 
Immobilised GST-Snurportin1 retained His-TIP48 above the levels seen with GST 
alone, both in the presence and absence of ATP and ADP (Figure 6.3). Interestingly, the 
presence of ATP or ADP reduced the retention of His-TIP48 by both GST-Snurportin1 
and the GST control. As the retention of His-TIP48 by GST-Snurportin1 was highest in 
the absence of ATP or ADP this indicates that the presence of nucleotides is not 
required for this interaction. Since the retention of His-TIP48 by GST-Snurportin1 was 
visible by both Coomassie blue staining (Figure 6.3 A) as well as the more sensitive 
Western blot assay (Figure 6.3 B) this suggests that the interactions were strong.  
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His-TIP49 was not retained by the GST negative control; however, was retained by 
GST-Snurportin1 (Figure 6.3 A and B). Interestingly, there was a reduction in the 
retention of His-TIP49 by GST-Snurportin1 in the presence of ATP or ADP. This 
indicates that the interaction between His-TIP49 and GST-Snurportin1 does not require 
nucleotide. As retention of His-TIP49 by immobilised GST-Snurportin1 was visible 
using Coomassie blue staining (Figure 6.3 A) as well as the more sensitive Western blot 
assay (Figure 6.3 B) this indicates that the interaction between GST-Snurportin1 and 
His-TIP49 was a strong stable interaction.  
 
Taken together these results indicate that Snurportin1 interacts with both TIP48 and 
TIP49 and these interactions do not require nucleotide. The fact that these interactions 
were seen by direct Coomassie blue staining of the gel as well as the more sensitive 
Western blot assay indicate that these are strong stable interactions.  
 
6.2.3. Snurportin1 does not interact with the box C/D snoRNP 
assembly factors NUFIP, TAF9, NOP17 or the transport factor PHAX 
 
Further in vitro interaction assays were performed to determine whether Snurportin1 
interacts with any other box C/D snoRNP assembly factors or the transport factor 
PHAX. Unfortunately, it was not possible to express and purify these assembly factors 
fused to N terminal His tags. Therefore the assembly factors NUFIP, TAF9 and NOP17 
and the transport factor PHAX were expressed using reticulocyte lysate in the presence 
of [
35
S] methionine (McKeegan et al, 2007). The interaction assays were performed as 
described earlier with the exception that results were visualised by autoradiography 
once proteins were separated on a 12 % SDS-PAGE gel.   
 
Immobilised GST-Snurportin1 failed to retain the in vitro-translated 
35
S-labelled 
NUFIP, TAF9, NOP17, BCD1 and PHAX proteins above the levels of GST alone, 
which indicates that Snurportin1 does not interact with any of these factors (Figure 6.4).  
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Figure 6.4: Interaction assay between Snurportin1 and the box C/D snoRNP 
assembly factors and the transport factor PHAX 
GST-Snurportin1 (GST-SPN1) or GST alone was immobilised on glutathione 
Sepharose beads and incubated with in vitro-translated 
35
S-labelled NUFIP, TAF9, 
NOP17, BCD1 or PHAX. Bound proteins were separated on a 12 % SDS-PAGE gel 
and results visualised by autoradiography. Input lane represents 10 % of in vitro-
translated 
35
S-labelled protein used in interaction assay. The identity of GST tagged 
protein used is indicated above each lane. The identity of the radiolabelled protein used 
is indicated to the left of the panel. 
 
 
6.2.4. Snurportin1 does not interact with the SMN complex  
 
As the SMN complex and Snurportin1 have been implicated in box C/D snoRNP 
biogenesis (Pellizzoni et al, 2001; Jones et al, 2001; Watkins et al, 2007) and are both 
found in pre-snRNP import complexes (Narayanan et al, 2002) in vitro interaction 
assays were performed to determine whether Snurportin1 interacts with any of the SMN 
complex proteins.  
 
The interaction assays were performed as described earlier with immobilised GST-
Snurportin1 or GST alone incubated with SMN complex proteins that were expressed 
using reticulocyte lysate in the presence of [
35
S] methionine (expression plasmids 
provided by U.Fischer, University of Wurzburg, Germany). 
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Figure 6.5: Interaction assay between Snurportin1 and components of the SMN 
complex  
GST-Snurportin1 (GST-SPN1) or GST alone was immobilised on glutathione 
Sepharose beads and incubated with in vitro-translated 
35
S-labelled SMN, Gemins2-8 or 
UNRIP. Bound proteins were separated on a 12 % SDS-PAGE gel and results 
visualised by autoradiography. Input lane represents 10 % of in vitro-translated 
35
S-
labelled protein used in interaction assay. The identity of the GST tagged protein and 
radiolabelled protein used is indicated above each lane. Asterisk indicates the full length 
protein where necessary.    
 
 
Immobilised GST-Snurportin1 did not retain in vitro-translated 
35
S-labelled SMN, 
Gemin2, 3, 5, 6, 7, 8 or UNRIP above the GST control level, which indicates that no 
interaction occurs between these factors (Figure 6.5). The only SMN complex factor 
that immobilised GST-Snurportin1 retained above GST levels was Gemin4. The 
retention of Gemin4 by GST-Snurportin1 was low and not convincing and therefore 
further investigation is required to determine whether the SMN complex interacts with 
Snurportin1.  
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6.3. Discussion   
 
Snurportin1 was first implicated in box C/D snoRNP biogenesis when it was found 
associated with cytoplasmic U8 pre-snoRNP complexes containing m3G capped 
snoRNA (Watkins et al, 2007). As Snurportin1 has previously been shown to bind the 
m3G caps of snRNAs it is conceivable that Snurportin1 associates with cytoplasmic U8 
pre-snoRNPs through an interaction with the 5’ m3G cap of the snoRNA. However, as 
intronic box C/D snoRNAs do not posses 5’ m3G caps this would indicate that 
Snurportin1 only functions in the biogenesis of independently transcribed snoRNAs.  
 
To further characterise the interactions of Snurportin1 with the box C/D pre-snoRNP a 
series of in vitro interaction assays were performed between Snurportin1 and box C/D 
snoRNP core proteins, assembly factors and the transport factor PHAX. The in vitro 
interaction assays indicate that Snurportin1 interacts with the common core protein 
NOP56 (Figure 6.2) and with the box C/D snoRNP assembly factors TIP48 and TIP49 
(Figure 6.3). As TIP48 and TIP49 are known ATPases the requirement of ATP and 
ADP for the interaction with Snurportin1 was also investigated and revealed that the 
presence of nucleotide is not required. The interactions of Snurportin1 with NOP56, 
TIP48 and TIP49 may represent the means, in addition to the 5’ m3G cap, by which 
Snurportin1 associates with U8 pre-snoRNP complexes. Since intronic snoRNAs, such 
as U14, do not posses a 5’ m3G cap the identification of these interactions show a 
mechanism by which Snurportin1 could associate with box C/D pre-snoRNPs that lack 
snoRNA with a 5’ m3G cap and thus function in their biogenesis. Further investigation 
is, however, required to determine if Snurportin1 associates with other species of box 
C/D pre-snoRNP. 
 
As SMN and Snurportin1 have been implicated in box C/D snoRNP biogenesis 
(Pellizzoni et al, 2001; Jones et al, 2001) and are both found in pre-snRNP import 
complexes (Narayanan et al, 2002) in vitro interaction assays were performed to 
determine whether Snurportin1 interacts with the SMN complex. These assays indicate 
that Snurportin1 and the SMN complex do not directly interact. There was a slight 
retention of Gemin4 by GST-Snurportin1 in the in vitro interaction assays; however, 
this was weak and far from conclusive (Figure 6.5). As other studies have indicated that 
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Snurportin1 and the SMN complex do not directly interact but are in the same snRNP 
import complex through a mutual association with the snRNA this suggests that these 
factors, more than likely, do not interact (Narayanan et al, 2002). 
 
The most likely function of Snurportin1 in box C/D snoRNP biogenesis is in the 
transport of cytoplasmic pre-snoRNPs to the nucleus. This is indicated by the fact that 
Snurportin1 was found specifically associated with cytoplasmic U8 pre-snoRNPs 
(Watkins et al, 2007), functions in the nuclear import of snRNPs (Huber et al, 1998) and 
the siRNA mediated depletion of Snurportin1 results in the accumulation of U8 
snoRNA in the cytoplasm (Watkins et al, 2007). It is also possible that Snurportin1 
could function in the transport of the pre-snoRNP to the Cajal bodies as Snurportin1 has 
been shown to localise to these sites during snRNP biogenesis (Ospina et al, 2005).  
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Chapter seven 
 
 
 
 
General discussion 
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7. Discussion 
 
7.1. Overview 
 
This study set out to further characterise box C/D snoRNP biogenesis. This included 
analysis of the interactions of the fibrillarin common core protein with the box C/D 
snoRNP assembly factors and the importance of the various domains of fibrillarin for 
localisation and association with the snoRNPs. Furthermore, as fibrillarin has been 
shown to interact with the SMN protein (Pellizzoni et al, 2001; Jones et al, 2001) the 
role of the SMN complex in box C/D snoRNP biogenesis was also investigated.  
 
7.2. Box C/D snoRNP biogenesis 
 
The association of the common core proteins to the box C/D snoRNP is a hierarchical 
process with the binding of 15.5K to the snoRNA essential for the subsequent 
association of fibrillarin, NOP56 and NOP58 (Watkins et al, 2002). Studies in yeast 
have shown that Snu13p (15.5K) and Nop58p (NOP58) are vital for the accumulation of 
box C/D snoRNA (Lafonatine and Tollervey, 1999; Watkins et al, 2000). In this study it 
was also shown that of the human common core proteins only the loss of NOP58 results 
in a dramatic reduction in box C/D snoRNA levels; however, it was not possible to test 
15.5K. Taken together as 15.5K and NOP58 are essential for the accumulation of box 
C/D snoRNA this could indicate that these common core proteins form a basic complex 
with the snoRNA enhancing its stability, perhaps by preventing degradation from 
exonucleases (Lafontaine and Tollervey, 1999; Watkins et al, 2000, 2004).  
 
Numerous factors have been identified in eukaryotes that are required for the assembly 
of the box C/D snoRNPs (Peng et al, 2003; Wang and Meier, 2004; Boulon et al, 2004, 
2008; Watkins et al, 2004, 2007; Gonzales et al, 2005; McKeegan et al, 2007). In this 
study multiple fibrillarin deletion mutants were used to analyse the interactions of 
fibrillarin with the box C/D snoRNP assembly factors. Protein-protein interaction 
studies revealed that the C terminal domain of fibrillarin (amino acids 141-321) 
mediates interactions with the assembly factors BCD1, NOP17, NUFIP, TIP48 and 
TIP49. Previous studies have shown that human fibrillarin also interacts with NOP56 
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(McKeegan et al, 2007) and investigations using archaeal proteins revealed that the 
fibrillarin C terminal domain interacts with the NOP56 / NOP58 homologue, Nop5 
(Aittaleb et al, 2003). It is therefore possible that the interaction of eukaryotic fibrillarin 
with NOP56 is also mediated by the fibrillarin C terminal domain. In this study the 
further use of the fibrillarin deletion mutants showed that the C terminal domain of 
fibrillarin was also essential for the correct cellular localisation, which is in agreement 
with previous studies (Snaar et al, 2000). As the fibrillarin C terminal domain is 
important for mediating interactions with the assembly factors (and potentially NOP56) 
and vital for localisation it is possible that this domain is required for the association of 
fibrillarin with the box C/D snoRNP (see future work).  
 
The site(s) of box C/D snoRNP biogenesis are not clear with data implicating the 
nucleoplasm (Terns et al, 1995; Watkins et al, 2004; Boulon et al, 2004), Cajal bodies 
(Verheggen et al, 2001; Boulon et al, 2004; Lemm et al, 2006) and cytoplasm (Baserga 
et al, 1992; Peculis et al, 2001; Watkins et al, 2007). In this study the localisation of the 
box C/D snoRNP assembly factors was investigated to provide further data on the 
site(s) of box C/D snoRNP biogenesis. Analysis in human cells revealed that the box 
C/D snoRNP assembly factors BCD1, NUFIP, TAF9, TIP48, and TIP49 were 
distributed throughout the nucleoplasm and not enriched in any nuclear bodies. This 
strengthens the case that box C/D snoRNP biogenesis occurs in the nucleoplasm and is 
in agreement with previous studies that have shown these assembly factors associate 
with nucleoplasmic box C/D pre-snoRNPs (Watkins et al, 2004, 2007; McKeegan et al, 
2007). The nucleoplasm and Cajal bodies were further implicated as sites of box C/D 
snoRNP biogenesis in this study as the depletion of NOP56 and / or fibrillarin in human 
cells resulted in the accumulation of the U3 box C/D snoRNA in these locations 
(McKeegan et al, 2007). The accumulation of U3 snoRNA in the nucleoplasm and Cajal 
bodies could indicate that only fully assembled box C/D snoRNPs can leave these sites 
or alternatively it is possible that these are the locations where box C/D snoRNPs 
accumulate when assembly cannot be completed.  
 
The Cajal bodies have been shown to be the location of U4/U6 di-snRNP and 
U4/U6.U5 tri-snRNP formation (Stanek et al, 2003; Schaffert et al, 2004) and have also 
been proposed as the site of the association of the snRNP core proteins (Nesic et al, 
2004). The Cajal bodies have been implicated in box C/D snoRNP biogenesis in a 
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number of studies (Verheggen et al, 2001; Boulon et al, 2004; Lemm et al, 2006); 
however, the purpose of the localisation of box C/D snoRNA to these sites is not clear 
(Naryanan et al, 1999). It has been proposed that the Cajal bodies are site where the box 
C/D snoRNP common core proteins are associated with the snoRNA and also the 
location where 5’ m7G cap of U3 box C/D snoRNA is converted to an m3G cap; 
however, further investigation is required to determine this (Verheggen et al, 2002; 
Boulon et al, 2004). In this study the observation that the U3 box C/D snoRNA 
accumulates in the Cajal bodies of NOP56 and fibrillarin depleted human cells provides 
further evidence that the Cajal bodies are sites of box C/D snoRNP biogenesis. 
Additional study is required to determine the purpose of box C/D snoRNA localisation 
to the Cajal bodies. Whether box H/ACA snoRNP biogenesis also occurs in the Cajal 
bodies is not clear as it has yet to be demonstrated that box H/ACA snoRNAs 
transiently localise to these nuclear bodies (Kiss, 2004). Furthermore, while the box 
H/ACA snoRNP core proteins such as GAR1 are found in Cajal bodies these may 
represent scaRNPs (Jady and Kiss, 2001).  
 
It has been proposed that only fully formed mature box C/D snoRNPs localise to the 
nucleolus as the depletion of yeast Snu13p, Nop56p, Nop58p and Nop1p inhibit the 
nucleolar localisation of box C/D snoRNAs (Verheggen et al, 2001). As depletion of 
Nop58p results in the dramatic reduction of box C/D snoRNA levels artificial snoRNAs 
with long terminal stems were used to determine that it was required for the nucleolar 
localisation of the box C/D snoRNPs (Verheggen et al, 2001). In this study depletion of 
NOP56 and fibrillarin (15.5K not tested) in human cells resulted in an accumulation of 
the U3 box C/D snoRNA in the nucleoplasm and Cajal bodies. Furthermore the 
depletion of NOP56 resulted in the accumulation of newly synthesised fibrillarin 
(expressed from a reporter plasmid) in the nucleoplasm. The depletion of NOP58 
resulted in such a dramatic reduction in box C/D snoRNA levels that it is not possible to 
determine whether it was required for nucleolar localisation. Nevertheless, in 
combination with the yeast data (Verheggen et al, 2001) these results indicate that a full 
set of common core proteins is required for the nucleolar localisation of box C/D 
snoRNPs. Whether the assembled mature box C/D snoRNP is itself a nucleolar 
localisation signal or that associated transport factors transfer the box C/D snoRNPs to 
the nucleolus is not clear. However, it has been demonstrated that the transport factor 
CRM1 is required for the nucleolar localisation of U3 box C/D snoRNA (Boulon et al, 
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2004) and Nopp140, which has been linked to box C/D snoRNP biogenesis (Yang et al, 
2000), has been shown to shuttle between the nucleolus and cytoplasm in mammalian 
cells (Meier and Blobel, 1992). Further investigation is required to determine the 
mechanism of nucleolar localisation.    
 
7.3. The SMN complex functions in the biogenesis of numerous RNPs 
 
One of the main aims of this study was to determine the role of the SMN complex in 
box C/D snoRNP biogenesis. The SMN complex has been linked to the biogenesis of 
numerous RNPs, including the snoRNPs (Pellizzoni et al, 2001; Jones et al, 2001), 
telomerase RNPs (Bachand et al, 2002) and miRNPs (Mourelatos et al, 2002); however, 
its function has been best defined in snRNP biogenesis (Yong et al, 2002, 2004; Chari et 
al, 2008). 
 
One of the functions of the SMN complex in snRNP biogenesis is facilitating the 
binding of the Sm protein core to the snRNAs (Chari et al, 2008). The SMN complex 
was first implicated in box C/D snoRNP biogenesis through the identification of an 
interaction between the SMN protein and fibrillarin, which was also shown in this study 
(Pellizzoni et al, 2001; Jones et al, 2001). Interestingly, in this study the SMN protein 
was also found to interact with the box C/D snoRNP assembly factors BCD1 and 
NUFIP, suggesting that SMN associates with the box C/D pre-snoRNP. Based on the 
interactions of SMN with fibrillarin and the pre-snoRNP it could be postulated that the 
SMN complex functions in the recruitment of fibrillarin to the box C/D pre-snoRNP. As 
fibrillarin and box C/D snoRNA are found enriched in Cajal bodies (Tollervey et al, 
1993; Narayanan et al, 1999) and SMN is found in both Cajal bodies and in Gems 
(which are sometimes associated with Cajal bodies) (Liu and Dreyfuss, 1996) it is 
tempting to propose that SMN functions in fibrillarin recruitment to the pre-snoRNP in 
these nuclear bodies. The assembly factors that SMN interacts with are, however, not 
enriched in Cajal bodies but found throughout the nucleoplasm, which indicates that 
they are associated only with nucleoplasmic pre-snoRNPs. Although the presence of the 
assembly factors in the Cajal bodies cannot be excluded it does indicate that if the SMN 
complex functions in the recruitment of fibrillarin to the box C/D pre-snoRNP then it 
does not occur in the Cajal bodies.  
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There are a number of issues with the proposal that SMN functions in the recruitment of 
fibrillarin with the box C/D pre-snoRNP or in other processes required for the 
association of fibrillarin with the box C/D snoRNA. For instance the siRNA mediated 
depletion of fibrillarin and SMN do not affect box C/D snoRNA localisation and levels 
in the same manner. This could, however, reflect a difference between the loss of 
fibrillarin and the lack of association with the box C/D snoRNP. Another issue with this 
proposal is that the deletion of the SMN interacting domain of fibrillarin (amino acids 
1-81) does not affect the localisation of fibrillarin. Further work is, however, required to 
determine whether in the absence of the SMN interacting domain fibrillarin can 
associate with the box C/D snoRNP (see future work).  
 
The SMN complex has also been proposed to function as a nuclear import factor 
(Narayanan et al, 2002, 2004). The snRNP nuclear import complex consists of the pre-
snRNP, SMN complex, Snurportin1 and importin β, and interestingly it has been shown 
that SMN can function in the nuclear import of pre-snRNPs independently of 
Snurportin1 (Narayanan et al, 2002, 2004). As some box C/D pre-snoRNPs, such as U8, 
U3 and U13 (Watkins et al, 2007), are found in the cytoplasm the SMN complex could 
function in their nuclear import (Figure 7.1). Also as the SMN complex localises to the 
Cajal bodies it could also function in the transport of box C/D pre-snoRNPs to this 
nuclear body (Figure 7.1). This proposal is supported by siRNA mediated depletion of 
components of the SMN complex, which results in the accumulation of box C/D 
snoRNA in the nucleoplasm and in some cases the cytoplasm.  
 
The SMN complex and Snurportin1 have been implicated in box C/D snoRNP 
biogenesis (Pellizzoni et al, 2001; Jones et al, 2001; Watkins et al, 2007) and are both 
found in pre-snRNP import complexes (Narayanan et al, 2004). In this study it was 
revealed that the SMN complex and Snurportin1 do not interact directly. This is in 
agreement with previous studies that have shown that the SMN complex and 
Snurportin1 are both associated with the pre-snRNP import complex through 
interactions with the snRNA (Narayanan et al, 2004). Interestingly, in this study 
Snurportin1 was shown to interact with the box C/D snoRNP common core protein 
NOP56 and the assembly factors TIP48 and TIP49, which may represent, in addition to 
the m3G cap of independently transcribed box C/D snoRNAs, how Snurportin1 interacts 
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with box C/D pre-snoRNPs. Further investigation is, however, required to determine if 
Snurportin1 interacts with other box C/D pre-snoRNPs and whether the m3G cap is 
required.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1: SMN could function as a transport factor in box C/D snoRNP 
biogenesis 
The box C/D snoRNA is represented as a black line with the 5’ m7G cap shown as an 
orange circle and the 3’ extended sequence as an orange box. The box C/D snoRNP 
core proteins are shown as a blue oval while the assembly, RNA processing and 
transport factors are represented by a brown oval. The SMN complex is represented as a 
green oval. The 5’ m3G cap of mature snoRNA is shown as a blue circle. Grey arrows 
show the progression of biogenesis. The nuclear membrane is represented by black 
outlined rectangles. Figure adapted from image provided by N.J.Watkins, Newcastle 
University, UK.  
 
 
This study strengthens the case that the SMN complex is involved in box C/D snoRNP 
biogenesis despite not being able to clearly identify its role. Based on the data presented 
the SMN complex, more than likely, functions in the transport of the box C/D snoRNPs 
rather than in the association of fibrillarin with the snoRNP (Figure 7.1). It is, however, 
necessary to establish de novo biogenesis assays before it can be concluded that the 
SMN complex is not involved in box C/D snoRNP protein assembly. The use of de 
novo biogenesis assays was essential for determining the role of the SMN complex in 
snRNP biogenesis (Shparagel and Matera, 2005) and therefore a variety of de novo 
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biogenesis assays were developed in this study; however, for a variety of reasons these 
were unsuccessful (see future work). 
 
Further analysis of the SMN complex is required, as the mutation of the gene encoding 
the SMN protein has been linked to the neurodegenerative disease SMA. While the 
genetics of this disease are well defined the molecular mechanisms that result in the 
specific degeneration of the motor neurons are not. A candidate process for SMA is the 
disruption of pre-mRNA splicing due to issues with snRNP biogenesis (Winkler et al 
2005; Shpargel and Matera, 2005; Zhang et al, 2008); however, the SMN complex has 
also been linked to the biogenesis of the box C/D and H/ACA snoRNPs (Pellizzoni et 
al, 200; Jones et al, 2001), telomerase RNPs (Bachand et al, 2002) and miRNPs 
(Mourelatos et al, 2002). This indicates that the SMN complex functions in the 
biogenesis of a range of small RNPs and therefore further investigation is required to 
determine whether the dysfunction of these processes also contribute to SMA 
pathology.      
 
7.4. Implications of study 
 
The characterisation of box C/D snoRNP biogenesis provides information that can be 
used as a basis for analysing other RNPs. For instance NUFIP and TIP48 have been 
implicated in box H/ACA snoRNP biogenesis; however, their function is not as well 
characterised as in box C/D snoRNP biogenesis (King et al, 2001; Boulon et al, 2008). 
Analysis of box C/D snoRNP biogenesis has shown that NUFIP and TIP48 associate 
with nucleoplasmic pre-snoRNPs and form an intricate network of interactions with the 
common core proteins (Watkins et al, 2004, 2007; McKeegan et al, 207). Furthermore, 
NUFIP has been shown to mediate the assembly of a partial box C/D snoRNP 
consisting of NOP56, 15.5K and snoRNA (McKeegan et al, 2007). It has therefore been 
proposed that NUFIP and TIP48 function in the recruitment and association of the 
common core proteins with the box C/D snoRNA (McKeegan et al, 2007). It is possible 
that NUFIP and TIP48 have similar functions in box H/ACA snoRNP biogenesis.  
 
The biogenesis of the box C/D snoRNPs and snRNPs share many similarities, for 
instance both utilise the same RNA processing (exosome), RNA modification (TGS1) 
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and transport factors (CRM1, PHAX, Snurportin1; Huber et al, 1998; Allmang et al, 
1999; Ohno et al, 2000; Verheggen et al, 2002; Boulon et al, 2004; Watkins et al, 2004, 
2007). The identification that the SMN complex functions in box C/D snoRNP 
biogenesis, in this study and others (Pellizzoni et al, 2001; Jones et al, 2001; Lemm et 
al, 2006), draws another parallel between the biogenesis of the box C/D snoRNPs and 
snRNPs. Furthermore, as the SMN protein also interacts with the box H/ACA snoRNP 
core protein GAR1 (Pellizzoni et al, 2001; Jones et al, 2001) it is possible that the SMN 
complex has a similar function in the biogenesis of both the box C/D and box H/ACA 
snoRNPs.   
 
The biogenesis of the box C/D snoRNPs, which only consist of five components 
(snoRNA and four common core proteins) and yet is a extremely complex process 
requiring numerous assembly, RNA processing and transport factors (for localisation to 
numerous cellular domains), serves as a paradigm for the biogenesis of larger RNPs 
such as the spliceosome and ribosome. For instance the box C/D snoRNP common core 
protein 15.5K is also a component of the U4 snRNP and is required for the formation of 
the U4/U6.U5 tri-snRNPs, which are the central components of the spliceosome. The 
incorporation of common core proteins in box C/D snoRNP biogenesis is a hierarchical 
process with the association of 15.5K to the C/D box of the snoRNA required for the 
subsequent binding of fibrillarin, NOP56 and NOP58 (Watkins et al, 2002). It has been 
proposed that the association of 15.5K with the snoRNA causes alterations in the RNA 
structure presenting additional binding sites (Watkins et al, 2002). The formation of the 
U4/U6.U5 tri-snRNP is also a hierarchical process, which is initiated by the association 
of 15.5K with the 5’ stem loop of the U4 snRNA, which results in the subsequent 
binding of hPRP31 and the formation of the U4/U6 di-snRNP (Nottrott et al, 1999, 
2002; Schaffert et al, 2004). The U5 snRNP is then incorporated to form the tri-snRNP 
through an interaction between the U5 snRNP hPRP6 (102K) and the U4 snRNP 
hPRP31 protein (Makarova et al, 2002). Therefore in both the formation of the 
spliceosome and box C/D snoRNPs 15.5K has a crucial role in their assembly, most 
likely through structural rearrangements of RNA.   
 
The analysis of the biogenesis of small RNPs also provides concepts and mechanisms 
that can be extrapolated to analyse the synthesis of the ribosome. For instance the 
human ribosomal proteins L7A (RPL7A) and L30 (RPL30) are members of the L7Ae 
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protein family, which includes the box C/D and H/ACA snoRNP core proteins 15.5K 
and NHP2, respectively (Koonin et al, 1994; Watkins et al, 2000). Therefore analysis of 
the association of 15.5K with the box C/D snoRNP could provide data on the 
mechanisms of ribosomal protein association.   
 
RNPs have been implicated in a variety of diseases, for instance the U50 box C/D 
snoRNP is a candidate tumour suppressor and mutation of the snoRNA sequence has 
been linked to prostate cancer (Dong et al, 2008). The box H/ACA snoRNPs and 
telomerase RNPs have been linked to the bone marrow failure syndrome dyskeratosis 
cogenital (Heiss et al, 1998). In addition the telomerase RNPs have been implicated in 
cancer, aging and cardiovascular disease (Oulton and Harrington, 2000). The snRNPs, 
which make up the spliceosome, have been linked to SMA (Eggert et al, 2006; Zhang et 
al, 2008) and retinitis pigmentosa (Vithana et al, 2001). Furthermore the biogenesis and 
function of the ribosome has also been implicated in diseases such as diamond-blackfan 
anemia (Flygare and Karlsson, 2006), Treacher-Collins syndrome (Trainor et al, 2009) 
and a variety of cancers (Dai and Lu, 2008) and is also a target of a number of antibiotics. 
Therefore the further investigation into the biogenesis and the function of RNPs is 
required to understand the molecular mechanisms of numerous human diseases.  
 
7.5. Future studies 
 
In this study the C terminal domain of fibrillarin was shown to be essential for the 
localisation of fibrillarin and for interactions with the box C/D snoRNP assembly 
factors. It was, however, not possible to determine whether the C terminal domain was 
required for the association of fibrillarin with the box C/D snoRNP due to issues with 
the transient transfection of the GFP tagged fibrillarin deletion mutants. An inducible 
HEK293 cell line that expresses FLAG tagged fibrillarin was developed in this study 
and numerous control experiments showed that FLAG-fibrillarin was expressed at 
levels comparable to endogenous fibrillarin, localised correctly and associated with box 
C/D snoRNPs (Chapter 3.2.6). Therefore to determine whether the C terminal domain 
of fibrillarin is essential for association with the box C/D snoRNPs inducible HEK293 
cell lines are being developed (by the lab) that express FLAG tagged fibrillarin deletion 
mutants. These inducible cell lines can also be used to determine whether the SMN 
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interacting domain of fibrillarin (amino acids 1-81) is required for association with the 
box C/D snoRNPs, providing further data on the role of SMN in box C/D snoRNP 
biogenesis. 
 
Despite strengthening the case that the SMN complex functions in box C/D snoRNP 
biogenesis further work is required to clarify its role. One issue that hindered the 
analysis of box C/D snoRNP biogenesis and the role of the SMN complex was the 
inability to produce de novo biogenesis assays. Inducible U3 and U14 box C/D snoRNA 
HEK293 cell lines were developed in this study; however, it was not possible to express 
either box C/D snoRNA at a high enough level to be comfortably detected (Chapter 
3.2.5). It may be possible to overcome the issue of low snoRNA expression by the 
incorporation of tandem repeats of the snoRNA sequence into these cell lines. The use 
of tandem repeats of snoRNA genes was used by Darzacq et al 2006 to produce an 
inducible cell line that expresses the E3 box H/ACA snoRNA at levels similar to 
endogenous E3. 
 
Inducible FLAG-SMN and FLAG-fibrillarin HEK293 cell lines were produced in this 
study and used to analyse the in vivo interactions of SMN with fibrillarin and the pre-
snoRNP. These cell lines were also developed to be used in experiments that utilised 
siRNA mediated depletion; however, it was not possible to efficiently deplete target 
proteins using siRNAs in these cell lines. The inability to specifically deplete proteins 
prevented the further use of these cell lines to analyse box C/D snoRNP biogenesis 
(Chapter 3.2.6). The targeted depletion of proteins in HEK293 cells has been performed 
in numerous studies (Lakkaraju et al, 2008); therefore, other methods of protein 
depletion are being investigated (by the lab) including the use of shRNA constructs.  
 
In this study Gemin5 was shown to be essential for the accumulation of box C/D 
snoRNA, which suggests that it is involved in box C/D snoRNP biogenesis. Gemin5 
does not interact with any of the box C/D snoRNP core proteins or assembly factors; 
however, Gemin5 has been shown to bind snRNAs (Battle et al 2006, 2007). Therefore, 
it is possible that Gemin5 interacts directly with box C/D snoRNA. Further 
investigations are therefore necessary to determine whether Gemin5 functions in box 
C/D snoRNP biogenesis by directly associating with the snoRNA.  
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The SMN complex is found in Cajal bodies (Liu and Dreyfuss, 1996), which are 
enriched in the scaRNPs (Jady and Kiss, 2001). As the SMN protein interacts with 
fibrillarin (Pellizzoni et al, 2001; Jones et al, 2001), which is a core protein of box C/D 
scaRNPs (Jady and Kiss, 2001), it may function in their biogenesis. Furthermore, as the 
scaRNPs function in the chemical modification of snRNA and the SMN complex 
associates with snRNPs it is possible that the SMN complex recruits scaRNPs to the 
snRNA. Further investigation is therefore required to determine whether the SMN 
complex is involved in the biogenesis and / or function of the scaRNPs. 
 
As SMA is caused by mutation of the SMN1 gene it would be interesting to determine 
whether in primary fibroblast cells derived from SMA patients’ box C/D snoRNP and 
ribosome biogenesis are affected. If the biogenesis of the box C/D snoRNPs and 
ribosome were affected in these cells it would provide another potential disease 
mechanism.  
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INVOLVEMENT OF THE SMN COMPLEX IN BOX C/D snoRNP BIOGENESIS 
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In the eukayotic nucleolus, the box C/D small nucleolar RNPs (snoRNPs) are essential 
for the processing and modification of the ribosomal RNA. Box C/D snoRNPs either 
direct 2’-O-methylation of the rRNA or function as RNA chaperones in pre-rRNA 
 252 
processing. We have demonstrated that box C/D snoRNP biogenesis is a highly 
complex and co-ordinated process that is mediated by a large, dynamic pre-snoRNP 
complex in the nucleoplasm
1
. This complex contains core box C/D proteins (15.5K, 
NOP56, NOP58, fibrillarin) and factors linked to assembly (TIP48, TIP49, NUFIP, 
NOP17, BCD1, TAF9), 3’ processing (La, LSm, and exosome) and nuclear transport 
(Snurportin1, PHAX, Ran and CRM1)
1,2,3
. SMN, the product of the gene linked to the 
neurodegenerative disorder spinal muscular atrophy, binds the core protein fibrillarin 
and has been linked to box C/D snoRNP biogenesis. However, this protein was not 
found in the pre-snoRNP complex
1
. Indeed, SMN and the associated gemin proteins 
have so far only been shown to be important for the assembly of spliceosomal snRNPs. 
 
We have investigated the potential role of SMN in box C/D snoRNP biogenesis. We 
show that SMN specifically interacts with the snoRNP assembly factors NUFIP and 
BCD1 in vitro. This suggests that the SMN complex interacts with the pre-snoRNP 
complex during the biogenesis process. Using RNAi, we found that the loss of either 
SMN or each of the individual gemin proteins did not significantly alter the levels of 
either the box C/D snoRNA or U1 snRNA in the cell. The exception was gemin5 which, 
when depleted, resulted in a decrease in the levels of the U3, U8 and U14 box C/D 
snoRNAs. The depletion of gemin5 also resulted in the reduction of U1 snRNA levels 
but had no effect on the amount of 7SL in the cell. Analysis of U3 and U8 snoRNA 
localisation in cells depleted of either SMN or the gemin proteins revealed that these 
factors are essential for correct localisation of the snoRNAs. Cells depleted of SMN or 
gemin proteins showed increased levels of the U3 and U8 snoRNAs in the nucleoplasm, 
the remnants of Cajal bodies and in some instances in the cytoplasm. We suggest that 
SMN, which likely functions through a transient interaction with the pre-snoRNP, is 
important for the efficient localisation of the snoRNP complexes. 
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